This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Abnormal findings on examination of urine, without diagnosis
R18_ABNORMAL_FINDI_EXAMI_URINE_WO_DIAGNOSIS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1794 |
4. Check minimum number of eventsNone |
1794 |
5. Include endpoints |
1794 |
6. Filter based on genotype QC (FinnGen only) |
1705 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R
- Name in latin
- Reperta abnormia inter examinationem urinae sine diagnosi
Similar endpoints
↥List of similar endpoints to
Abnormal findings on examination of urine, without diagnosis
based on the number of shared cases.
Similar with more cases:
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1705 | 768 | 937 |
| Unadjusted period prevalence (%) | 0.36 | 0.27 | 0.43 |
| Median age at first event (years) | 56.63 | 49.05 | 62.84 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1794
- Matched controls
- 17940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R82.7
ICD-10 Finland
Abnormal findings on microbiological examination of urine
174.0
307.7
201
13
R82.9
ICD-10 Finland
Other and unspecified abnormal findings in urine
167.3
307.7
167
11
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
42.3
307.7
286
80
R80
ICD-10 Finland
Isolated proteinuria
3226.7
307.7
1114
9
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
61.4
281.4
157
28
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
62.4
268.0
149
26
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
7.4
224.7
371
610
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
1161.2
215.1
206
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.8
179.6
191
179
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
12.1
178.7
187
171
R31
ICD-10 Finland
Unspecified haematuria
5.0
178.2
469
1179
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
70.0
170.7
93
14
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.1
165.9
323
619
KA1AE
NOMESCO Finland
Kidney ultrasound examination
10.0
161.5
193
213
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
18.2
151.7
124
73
A11CC03
ATC
alfacalcidol; systemic
9.9
140.8
169
187
UKC02
NOMESCO Finland
Cystoscopy
3.7
131.2
548
1897
N18.8
ICD-10 Finland
Other chronic renal failure
10.1
130.3
153
164
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
51.4
128.4
74
15
L04AA06
ATC
mycophenolic acid; systemic
11.5
126.7
135
126
TK800
NOMESCO Finland
Hemodialysis
9.9
123.7
147
160
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
60.3
114.4
64
11
Z94.0
ICD-10 Finland
Kidney transplant status
15.0
112.4
101
71
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
18.4
106.5
86
49
C03CA01
ATC
furosemide; systemic
2.9
104.8
782
3741
Z49.0
ICD-10 Finland
Preparatory care for dialysis
15.9
104.8
91
60
127
Kela drug reimbursment
Transplant complication
11.4
104.3
111
103
Z49.1
ICD-10 Finland
Extracorporeal dialysis
11.7
103.9
109
99
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
14.9
101.2
91
64
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
22.7
98.0
72
33
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
15.6
96.9
85
57
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
10.4
96.9
110
112
A12AA04
ATC
calcium carbonate; oral
9.6
90.7
109
120
B03XA02
ATC
darbepoetin alfa; parenteral
7.7
87.6
127
176
N18.0
ICD-10 Finland
End-stage renal disease
13.4
84.9
81
63
205
Kela drug reimbursment
Chronic hypertension
2.7
83.8
655
3135
L04AD02
ATC
tacrolimus; systemic
11.7
79.0
82
73
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
14.8
77.9
70
49
Z49.2
ICD-10 Finland
Other dialysis
15.2
74.4
66
45
C09AA02
ATC
enalapril; systemic
2.7
71.9
486
2136
V03AE01
ATC
polystyrene sulfonate; oral
9.7
71.1
84
90
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
70.1
383
1501
R81
ICD-10 Finland
Glycosuria
704.7
69.5
68
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
15.9
69.4
60
39
137
Kela drug reimbursment
Uraemia requiring dialysis
12.3
68.9
69
58
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.2
68.7
149
308
KBV00
NOMESCO Finland
Insertion of stent into ureter
15.2
66.7
59
40
C08CA01
ATC
amlodipine; oral
2.3
64.9
819
4762
M04AA01
ATC
allopurinol; systemic
2.9
63.9
364
1454
O12.1
ICD-10 Finland
Gestational proteinuria
23.6
63.7
46
20
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
15.7
63.3
55
36
B05DB
ATC
Hypertonic solutions
13.7
60.7
57
43
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.2
59.8
55
40
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
16.0
58.2
50
32
196
Kela drug reimbursment
Paricalcitol and cinacalcet
16.0
58.2
50
32
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
74.7
57.5
65
9
L04AD01
ATC
ciclosporin; systemic
7.7
57.1
81
109
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
9.2
56.9
70
79
B05DA
ATC
Isotonic solutions
12.0
56.9
58
50
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
56.2
346
1432
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
8.3
54.0
72
90
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
53.6
985
6500
I10
ICD-10 Finland
Essential (primary) hypertension
2.2
52.9
1169
8263
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
51.7
373
1665
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
9.2
51.3
63
71
C08CA13
ATC
lercanidipine; oral
2.6
51.0
344
1485
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
5.9
50.8
93
164
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
50.3
189
587
V03AE02
ATC
sevelamer; oral
16.5
49.6
42
26
N19
ICD-10 Finland
Unspecified kidney failure
4.3
49.0
133
329
U14
ICPC
Kidney symptom/complaint
6.7
48.3
78
121
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
8.8
46.6
59
69
V03AE03
ATC
lanthanum carbonate; oral
18.0
45.6
37
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
44.7
641
3783
C02AC05
ATC
moxonidine; oral
3.8
44.0
144
407
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
43.5
134
363
H05BX01
ATC
cinacalcet; oral
11.5
43.2
45
40
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
12.6
42.8
42
34
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
16.7
42.8
36
22
ZX120
NOMESCO Finland
Intravenous
2.8
42.5
231
888
H02AB06
ATC
prednisolone; systemic
2.0
42.5
924
6287
J01MA02
ATC
ciprofloxacin; systemic
2.0
42.2
777
4991
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
12.3
42.0
42
35
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
14.4
41.7
38
27
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
146.8
40.9
43
*
TK820
NOMESCO Finland
Peritoneal dialysis
13.8
40.9
38
28
UKB02
NOMESCO Finland
Retrograde ureteroscopy
8.6
40.5
52
62
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
16.5
40.1
34
21
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
39.1
132
381
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
38.8
483
2680
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
73.2
38.1
43
6
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
+∞
37.6
36
*
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
5.0
36.3
80
167
3025
Kela drug reimbursment
Calcium carbonate
10.8
35.8
39
37
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.2
35.6
153
514
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
68.1
35.1
40
6
L04AX01
ATC
azathioprine; systemic
3.7
34.6
116
333
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
10.2
34.6
39
39
KCD02
NOMESCO Finland
Transurethral resection of bladder
4.6
34.4
84
191
N30.0
ICD-10 Finland
Acute cystitis
2.2
33.9
344
1754
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
33.7
263
1201
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
33.2
128
402
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
64.6
33.1
38
6
R4190
NOMESCO Finland
Nutritional therapy
3.4
32.3
119
363
B01AB10
ATC
tinzaparin; parenteral
2.4
32.3
242
1083
J01EA01
ATC
trimethoprim; systemic
2.0
32.3
471
2741
A10BK01
ATC
dapagliflozin; oral
2.6
32.2
196
795
C10AA05
ATC
atorvastatin; oral
1.8
31.9
784
5385
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
37.2
31.6
40
11
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.3
30.8
80
191
R50.9
ICD-10 Finland
Fever, unspecified
2.1
29.2
340
1818
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.8
29.2
54
96
H02AB04
ATC
methylprednisolone; systemic
2.2
29.1
288
1447
321
Kela drug reimbursment
Paricalcitol and cinacalcet
8.9
29.0
36
41
A46
ICD-10 Finland
Erysipelas
2.1
29.0
314
1635
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
81.5
28.8
32
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
28.8
227
1037
M10.9
ICD-10 Finland
Gout, unspecified
2.6
28.8
181
745
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
44.5
28.7
35
8
C09CA01
ATC
losartan; oral
1.9
28.7
485
2947
Z3231
NOMESCO Finland
Registered nurse
1.8
28.5
533
3345
C10AA01
ATC
simvastatin; oral
1.7
27.7
751
5244
L04AA01
ATC
[U] ciclosporin
6.7
27.7
44
67
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
4.6
27.7
67
151
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
27.1
376
2135
RD210, ,
NOMESCO Finland
4.8
27.0
62
134
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
46.5
26.5
32
7
KH1AD
NOMESCO Finland
CT of urinary organs
3.4
26.5
98
300
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
26.5
478
2956
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
26.4
239
1156
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
26.2
269
1369
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
5.0
26.1
56
114
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.7
26.0
85
240
C09CA06
ATC
candesartan; oral
1.9
25.8
448
2734
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
25.5
518
3313
J01DB01
ATC
cefalexin; oral
2.0
25.5
1477
12643
E87.5
ICD-10 Finland
Hyperkalaemia
4.6
25.1
60
134
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
25.0
521
3354
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.7
24.6
136
524
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
24.2
532
3474
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
24.0
205
966
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
23.9
350
2016
C10AX09
ATC
ezetimibe; oral
1.9
23.9
332
1880
XKD00
NOMESCO Finland
Uroflowmetry
1.9
23.9
342
1956
ZX108
NOMESCO Finland
Inhalation
7.5
23.8
34
46
TK810
NOMESCO Finland
Hemofiltration
7.7
23.0
32
42
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
6.2
22.9
39
64
WW200
NOMESCO Finland
Immunization
3.7
22.8
73
203
M10.3
ICD-10 Finland
Gout due to impairment of renal function
9.4
22.7
27
29
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
22.4
455
2894
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.7
22.3
52
114
N06.1
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, focal and segmental glomerular lesions
+∞
21.9
21
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
21.8
229
1170
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
21.7
154
669
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
21.7
124
486
C07AB07
ATC
bisoprolol; oral
1.6
21.4
860
6515
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.4
21.4
42
79
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.3
21.2
31
43
J01MA12
ATC
levofloxacin; systemic
1.8
21.2
352
2104
R33
ICD-10 Finland
Retention of urine
2.2
21.1
187
894
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
6.4
21.0
35
56
JN4AD
NOMESCO Finland
Body CT examination
2.0
20.9
237
1246
C09AA05
ATC
ramipril; oral
1.7
20.8
466
3038
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
30.4
20.6
27
9
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
20.5
285
1607
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
4.4
20.0
50
116
3AC01, ,
NOMESCO Finland
6.2
19.9
34
56
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
19.6
135
578
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
19.5
87
298
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
19.4
287
1651
ZX136
NOMESCO Finland
Intravesicalis
6.8
19.2
30
45
N18
ICD-10 Finland
Chronic kidney disease
5.2
19.1
39
76
A10AB05
ATC
insulin aspart; parenteral
2.2
19.1
169
807
KBV10
NOMESCO Finland
Removal of stent from ureter
6.1
19.1
33
55
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
18.9
222
1181
TKA00
NOMESCO Finland
Needle biopsy of kidney or pelvis of kidney
+∞
18.8
18
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
18.7
222
1185
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.7
18.6
59
163
A02BC02
ATC
pantoprazole; systemic
1.6
18.6
1168
9687
S97
ICPC
Chronic ulcer skin
2.4
18.6
139
618
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
18.4
636
4603
C66
ICD-10 Finland
Malignant neoplasm of ureter
22.0
18.2
26
12
C02CA01
ATC
prazosin; oral
4.3
18.1
46
108
T90
ICPC
Diabetes non-insulin dependent
1.7
18.0
440
2921
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
5.9
17.9
32
55
SPAT1262
SPAT
Handing over of treatment supplies
1.8
17.7
316
1921
C08CA05
ATC
nifedipine; systemic
2.4
17.6
121
518
WZC30
NOMESCO Finland
Teaching
1.8
17.5
305
1842
J01FF01
ATC
clindamycin; systemic
1.6
17.4
470
3197
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
17.3
348
2188
A10BH05
ATC
linagliptin; oral
2.5
17.0
111
464
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
17.6
16.9
26
15
R60.0
ICD-10 Finland
Localized oedema
1.9
16.8
236
1331
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.5
16.8
59
175
J01CA08
ATC
pivmecillinam; oral
1.6
16.7
590
4269
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
16.6
79
281
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.8
16.6
82
298
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
16.5
16.6
26
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
16.5
180
930
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.6
16.4
55
158
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.7
16.4
38
83
R11
ICD-10 Finland
Nausea and vomiting
2.0
16.3
175
900
N02AX02
ATC
tramadol; systemic, rectal
1.5
16.1
732
5585
K65.0
ICD-10 Finland
Acute peritonitis
5.2
16.0
33
65
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
16.0
105
440
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.8
15.9
36
77
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
14.6
15.8
26
18
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
14.6
15.8
26
18
C08CA02
ATC
felodipine; oral
2.0
15.8
180
944
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
15.8
175
909
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
15.7
61
193
R82.3
ICD-10 Finland
Haemoglobinuria
+∞
15.6
15
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
15.6
132
618
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
15.6
218
1226
N30.2
ICD-10 Finland
Other chronic cystitis
6.3
15.5
26
42
N02BE01
ATC
paracetamol; systemic, rectal
1.8
15.5
1545
13956
WX202
NOMESCO Finland
Supraclavicular plexus blockade
4.1
15.5
42
104
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
28.9
15.2
20
7
I50.0
ICD-10 Finland
Congestive heart failure
2.1
15.2
150
747
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.9
15.0
43
111
B01AA03
ATC
warfarin; systemic
1.7
15.0
336
2169
SPAT1301
SPAT
No procedures
1.5
14.9
532
3841
C03AA03
ATC
hydrochlorothiazide; oral
2.0
14.7
161
833
C07AG02
ATC
carvedilol; oral
2.3
14.7
116
528
M10
ICD-10 Finland
Gout
2.5
14.6
96
403
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
14.5
424
2920
L01BA01
ATC
methotrexate; systemic
2.9
14.4
69
247
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
14.2
238
1414
M10.0
ICD-10 Finland
Idiopathic gout
2.6
14.1
81
318
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
14.0
322
2089
N20.0
ICD-10 Finland
Calculus of kidney
3.3
13.9
52
161
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.8
327
2138
SPAT1255
SPAT
Intravenous administration of medicine
2.1
13.7
128
623
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
13.7
88
365
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
13.7
107
485
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
13.6
87
360
XF602
NOMESCO Finland
Bloodpressure monitoring
4.5
13.6
33
75
U88
ICPC
Glomerulonephritis/nephrosis
34.3
13.5
17
5
A10AE04
ATC
insulin glargine; parenteral
1.9
13.4
186
1043
A10BH02
ATC
vildagliptin; oral
3.5
13.4
45
130
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
13.4
151
790
R06.0
ICD-10 Finland
Dyspnoea
1.5
13.3
476
3421
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
13.3
422
2955
ZXA00
NOMESCO Finland
Right side
1.6
13.2
426
2994
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.3
13.2
49
151
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
13.2
704
5491
R53
ICD-10 Finland
Malaise and fatigue
1.5
13.1
442
3134
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
13.1
61
215
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
13.1
237
1440
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
10.1
13.0
25
25
E85.9
ICD-10 Finland
Amyloidosis, unspecified
19.2
12.9
19
10
P01BA02
ATC
hydroxychloroquine; oral
2.1
12.9
132
666
XW000
NOMESCO Finland
Bone marrow biopsy
2.5
12.9
83
345
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
12.9
312
2047
C90.0
ICD-10 Finland
Multiple myeloma
4.4
12.9
32
74
U29
ICPC
Urinary symptom/complaint other
2.7
12.9
70
268
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
12.8
464
3343
N25.0
ICD-10 Finland
Renal osteodystrophy
14.1
12.8
21
15
C07AB02
ATC
metoprolol; systemic
1.6
12.7
332
2221
SPAT1263
SPAT
Sampling
1.5
12.6
687
5366
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
32.3
12.6
16
5
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
32.3
12.6
16
5
ZXD05
NOMESCO Finland
Urgent procedure
1.5
12.5
516
3815
N00.0
ICD-10 Finland
Acute nephritic syndrome, Minor glomerular abnormality
130.9
12.4
13
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
12.3
170
951
A10AC01
ATC
insulin (human); parenteral
2.0
12.2
143
758
U02
ICPC
Urinary frequency/urgency
1.7
12.2
242
1508
R60.1
ICD-10 Finland
Generalized oedema
6.1
12.1
21
35
E0000UV, ,
ATC
1.4
12.1
687
5394
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
26.9
12.0
16
6
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.3
12.0
24
46
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
13.5
11.9
20
15
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
11.9
87
383
C03DA01
ATC
spironolactone; oral
1.7
11.8
217
1323
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
11.8
371
2585
N05CF01
ATC
zopiclone; oral
1.5
11.7
508
3783
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
30.2
11.6
15
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
11.6
376
2637
L28
ICPC
Limited function/disability (L)
1.6
11.5
319
2157
B01AB05
ATC
enoxaparin; parenteral
1.5
11.5
503
3752
R82.4
ICD-10 Finland
Acetonuria
+∞
11.5
11
*
N06.2
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse membranous glomerulonephritis
+∞
11.5
11
*
A10BA02
ATC
metformin; oral
1.5
11.4
478
3533
212
Kela drug reimbursment
Gout
3.2
11.4
44
139
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
11.4
622
4836
B01AC04
ATC
clopidogrel; oral
1.6
11.4
291
1931
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.4
870
7182
Z2446
NOMESCO Finland
Social worker
2.0
11.3
123
634
B01AB04
ATC
dalteparin; parenteral
2.3
11.3
89
405
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
11.3
115
580
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
11.2
108
533
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.9
11.2
51
178
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.7
11.1
57
212
R4110
NOMESCO Finland
Physiotherapy
1.5
11.0
456
3362
RS222, ,
NOMESCO Finland
4.1
10.9
29
71
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
10.8
139
760
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
10.8
261
1708
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
8.9
10.8
22
25
RS221, ,
NOMESCO Finland
3.5
10.7
36
104
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
10.7
423
3084
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
28.2
10.7
14
5
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
17.9
10.7
16
9
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
10.7
117
605
D69.0
ICD-10 Finland
Allergic purpura
5.6
10.7
20
36
D07AC01
ATC
betamethasone; topical
1.4
10.7
588
4566
C09CA07
ATC
telmisartan; oral
2.0
10.7
121
634
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.3
10.7
77
338
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
60.4
10.6
12
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
10.5
494
3726
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.2
10.4
84
386
N00.2
ICD-10 Finland
Acute nephritic syndrome, Diffuse membranous glomerulonephritis
+∞
10.4
10
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.6
10.3
34
97
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.3
183
1103
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
3.2
10.3
39
122
SPAT1229
SPAT
Assessment of need for aid
1.9
10.3
124
664
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
18.9
10.3
15
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
10.2
99
490
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
10.2
109
559
J01MA06
ATC
norfloxacin; oral
1.7
10.2
193
1185
UJF32
NOMESCO Finland
Coloscopy
1.5
10.2
414
3034
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
10.1
231
1488
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
10.1
98
485
C09CA03
ATC
valsartan; oral
1.8
10.1
156
904
WX730
NOMESCO Finland
Conventional respirator
3.6
10.1
33
94
AA1AD
NOMESCO Finland
CT of head and brain
1.4
10.1
479
3616
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
5.0
10.1
21
42
WX892
NOMESCO Finland
Monitored bed care
1.8
9.9
140
788
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.9
267
1792
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
8.8
9.8
20
23
OAB50, ,
SPAT
1.8
9.8
143
815
U07
ICPC
Urine symptom/complaint other
1.8
9.8
143
815
J01MA14
ATC
moxifloxacin; systemic
1.8
9.7
152
883
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.9
9.7
44
153
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
9.7
204
1287
E66.8
ICD-10 Finland
Other obesity
2.1
9.7
89
432
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.2
9.6
25
60
KED22
NOMESCO Finland
Transurethral resection of prostate
1.9
9.6
116
621
SPAT1254
SPAT
Administration of medicine
1.6
9.6
244
1613
R04.0
ICD-10 Finland
Epistaxis
1.8
9.6
138
782
B03XA01
ATC
erythropoietin; parenteral
4.3
9.6
24
56
SPAT1260
SPAT
Consultation of another employee
1.6
9.6
278
1896
A02BC01
ATC
omeprazole; systemic
1.4
9.5
427
3182
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
9.5
124
681
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
9.1
9.5
19
21
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.7
9.5
177
1082
WX402
NOMESCO Finland
General anaesthesia
1.5
9.4
360
2601
N04.5
ICD-10 Finland
Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis
100.6
9.4
10
*
R82.0
ICD-10 Finland
Chyluria
+∞
9.4
9
*
N08.4
ICD-10 Finland
Glomerular disorders in other endocrine, nutritional and metabolic diseases
+∞
9.4
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
9.4
264
1788
C09AA03
ATC
lisinopril; oral
2.2
9.4
81
384
N02AA05
ATC
oxycodone; systemic
1.5
9.3
305
2134
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
9.3
154
910
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.9
9.3
42
146
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
4.7
9.3
21
45
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.0
9.3
93
467
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
9.2
79
373
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
9.2
91
454
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
9.2
141
816
H02AB07
ATC
prednisone; oral
1.6
9.1
214
1387
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
9.1
97
497
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
9.1
463
3528
KAC20
NOMESCO Finland
Nephroureterectomy
15.7
9.0
14
9
Z3226
NOMESCO Finland
Physiotherapist
1.5
9.0
293
2047
G47.3
ICD-10 Finland
Sleep apnoea
1.5
9.0
370
2712
C01DA14
ATC
isosorbide mononitrate; oral
1.5
8.9
261
1782
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
24.1
8.9
12
5
N32.0
ICD-10 Finland
Bladder-neck obstruction
4.4
8.9
22
51
TKC50
NOMESCO Finland
Training of urinary bladder
12.6
8.9
15
12
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.5
8.8
52
208
A10BK03
ATC
empagliflozin; oral
1.7
8.8
175
1087
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.8
685
5599
G04CA02
ATC
tamsulosin; oral
1.4
8.7
440
3346
N04.89
ICD-10 Finland
Nephrotic syndrome, other
50.2
8.7
10
*
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
50.2
8.7
10
*
J01CA04
ATC
amoxicillin; systemic
1.4
8.7
1379
12574
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
8.6
285
1998
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
3.6
8.6
27
75
M54.5
ICD-10 Finland
Low back pain
1.4
8.5
570
4539
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.5
154
933
RJ410, ,
NOMESCO Finland
9.0
8.5
17
19
TQW80
NOMESCO Finland
Local dermatologic skincare
2.6
8.5
49
194
B01AF02
ATC
apixaban; oral
1.6
8.5
222
1476
U70
ICPC
Pyelonephritis/pyelitis
3.4
8.5
30
90
N17.8
ICD-10 Finland
Other acute renal failure
3.3
8.5
31
95
T92
ICPC
Gout
2.7
8.5
45
171
N06.0
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, minor glomerular abnormality
27.6
8.5
11
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
4.3
8.4
21
49
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.7
8.4
20
30
R82.2
ICD-10 Finland
Biliuria
+∞
8.3
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
8.3
148
894
Z2221
NOMESCO Finland
Medical doctor
1.4
8.3
431
3290
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
8.3
116
653
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.8
8.3
40
145
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
8.2
59
259
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
8.2
396
2982
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.5
8.2
49
198
WX702
NOMESCO Finland
Supraglottic ventilation device
2.0
8.2
92
482
A06AD11
ATC
lactulose; oral
1.5
8.1
235
1601
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
8.1
507
3991
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
17.2
8.1
12
7
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.2
8.0
21
51
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
8.0
111
624
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
7.9
440
3395
RJ190, ,
NOMESCO Finland
13.1
7.9
13
10
L04AX03
ATC
methotrexate; systemic
1.7
7.8
148
909
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
7.8
100
548
A28
ICPC
Limited function/disability NOS
1.5
7.7
286
2049
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.0
7.7
83
429
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
3.7
7.6
23
62
R55
ICD-10 Finland
Syncope and collapse
1.6
7.6
182
1185
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.6
293
2114
KA3GB
NOMESCO Finland
Retrograde pyelography
18.4
7.6
11
6
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.1
7.6
16
20
R35
ICD-10 Finland
Polyuria
1.8
7.6
120
701
E85.89
ICD-10 Finland
Other amyloidosis
25.1
7.6
10
*
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.8
7.6
103
575
TGC00
NOMESCO Finland
Bronchial lavation
2.4
7.5
48
200
N03AX16
ATC
[U] pregabalin
1.4
7.5
339
2518
M79.6
ICD-10 Finland
Pain in limb
1.3
7.5
683
5675
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
7.5
681
5656
A10BJ06
ATC
semaglutide; parenteral
1.9
7.4
88
469
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.9
7.4
33
114
A07AA09
ATC
vancomycin; oral
3.1
7.4
30
98
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.9
7.4
21
54
N00.3
ICD-10 Finland
Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis
80.4
7.4
8
*
KCB00
NOMESCO Finland
Biopsy of bladder
7.7
7.4
16
21
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
7.7
7.4
16
21
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.4
371
2809
WX002
NOMESCO Finland
Sedation and analgesia
1.4
7.4
299
2178
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
7.4
208
1408
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
4.0
7.3
20
50
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
7.3
452
3539
C07FB02
ATC
metoprolol and felodipine; systemic
2.4
7.3
49
209
R82.5
ICD-10 Finland
Elevated urine levels of drugs, medicaments and biological substances
+∞
7.3
7
*
R82.1
ICD-10 Finland
Myoglobinuria
+∞
7.3
7
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
7.3
54
241
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
9.4
7.3
14
15
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
15.8
7.2
11
7
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
7.2
58
268
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
7.2
159
1017
KBD00
NOMESCO Finland
Partial excision of ureter
30.1
7.1
9
*
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
30.1
7.1
9
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.1
7.1
63
302
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.6
7.1
157
1002
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
20.1
7.1
10
5
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
7.1
68
336
G04BD07
ATC
tolterodine; oral
2.0
7.1
73
371
A10AE05
ATC
insulin detemir; parenteral
1.9
7.1
91
499
Z71.8
ICD-10 Finland
Other specified counselling
1.3
7.1
537
4338
I15.0
ICD-10 Finland
Renovascular hypertension
6.0
7.1
18
30
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.6
7.1
38
146
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
3.1
7.1
29
96
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.9
7.0
82
436
153
Kela drug reimbursment
Lenalidomid
4.4
7.0
17
39
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.4
7.0
17
39
L04AX04
ATC
lenalidomide; oral
4.4
7.0
17
39
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
7.0
54
246
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
6.9
51
227
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
6.9
246
1746
R03AC02
ATC
salbutamol; inhalant
1.3
6.9
869
7522
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
6.9
124
751
XCK00
NOMESCO Finland
Perimetry
1.9
6.9
90
496
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.3
6.9
52
234
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.8
6.9
101
577
E66.9
ICD-10 Finland
Obesity, unspecified
2.1
6.9
61
293
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
6.9
61
293
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
13.8
6.9
11
8
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
13.8
6.9
11
8
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
13.8
6.9
11
8
C10AA03
ATC
pravastatin; oral
1.7
6.9
114
675
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
6.9
117
698
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.3
6.9
48
209
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
8.3
6.8
14
17
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
6.7
6.8
16
24
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
11.0
6.8
12
11
306
Kela drug reimbursment
Erythropoietin and darbepoetin
9.3
6.8
13
14
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.5
6.8
40
161
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.8
491
3935
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.1
6.8
17
28
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.4
6.8
46
198
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.8
628
5215
N06.8
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, other
40.2
6.8
8
*
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
40.2
6.8
8
*
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
16.8
6.7
10
6
S18
ICPC
Laceration/cut
1.3
6.7
756
6439
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
6.7
196
1335
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.6
6.7
37
144
KH1DD
NOMESCO Finland
CT urography of urinary organs
7.2
6.7
15
21
RJ421, ,
NOMESCO Finland
7.2
6.7
15
21
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.7
585
4816
O12.2
ICD-10 Finland
Gestational oedema with proteinuria
22.6
6.7
9
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
22.6
6.7
9
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
6.6
200
1372
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
6.6
390
3026
W84
ICPC
Pregnancy high risk
2.2
6.6
51
232
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
6.6
118
714
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
3.4
6.6
23
69
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.6
340
2584
J01XE01
ATC
nitrofurantoin; oral
3.0
6.5
28
95
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
6.5
477
3824
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
6.9
6.5
15
22
R42
ICD-10 Finland
Dizziness and giddiness
1.4
6.5
349
2667
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
6.5
100
581
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.6
6.5
36
141
WX610
NOMESCO Finland
Patient controlled analgesia
3.9
6.4
18
46
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
70.1
6.4
7
*
R30.0
ICD-10 Finland
Dysuria
1.9
6.4
73
385
RS220, ,
NOMESCO Finland
3.0
6.4
27
91
ZXA05
NOMESCO Finland
Left side
1.4
6.4
357
2747
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
6.3
156
1024
KA3EB
NOMESCO Finland
Antegrade pyelography
6.0
6.3
16
27
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
6.0
6.3
16
27
KCC10
NOMESCO Finland
Cystoprostatectomy
5.5
6.3
17
31
N03AX12
ATC
[U] gabapentin; oral
1.5
6.3
237
1701
E86
ICD-10 Finland
Volume depletion
2.3
6.3
46
205
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.4
6.3
42
180
N06.3
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis
+∞
6.3
6
*
N08.2*D89.1
ICD-10 Finland
Glomerular disorders in cryoglobulinaemia
+∞
6.3
6
*
D638, N189,
ICD-10 Finland
26.8
6.2
8
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.6
6.2
34
132
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
7.0
6.2
14
20
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
6.2
165
1102
C09BA02
ATC
enalapril and diuretics; systemic
1.7
6.2
120
743
O14.1
ICD-10 Finland
Severe pre-eclampsia
4.0
6.2
17
43
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.0
6.2
17
43
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.9
6.1
71
377
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
7.7
6.1
13
17
L17
ICPC
Foot/toe symptom/complaint
1.3
6.1
472
3810
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.8
6.1
18
48
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
6.1
126
793
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
12.6
6.1
10
8
C08DB01
ATC
diltiazem; oral
1.8
6.1
79
436
SPAT1312
SPAT
General health counselling
1.3
6.0
479
3879
R03AC03
ATC
terbutaline; inhalant
1.5
6.0
197
1374
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
6.7
6.0
14
21
M05BX04
ATC
denosumab; parenteral
1.8
6.0
85
481
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
6.0
293
2202
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Nephrology
39 [38004479]
39 [38004479]
1.6e+00
2.7e+00
2.9e+00
—
4.5e+00
4.6e+00
3.8e+00
cases:3.39%
controls:0.68%
cases:7.18%
controls:0.53%
cases:3.50%
controls:0.21%
—
—
cases:17.31%
controls:0.23%
cases:37.12%
controls:0.60%
cases:30.64%
controls:0.95%
60
120
1710
17550
127
94
1643
17576
62
37
1708
17633
—
306
41
1462
17599
634
103
1074
17088
452
144
1023
14996
Unspecified haematuria
R31 [45553726]
R31 [45553726]
1.5e+00
3.2e+00
4.0e+00
1.0e+50
4.4e+00
3.1e+00
1.6e+00
cases:4.46%
controls:1.02%
cases:8.19%
controls:0.38%
cases:2.43%
controls:0.05%
cases:7.34%
controls:0.00%
cases:3.56%
controls:0.05%
cases:7.32%
controls:0.37%
cases:6.17%
controls:1.28%
79
180
1691
17490
145
67
1625
17603
43
8
1727
17662
130
0
1640
17670
63
8
1705
17632
125
63
1583
17128
91
194
1384
14946
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
6.9e-01
1.6e+00
3.7e+00
4.7e+00
3.0e+00
2.0e+00
1.3e+00
cases:10.56%
controls:5.61%
cases:13.45%
controls:2.95%
cases:15.25%
controls:0.45%
cases:4.35%
controls:0.04%
cases:7.47%
controls:0.41%
cases:17.97%
controls:2.90%
cases:26.03%
controls:8.90%
187
991
1583
16679
238
522
1532
17148
270
79
1500
17591
77
7
1693
17663
132
72
1636
17568
307
498
1401
16693
384
1347
1091
13793
Urology
34 [38004474]
34 [38004474]
8.0e-01
1.5e+00
2.4e+00
6.4e+00
2.6e+00
1.9e+00
9.0e-01
cases:13.22%
controls:6.39%
cases:13.45%
controls:3.38%
cases:6.44%
controls:0.62%
cases:15.08%
controls:0.03%
cases:7.69%
controls:0.61%
cases:18.85%
controls:3.45%
cases:18.31%
controls:8.38%
234
1129
1536
16541
238
598
1532
17072
114
109
1656
17561
267
5
1503
17665
136
107
1632
17533
322
593
1386
16598
270
1269
1205
13871
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.3e-01
1.5e+00
3.4e+00
5.1e+00
2.8e+00
1.7e+00
1.0e+00
cases:8.64%
controls:5.27%
cases:12.54%
controls:3.09%
cases:11.47%
controls:0.44%
cases:4.29%
controls:0.03%
cases:6.17%
controls:0.41%
cases:15.05%
controls:3.11%
cases:22.10%
controls:9.12%
153
932
1617
16738
222
546
1548
17124
203
77
1567
17593
76
5
1694
17665
109
72
1659
17568
257
535
1451
16656
326
1381
1149
13759
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
1.3e+00
2.4e+00
3.8e+00
—
3.9e+00
2.6e+00
1.8e+00
cases:1.19%
controls:0.34%
cases:1.53%
controls:0.14%
cases:1.81%
controls:0.04%
—
—
cases:1.70%
controls:0.03%
cases:2.87%
controls:0.22%
cases:3.46%
controls:0.57%
21
60
1749
17610
27
25
1743
17645
32
7
1738
17663
—
30
6
1738
17634
49
38
1659
17153
51
86
1424
15054
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
1.3e+00
2.4e+00
3.8e+00
—
3.9e+00
2.6e+00
1.8e+00
cases:1.19%
controls:0.34%
cases:1.47%
controls:0.14%
cases:1.81%
controls:0.04%
—
—
cases:1.70%
controls:0.03%
cases:2.87%
controls:0.22%
cases:3.39%
controls:0.57%
21
60
1749
17610
26
25
1744
17645
32
7
1738
17663
—
30
6
1738
17634
49
38
1659
17153
50
86
1425
15054
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
8.5e-01
2.0e+00
4.2e+00
1.0e+50
3.5e+00
2.9e+00
2.1e+00
cases:1.19%
controls:0.51%
cases:1.69%
controls:0.24%
cases:2.66%
controls:0.04%
cases:0.34%
controls:0.00%
cases:1.70%
controls:0.05%
cases:3.75%
controls:0.22%
cases:4.81%
controls:0.62%
21
90
1749
17580
30
42
1740
17628
47
7
1723
17663
6
0
1764
17670
30
9
1738
17631
64
37
1644
17154
71
94
1404
15046
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
33863-2 [3030366]
1.2e+00
2.2e+00
3.7e+00
—
3.4e+00
2.6e+00
2.0e+00
cases:1.24%
controls:0.37%
cases:2.03%
controls:0.24%
cases:2.03%
controls:0.05%
—
—
cases:1.19%
controls:0.04%
cases:2.69%
controls:0.20%
cases:4.47%
controls:0.61%
22
65
1748
17605
36
42
1734
17628
36
9
1734
17661
—
21
7
1747
17633
46
34
1662
17157
66
93
1409
15047
Cytology report of Urine Cyto stain
47525-1 [3049717]
47525-1 [3049717]
1.4e+00
2.6e+00
3.9e+00
—
3.6e+00
2.1e+00
1.5e+00
cases:2.09%
controls:0.51%
cases:3.56%
controls:0.27%
cases:2.09%
controls:0.05%
—
—
cases:1.02%
controls:0.03%
cases:2.40%
controls:0.29%
cases:3.53%
controls:0.83%
37
90
1733
17580
63
47
1707
17623
37
8
1733
17662
—
18
5
1750
17635
41
50
1667
17141
52
126
1423
15014
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
5.6e-01
1.4e+00
3.1e+00
5.0e+00
2.2e+00
1.4e+00
7.5e-01
cases:12.26%
controls:7.36%
cases:15.03%
controls:4.34%
cases:12.15%
controls:0.59%
cases:4.97%
controls:0.03%
cases:5.71%
controls:0.65%
cases:17.21%
controls:4.75%
cases:25.42%
controls:13.91%
217
1301
1553
16369
266
766
1504
16904
215
105
1555
17565
88
6
1682
17664
101
115
1667
17525
294
816
1414
16375
375
2106
1100
13034
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
5.6e-01
1.4e+00
3.1e+00
5.0e+00
2.2e+00
1.4e+00
7.5e-01
cases:12.49%
controls:7.56%
cases:15.03%
controls:4.36%
cases:12.32%
controls:0.61%
cases:4.97%
controls:0.03%
cases:5.77%
controls:0.66%
cases:17.15%
controls:4.80%
cases:25.90%
controls:14.16%
221
1335
1549
16335
266
771
1504
16899
218
107
1552
17563
88
6
1682
17664
102
117
1666
17523
293
825
1415
16366
382
2144
1093
12996
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
7.3e-01
2.2e+00
4.6e+00
—
3.5e+00
2.0e+00
1.4e+00
cases:1.75%
controls:0.85%
cases:3.33%
controls:0.37%
cases:4.35%
controls:0.05%
—
—
cases:1.98%
controls:0.06%
cases:2.93%
controls:0.41%
cases:4.61%
controls:1.21%
31
150
1739
17520
59
65
1711
17605
77
8
1693
17662
—
35
11
1733
17629
50
70
1658
17121
68
183
1407
14957
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
5.3e-01
1.3e+00
3.1e+00
5.0e+00
2.2e+00
1.4e+00
7.4e-01
cases:12.54%
controls:7.75%
cases:15.14%
controls:4.44%
cases:12.49%
controls:0.61%
cases:4.97%
controls:0.03%
cases:5.83%
controls:0.69%
cases:17.27%
controls:4.86%
cases:25.83%
controls:14.23%
222
1370
1548
16300
268
785
1502
16885
221
108
1549
17562
88
6
1682
17664
103
121
1665
17519
295
836
1413
16355
381
2154
1094
12986
Malignant neoplasm: Overlapping lesion of bladder
C67.8 [45532924]
C67.8 [45532924]
1.8e+00
2.0e+00
2.3e+00
—
3.1e+00
2.8e+00
2.3e+00
cases:1.47%
controls:0.24%
cases:1.36%
controls:0.18%
cases:0.45%
controls:0.05%
—
—
cases:0.96%
controls:0.05%
cases:3.10%
controls:0.20%
cases:3.46%
controls:0.34%
26
42
1744
17628
24
32
1746
17638
8
8
1762
17662
—
17
8
1751
17632
53
34
1655
17157
51
52
1424
15088
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
4.1e-01
1.3e+00
2.9e+00
4.9e+00
2.4e+00
1.3e+00
8.2e-01
cases:17.34%
controls:12.21%
cases:19.89%
controls:6.63%
cases:15.54%
controls:0.97%
cases:4.58%
controls:0.03%
cases:8.94%
controls:0.91%
cases:20.73%
controls:6.70%
cases:33.42%
controls:18.12%
307
2157
1463
15513
352
1172
1418
16498
275
172
1495
17498
81
6
1689
17664
158
161
1610
17479
354
1151
1354
16040
493
2744
982
12396
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
32551-4 [3017817]
1.9e+00
4.0e+00
—
—
—
4.3e+00
3.7e+00
cases:0.68%
controls:0.10%
cases:2.77%
controls:0.05%
—
—
—
—
—
—
cases:3.92%
controls:0.06%
cases:6.10%
controls:0.17%
12
18
1758
17652
49
9
1721
17661
—
—
—
67
10
1641
17181
90
25
1385
15115
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
1.0e+00
1.7e+00
3.7e+00
1.0e+50
2.7e+00
2.6e+00
2.2e+00
cases:3.33%
controls:1.21%
cases:3.90%
controls:0.75%
cases:6.78%
controls:0.18%
cases:0.40%
controls:0.00%
cases:2.77%
controls:0.20%
cases:9.66%
controls:0.79%
cases:13.97%
controls:1.84%
59
213
1711
17457
69
132
1701
17538
120
32
1650
17638
7
0
1763
17670
49
35
1719
17605
165
136
1543
17055
206
279
1269
14861
Internal Medicine
11 [38004456]
11 [38004456]
5.1e-01
1.0e+00
1.6e+00
5.8e+00
2.2e+00
1.4e+00
9.3e-01
cases:32.15%
controls:22.12%
cases:22.54%
controls:9.33%
cases:7.97%
controls:1.66%
cases:22.32%
controls:0.08%
cases:12.78%
controls:1.67%
cases:30.15%
controls:9.30%
cases:41.76%
controls:22.03%
569
3908
1201
13762
399
1648
1371
16022
141
293
1629
17377
395
15
1375
17655
226
295
1542
17345
515
1599
1193
15592
616
3336
859
11804
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
4.3e-01
1.2e+00
2.7e+00
4.9e+00
2.3e+00
1.3e+00
7.2e-01
cases:17.01%
controls:11.76%
cases:18.70%
controls:6.30%
cases:12.49%
controls:0.98%
cases:6.27%
controls:0.05%
cases:8.77%
controls:0.94%
cases:19.50%
controls:6.21%
cases:30.44%
controls:17.58%
301
2078
1469
15592
331
1114
1439
16556
221
174
1549
17496
111
9
1659
17661
155
166
1613
17474
333
1068
1375
16123
449
2662
1026
12478
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
9.4e-01
2.0e+00
2.4e+00
—
3.2e+00
2.6e+00
2.2e+00
cases:1.53%
controls:0.60%
cases:2.71%
controls:0.37%
cases:1.19%
controls:0.11%
—
—
cases:2.15%
controls:0.09%
cases:5.91%
controls:0.44%
cases:9.08%
controls:1.08%
27
106
1743
17564
48
66
1722
17604
21
20
1749
17650
—
38
15
1730
17625
101
76
1607
17115
134
164
1341
14976
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
51484-4 [3030981]
9.1e-01
1.9e+00
4.1e+00
1.0e+50
3.1e+00
2.3e+00
1.2e+00
cases:1.98%
controls:0.80%
cases:3.28%
controls:0.52%
cases:3.05%
controls:0.05%
cases:1.41%
controls:0.00%
cases:1.81%
controls:0.09%
cases:5.21%
controls:0.57%
cases:6.85%
controls:2.21%
35
142
1735
17528
58
92
1712
17578
54
9
1716
17661
25
0
1745
17670
32
15
1736
17625
89
98
1619
17093
101
335
1374
14805
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
8.0e-01
2.1e+00
4.1e+00
—
3.2e+00
1.9e+00
1.3e+00
cases:2.09%
controls:0.95%
cases:3.39%
controls:0.43%
cases:4.29%
controls:0.07%
—
—
cases:1.98%
controls:0.08%
cases:3.10%
controls:0.49%
cases:5.56%
controls:1.59%
37
168
1733
17502
60
76
1710
17594
76
13
1694
17657
—
35
14
1733
17626
53
84
1655
17107
82
241
1393
14899
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
8.4e-01
1.6e+00
3.8e+00
—
2.5e+00
2.5e+00
2.0e+00
cases:3.90%
controls:1.73%
cases:5.37%
controls:1.14%
cases:8.25%
controls:0.20%
—
—
cases:3.11%
controls:0.26%
cases:11.53%
controls:1.08%
cases:17.08%
controls:2.66%
69
305
1701
17365
95
202
1675
17468
146
36
1624
17634
—
55
46
1713
17594
197
185
1511
17006
252
402
1223
14738
Cystoscopy
UKC02 [2001306005]
UKC02 [2001306005]
1.2e+00
2.3e+00
3.0e+00
1.0e+50
2.8e+00
2.5e+00
1.4e+00
cases:6.89%
controls:2.16%
cases:7.23%
controls:0.79%
cases:1.58%
controls:0.08%
cases:7.51%
controls:0.00%
cases:1.36%
controls:0.09%
cases:8.84%
controls:0.81%
cases:9.90%
controls:2.65%
122
382
1648
17288
128
139
1642
17531
28
14
1742
17656
133
0
1637
17670
24
15
1744
17625
151
139
1557
17052
146
401
1329
14739
Inpatient Hospital
21 [8717]
21 [8717]
4.5e-01
9.1e-01
1.3e+00
6.1e+00
2.2e+00
1.3e+00
6.8e-01
cases:44.01%
controls:33.35%
cases:24.41%
controls:11.46%
cases:6.89%
controls:2.02%
cases:19.21%
controls:0.05%
cases:12.95%
controls:1.57%
cases:31.38%
controls:11.00%
cases:42.44%
controls:27.19%
779
5893
991
11777
432
2025
1338
15645
122
357
1648
17313
340
9
1430
17661
229
277
1539
17363
536
1891
1172
15300
626
4117
849
11023
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
57778-3 [40760888]
1.3e+00
2.6e+00
—
—
3.7e+00
2.6e+00
2.1e+00
cases:1.07%
controls:0.29%
cases:1.24%
controls:0.09%
—
—
—
—
cases:1.19%
controls:0.03%
cases:2.05%
controls:0.15%
cases:2.78%
controls:0.34%
19
52
1751
17618
22
16
1748
17654
—
—
21
5
1747
17635
35
26
1673
17165
41
51
1434
15089
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
9.9e-01
1.4e+00
3.7e+00
—
2.1e+00
2.3e+00
1.9e+00
cases:2.20%
controls:0.83%
cases:2.54%
controls:0.62%
cases:3.45%
controls:0.09%
—
—
cases:1.02%
controls:0.13%
cases:5.27%
controls:0.54%
cases:9.08%
controls:1.45%
39
146
1731
17524
45
110
1725
17560
61
16
1709
17654
—
18
23
1750
17617
90
92
1618
17099
134
220
1341
14920
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
1.2e+00
2.3e+00
—
—
3.9e+00
3.0e+00
1.7e+00
cases:1.07%
controls:0.31%
cases:1.47%
controls:0.15%
—
—
—
—
cases:1.41%
controls:0.03%
cases:2.11%
controls:0.11%
cases:2.58%
controls:0.47%
19
55
1751
17615
26
26
1744
17644
—
—
25
5
1743
17635
36
19
1672
17172
38
71
1437
15069
Cystoscopy and bladder biopsy
UKC05 [2001306006]
UKC05 [2001306006]
2.2e+00
2.7e+00
—
1.0e+50
—
3.3e+00
3.9e+00
cases:0.68%
controls:0.07%
cases:0.51%
controls:0.03%
—
—
cases:0.45%
controls:0.00%
—
—
cases:1.11%
controls:0.04%
cases:1.56%
controls:0.03%
12
13
1758
17657
9
6
1761
17664
—
8
0
1762
17670
—
19
7
1689
17184
23
5
1452
15135
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
8.4e-01
2.3e+00
3.7e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:0.90%
controls:0.39%
cases:1.86%
controls:0.19%
cases:1.81%
controls:0.05%
—
—
cases:0.57%
controls:0.03%
cases:1.41%
controls:0.23%
cases:2.78%
controls:0.69%
16
69
1754
17601
33
33
1737
17637
32
8
1738
17662
—
10
6
1758
17634
24
39
1684
17152
41
105
1434
15035
Outpatient Visit
OP [9202]
OP [9202]
4.8e-01
8.0e-01
1.1e+00
5.3e+00
1.6e+00
1.6e+00
1.1e+00
cases:77.74%
controls:68.28%
cases:66.95%
controls:47.67%
cases:25.65%
controls:10.74%
cases:51.81%
controls:0.51%
cases:36.93%
controls:10.49%
cases:82.20%
controls:47.07%
cases:90.64%
controls:76.31%
1376
12065
394
5605
1185
8423
585
9247
454
1898
1316
15772
917
90
853
17580
653
1850
1115
15790
1404
8092
304
9099
1337
11553
138
3587
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
7.3e-01
2.2e+00
3.7e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:0.90%
controls:0.44%
cases:1.92%
controls:0.21%
cases:1.81%
controls:0.05%
—
—
cases:0.57%
controls:0.03%
cases:1.46%
controls:0.26%
cases:2.85%
controls:0.74%
16
77
1754
17593
34
37
1736
17633
32
8
1738
17662
—
10
6
1758
17634
25
44
1683
17147
42
112
1433
15028
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
7.3e-01
2.2e+00
3.7e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:0.90%
controls:0.44%
cases:1.92%
controls:0.21%
cases:1.81%
controls:0.05%
—
—
cases:0.57%
controls:0.03%
cases:1.46%
controls:0.26%
cases:2.85%
controls:0.74%
16
77
1754
17593
34
37
1736
17633
32
8
1738
17662
—
10
6
1758
17634
25
44
1683
17147
42
112
1433
15028
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
7.3e-01
2.2e+00
3.7e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:0.90%
controls:0.44%
cases:1.92%
controls:0.21%
cases:1.81%
controls:0.05%
—
—
cases:0.57%
controls:0.03%
cases:1.46%
controls:0.26%
cases:2.85%
controls:0.74%
16
77
1754
17593
34
37
1736
17633
32
8
1738
17662
—
10
6
1758
17634
25
44
1683
17147
42
112
1433
15028
Outpatient Hospital
22 [8756]
22 [8756]
4.0e-01
8.3e-01
1.1e+00
5.4e+00
2.1e+00
1.3e+00
7.1e-01
cases:33.62%
controls:25.30%
cases:16.21%
controls:7.75%
cases:3.62%
controls:1.26%
cases:8.36%
controls:0.04%
cases:7.01%
controls:0.88%
cases:21.19%
controls:7.02%
cases:34.17%
controls:20.32%
595
4471
1175
13199
287
1369
1483
16301
64
222
1706
17448
148
7
1622
17663
124
156
1644
17484
362
1207
1346
15984
504
3076
971
12064
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
5.0e-01
8.4e-01
1.2e+00
5.3e+00
2.0e+00
1.2e+00
7.6e-01
cases:24.12%
controls:16.12%
cases:16.89%
controls:8.06%
cases:4.41%
controls:1.35%
cases:12.43%
controls:0.07%
cases:8.43%
controls:1.24%
cases:23.42%
controls:8.64%
cases:35.19%
controls:20.25%
427
2849
1343
14821
299
1425
1471
16245
78
239
1692
17431
220
12
1550
17658
149
218
1619
17422
400
1486
1308
15705
519
3066
956
12074
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
15189-4 [3007778]
1.3e+00
2.4e+00
3.6e+00
—
—
2.6e+00
1.9e+00
cases:1.19%
controls:0.33%
cases:1.41%
controls:0.13%
cases:1.47%
controls:0.04%
—
—
—
—
cases:2.63%
controls:0.20%
cases:3.19%
controls:0.51%
21
59
1749
17611
25
23
1745
17647
26
7
1744
17663
—
—
45
35
1663
17156
47
77
1428
15063
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
8.4e-01
1.5e+00
3.3e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:1.58%
controls:0.69%
cases:1.64%
controls:0.36%
cases:0.79%
controls:0.03%
—
—
cases:0.57%
controls:0.03%
cases:2.05%
controls:0.35%
cases:3.19%
controls:0.79%
28
122
1742
17548
29
63
1741
17607
14
5
1756
17665
—
10
6
1758
17634
35
61
1673
17130
47
120
1428
15020
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
6.1e-01
2.2e+00
3.7e+00
—
2.8e+00
1.7e+00
1.4e+00
cases:0.73%
controls:0.40%
cases:1.75%
controls:0.20%
cases:1.30%
controls:0.03%
—
—
cases:0.45%
controls:0.03%
cases:1.29%
controls:0.24%
cases:2.24%
controls:0.57%
13
71
1757
17599
31
35
1739
17635
23
6
1747
17664
—
8
5
1760
17635
22
41
1686
17150
33
86
1442
15054
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
6.2e-01
1.6e+00
3.4e+00
1.0e+50
3.0e+00
1.8e+00
1.1e+00
cases:6.16%
controls:3.40%
cases:6.84%
controls:1.49%
cases:6.10%
controls:0.21%
cases:3.73%
controls:0.00%
cases:3.34%
controls:0.18%
cases:7.90%
controls:1.38%
cases:12.27%
controls:4.25%
109
600
1661
17070
121
264
1649
17406
108
37
1662
17633
66
0
1704
17670
59
31
1709
17609
135
237
1573
16954
181
643
1294
14497
Leukocytes [Presence] in Urine
33052-2 [3045414]
33052-2 [3045414]
1.9e-01
1.7e+00
4.0e+00
—
3.2e+00
1.8e+00
8.0e-01
cases:0.40%
controls:0.33%
cases:1.92%
controls:0.35%
cases:1.53%
controls:0.03%
—
—
cases:0.85%
controls:0.03%
cases:2.58%
controls:0.44%
cases:4.00%
controls:1.84%
7
58
1763
17612
34
61
1736
17609
27
5
1743
17665
—
15
6
1753
17634
44
76
1664
17115
59
279
1416
14861
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
2889-4 [3020876]
1.6e+00
3.1e+00
—
—
1.0e+50
4.0e+00
2.6e+00
cases:0.85%
controls:0.17%
cases:2.32%
controls:0.10%
—
—
—
—
cases:0.85%
controls:0.00%
cases:2.81%
controls:0.05%
cases:3.80%
controls:0.29%
15
30
1755
17640
41
18
1729
17652
—
—
15
0
1753
17640
48
9
1660
17182
56
44
1419
15096
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
5.3e-01
1.7e+00
4.2e+00
1.0e+50
3.2e+00
1.3e+00
9.6e-01
cases:2.37%
controls:1.41%
cases:3.16%
controls:0.62%
cases:2.66%
controls:0.04%
cases:0.28%
controls:0.00%
cases:1.70%
controls:0.07%
cases:2.11%
controls:0.59%
cases:4.95%
controls:1.95%
42
249
1728
17421
56
110
1714
17560
47
7
1723
17663
5
0
1765
17670
30
12
1738
17628
36
101
1672
17090
73
295
1402
14845
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
5.3e-01
1.6e+00
3.5e+00
—
2.8e+00
1.8e+00
1.1e+00
cases:7.97%
controls:4.84%
cases:11.58%
controls:2.63%
cases:11.13%
controls:0.38%
—
—
cases:5.60%
controls:0.35%
cases:14.40%
controls:2.65%
cases:20.88%
controls:8.03%
141
855
1629
16815
205
464
1565
17206
197
67
1573
17603
—
99
62
1669
17578
246
455
1462
16736
308
1215
1167
13925
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.1e-01
9.1e-01
1.9e+00
4.5e+00
1.3e+00
1.3e+00
9.0e-01
cases:10.40%
controls:7.12%
cases:7.23%
controls:3.03%
cases:2.49%
controls:0.36%
cases:2.54%
controls:0.03%
cases:1.19%
controls:0.33%
cases:9.43%
controls:2.84%
cases:18.85%
controls:8.63%
184
1258
1586
16412
128
536
1642
17134
44
64
1726
17606
45
5
1725
17665
21
58
1747
17582
161
488
1547
16703
278
1307
1197
13833
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
8.3e-01
1.8e+00
3.2e+00
1.0e+50
2.3e+00
2.0e+00
1.0e+00
cases:1.30%
controls:0.57%
cases:1.53%
controls:0.24%
cases:0.79%
controls:0.03%
cases:0.73%
controls:0.00%
cases:0.85%
controls:0.09%
cases:2.40%
controls:0.34%
cases:4.00%
controls:1.50%
23
101
1747
17569
27
43
1743
17627
14
6
1756
17664
13
0
1757
17670
15
15
1753
17625
41
58
1667
17133
59
227
1416
14913
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
3.2e-01
1.5e+00
3.4e+00
1.0e+50
3.1e+00
1.9e+00
1.3e+00
cases:4.52%
controls:3.32%
cases:6.84%
controls:1.63%
cases:6.21%
controls:0.23%
cases:2.26%
controls:0.00%
cases:3.62%
controls:0.17%
cases:9.02%
controls:1.50%
cases:14.64%
controls:4.66%
80
587
1690
17083
121
288
1649
17382
110
40
1660
17630
40
0
1730
17670
64
30
1704
17610
154
258
1554
16933
216
705
1259
14435
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
8.6e-01
1.5e+00
3.5e+00
—
2.6e+00
1.6e+00
9.5e-01
cases:4.35%
controls:1.90%
cases:4.86%
controls:1.11%
cases:4.75%
controls:0.15%
—
—
cases:2.04%
controls:0.15%
cases:5.85%
controls:1.25%
cases:9.42%
controls:3.85%
77
335
1693
17335
86
196
1684
17474
84
27
1686
17643
—
36
27
1732
17613
100
215
1608
16976
139
583
1336
14557
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
1.1e+00
2.1e+00
—
1.0e+50
4.1e+00
2.5e+00
1.3e+00
cases:1.30%
controls:0.46%
cases:2.15%
controls:0.27%
—
—
cases:0.28%
controls:0.00%
cases:1.92%
controls:0.03%
cases:1.81%
controls:0.16%
cases:2.51%
controls:0.68%
23
81
1747
17589
38
47
1732
17623
—
5
0
1765
17670
34
6
1734
17634
31
27
1677
17164
37
103
1438
15037
Emergency Room Visit
ER [9203]
ER [9203]
4.8e-01
1.0e+00
1.6e+00
5.1e+00
1.4e+00
7.8e-01
6.8e-01
cases:44.63%
controls:33.18%
cases:26.95%
controls:11.92%
cases:8.19%
controls:1.85%
cases:11.41%
controls:0.08%
cases:6.28%
controls:1.69%
cases:22.60%
controls:11.79%
cases:48.54%
controls:32.36%
790
5863
980
11807
477
2107
1293
15563
145
327
1625
17343
202
14
1568
17656
111
298
1657
17342
386
2027
1322
15164
716
4899
759
10241
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
8.5e-01
2.0e+00
2.7e+00
1.0e+50
2.7e+00
1.8e+00
9.8e-01
cases:3.05%
controls:1.32%
cases:3.45%
controls:0.49%
cases:0.73%
controls:0.05%
cases:0.85%
controls:0.00%
cases:0.90%
controls:0.06%
cases:2.46%
controls:0.43%
cases:4.95%
controls:1.92%
54
234
1716
17436
61
87
1709
17583
13
9
1757
17661
15
0
1755
17670
16
11
1752
17629
42
74
1666
17117
73
290
1402
14850
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
7.9e-01
1.3e+00
3.1e+00
—
2.6e+00
1.9e+00
1.3e+00
cases:3.05%
controls:1.41%
cases:2.20%
controls:0.63%
cases:2.99%
controls:0.14%
—
—
cases:1.47%
controls:0.11%
cases:3.92%
controls:0.62%
cases:6.37%
controls:1.86%
54
250
1716
17420
39
111
1731
17559
53
25
1717
17645
—
26
20
1742
17620
67
106
1641
17085
94
281
1381
14859
Emergency Medicine
93 [38004510]
93 [38004510]
3.3e-01
8.1e-01
1.5e+00
5.5e+00
1.5e+00
7.7e-01
3.8e-01
cases:13.50%
controls:10.07%
cases:11.81%
controls:5.63%
cases:3.67%
controls:0.80%
cases:7.85%
controls:0.03%
cases:3.45%
controls:0.78%
cases:12.06%
controls:5.94%
cases:23.93%
controls:17.77%
239
1779
1531
15891
209
994
1561
16676
65
142
1705
17528
139
6
1631
17664
61
138
1707
17502
206
1022
1502
16169
353
2690
1122
12450
Specific gravity of Urine by Test strip
5811-5 [3000330]
5811-5 [3000330]
8.8e-01
1.8e+00
3.7e+00
—
2.2e+00
1.8e+00
5.9e-01
cases:1.69%
controls:0.71%
cases:2.20%
controls:0.37%
cases:1.75%
controls:0.05%
—
—
cases:0.68%
controls:0.08%
cases:2.34%
controls:0.40%
cases:2.85%
controls:1.61%
30
126
1740
17544
39
66
1731
17604
31
8
1739
17662
—
12
14
1756
17626
40
69
1668
17122
42
243
1433
14897
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
9.7e-01
1.7e+00
3.2e+00
1.0e+50
2.3e+00
1.8e+00
8.3e-01
cases:1.36%
controls:0.52%
cases:1.30%
controls:0.24%
cases:0.68%
controls:0.03%
cases:0.79%
controls:0.00%
cases:0.79%
controls:0.08%
cases:1.81%
controls:0.29%
cases:3.46%
controls:1.53%
24
92
1746
17578
23
42
1747
17628
12
5
1758
17665
14
0
1756
17670
14
14
1754
17626
31
50
1677
17141
51
232
1424
14908
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
5.1e-01
1.5e+00
3.4e+00
—
2.7e+00
1.7e+00
1.1e+00
cases:6.72%
controls:4.17%
cases:8.87%
controls:2.21%
cases:8.25%
controls:0.31%
—
—
cases:4.19%
controls:0.29%
cases:10.48%
controls:2.20%
cases:17.76%
controls:6.55%
119
736
1651
16934
157
390
1613
17280
146
55
1624
17615
—
74
52
1694
17588
179
378
1529
16813
262
992
1213
14148
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
4.8e-01
1.5e+00
3.2e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:6.33%
controls:4.00%
cases:8.53%
controls:2.04%
cases:7.68%
controls:0.32%
—
—
cases:3.62%
controls:0.24%
cases:9.37%
controls:2.04%
cases:16.95%
controls:6.24%
112
706
1658
16964
151
360
1619
17310
136
57
1634
17613
—
64
42
1704
17598
160
351
1548
16840
250
945
1225
14195
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
1.1e+00
2.0e+00
2.5e+00
1.0e+50
2.8e+00
1.5e+00
9.1e-01
cases:4.29%
controls:1.47%
cases:3.28%
controls:0.47%
cases:0.79%
controls:0.07%
cases:0.62%
controls:0.00%
cases:0.62%
controls:0.04%
cases:2.63%
controls:0.60%
cases:5.42%
controls:2.26%
76
260
1694
17410
58
83
1712
17587
14
12
1756
17658
11
0
1759
17670
11
7
1757
17633
45
104
1663
17087
80
342
1395
14798
Malignant neoplasm: Lateral wall of bladder
C67.2 [45586020]
C67.2 [45586020]
1.8e+00
1.9e+00
—
1.0e+50
2.3e+00
2.5e+00
2.0e+00
cases:0.62%
controls:0.10%
cases:0.62%
controls:0.10%
—
—
cases:0.28%
controls:0.00%
cases:0.34%
controls:0.03%
cases:0.94%
controls:0.08%
cases:1.29%
controls:0.17%
11
18
1759
17652
11
17
1759
17653
—
5
0
1765
17670
6
6
1762
17634
16
13
1692
17178
19
26
1456
15114
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
7.9e-01
1.6e+00
3.0e+00
—
2.6e+00
1.7e+00
8.4e-01
cases:8.81%
controls:4.22%
cases:9.38%
controls:2.08%
cases:5.82%
controls:0.31%
—
—
cases:4.07%
controls:0.32%
cases:10.60%
controls:2.10%
cases:15.93%
controls:7.56%
156
745
1614
16925
166
368
1604
17302
103
55
1667
17615
—
72
56
1696
17584
181
361
1527
16830
235
1144
1240
13996
enalapril; oral, parenteral
C09AA02 [21601786]
C09AA02 [21601786]
4.8e-01
7.7e-01
1.1e+00
3.6e+00
1.7e+00
1.5e+00
1.3e+00
cases:7.46%
controls:4.77%
cases:7.34%
controls:3.53%
cases:2.77%
controls:0.95%
cases:1.24%
controls:0.03%
cases:5.20%
controls:0.95%
cases:13.47%
controls:3.45%
cases:15.05%
controls:4.68%
132
842
1638
16828
130
623
1640
17047
49
168
1721
17502
22
6
1748
17664
92
168
1676
17472
230
593
1478
16598
222
709
1253
14431
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
6.7e-01
1.5e+00
2.8e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:2.37%
controls:1.23%
cases:2.60%
controls:0.61%
cases:1.64%
controls:0.10%
cases:1.13%
controls:0.00%
cases:1.47%
controls:0.14%
cases:4.22%
controls:0.69%
cases:8.61%
controls:2.58%
42
218
1728
17452
46
108
1724
17562
29
18
1741
17652
20
0
1750
17670
26
24
1742
17616
72
119
1636
17072
127
390
1348
14750
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
7.0e-01
1.5e+00
3.4e+00
—
2.4e+00
1.5e+00
9.5e-01
cases:3.62%
controls:1.83%
cases:4.75%
controls:1.14%
cases:4.46%
controls:0.16%
—
—
cases:1.92%
controls:0.18%
cases:5.50%
controls:1.29%
cases:9.97%
controls:4.11%
64
323
1706
17347
84
202
1686
17468
79
28
1691
17642
—
34
31
1734
17609
94
221
1614
16970
147
622
1328
14518
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
6.3e-01
1.4e+00
2.8e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:2.26%
controls:1.22%
cases:2.49%
controls:0.62%
cases:1.64%
controls:0.10%
cases:1.19%
controls:0.00%
cases:1.41%
controls:0.13%
cases:4.16%
controls:0.68%
cases:8.47%
controls:2.54%
40
215
1730
17455
44
109
1726
17561
29
18
1741
17652
21
0
1749
17670
25
23
1743
17617
71
117
1637
17074
125
385
1350
14755
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
100906-7 [1761482]
1.2e+00
2.1e+00
3.0e+00
1.0e+50
2.1e+00
1.9e+00
4.4e-01
cases:1.58%
controls:0.49%
cases:1.64%
controls:0.20%
cases:1.02%
controls:0.05%
cases:1.24%
controls:0.00%
cases:0.51%
controls:0.06%
cases:1.52%
controls:0.23%
cases:1.49%
controls:0.96%
28
87
1742
17583
29
35
1741
17635
18
9
1752
17661
22
0
1748
17670
9
11
1759
17629
26
40
1682
17151
22
146
1453
14994
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
6.5e-01
1.4e+00
2.7e+00
1.0e+50
2.4e+00
1.8e+00
1.3e+00
cases:2.37%
controls:1.25%
cases:2.54%
controls:0.62%
cases:1.64%
controls:0.11%
cases:1.24%
controls:0.00%
cases:1.36%
controls:0.13%
cases:4.22%
controls:0.73%
cases:8.61%
controls:2.54%
42
221
1728
17449
45
110
1725
17560
29
19
1741
17651
22
0
1748
17670
24
23
1744
17617
72
126
1636
17065
127
384
1348
14756
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
9.5e-01
2.1e+00
3.6e+00
—
—
2.0e+00
1.5e+00
cases:0.90%
controls:0.35%
cases:1.53%
controls:0.18%
cases:1.69%
controls:0.05%
—
—
—
—
cases:1.35%
controls:0.19%
cases:2.51%
controls:0.59%
16
62
1754
17608
27
32
1743
17638
30
8
1740
17662
—
—
23
32
1685
17159
37
90
1438
15050
Kidney ultrasound examination
KA1AE [2001305627]
KA1AE [2001305627]
1.4e+00
3.2e+00
1.0e+50
1.0e+50
—
3.4e+00
2.1e+00
cases:0.62%
controls:0.15%
cases:1.13%
controls:0.05%
cases:0.28%
controls:0.00%
cases:2.54%
controls:0.00%
—
—
cases:1.81%
controls:0.06%
cases:1.56%
controls:0.20%
11
26
1759
17644
20
8
1750
17662
5
0
1765
17670
45
0
1725
17670
—
31
11
1677
17180
23
30
1452
15110
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
7.6e-01
1.4e+00
2.6e+00
—
2.5e+00
1.5e+00
1.3e+00
cases:1.92%
controls:0.91%
cases:1.98%
controls:0.51%
cases:0.85%
controls:0.06%
—
—
cases:0.79%
controls:0.07%
cases:2.81%
controls:0.61%
cases:4.27%
controls:1.16%
34
160
1736
17510
35
91
1735
17579
15
11
1755
17659
—
14
12
1754
17628
48
105
1660
17086
63
176
1412
14964
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
8.8e-01
1.1e+00
2.5e+00
1.0e+50
3.2e+00
1.3e+00
1.1e+00
cases:1.92%
controls:0.80%
cases:1.30%
controls:0.46%
cases:1.02%
controls:0.08%
cases:0.34%
controls:0.00%
cases:0.96%
controls:0.04%
cases:2.05%
controls:0.59%
cases:4.41%
controls:1.49%
34
142
1736
17528
23
81
1747
17589
18
15
1752
17655
6
0
1764
17670
17
7
1751
17633
35
102
1673
17089
65
225
1410
14915
Retention of urine
R33 [45587507]
R33 [45587507]
1.2e+00
1.8e+00
2.5e+00
—
2.3e+00
1.6e+00
6.2e-01
cases:2.60%
controls:0.84%
cases:2.03%
controls:0.35%
cases:0.62%
controls:0.05%
—
—
cases:0.68%
controls:0.07%
cases:1.70%
controls:0.34%
cases:2.44%
controls:1.33%
46
148
1724
17522
36
61
1734
17609
11
9
1759
17661
—
12
12
1756
17628
29
59
1679
17132
36
201
1439
14939
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
9.1e-01
1.0e+00
2.4e+00
1.0e+50
3.2e+00
1.1e+00
1.2e+00
cases:1.92%
controls:0.78%
cases:1.19%
controls:0.44%
cases:0.96%
controls:0.08%
cases:0.34%
controls:0.00%
cases:0.85%
controls:0.03%
cases:1.58%
controls:0.53%
cases:3.93%
controls:1.25%
34
138
1736
17532
21
77
1749
17593
17
15
1753
17655
6
0
1764
17670
15
6
1753
17634
27
91
1681
17100
58
190
1417
14950
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
8.8e-01
1.1e+00
2.5e+00
1.0e+50
3.0e+00
1.2e+00
1.1e+00
cases:1.92%
controls:0.81%
cases:1.41%
controls:0.46%
cases:1.02%
controls:0.08%
cases:0.34%
controls:0.00%
cases:0.90%
controls:0.05%
cases:2.11%
controls:0.62%
cases:4.41%
controls:1.50%
34
143
1736
17527
25
82
1745
17588
18
15
1752
17655
6
0
1764
17670
16
8
1752
17632
36
106
1672
17085
65
227
1410
14913
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
7.4e-01
1.0e+00
2.3e+00
—
3.2e+00
1.5e+00
1.1e+00
cases:1.92%
controls:0.93%
cases:1.30%
controls:0.47%
cases:0.56%
controls:0.06%
—
—
cases:1.13%
controls:0.05%
cases:2.40%
controls:0.57%
cases:5.02%
controls:1.79%
34
164
1736
17506
23
83
1747
17587
10
10
1760
17660
—
20
8
1748
17632
41
98
1667
17093
74
271
1401
14869
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
6.4e-01
1.3e+00
2.8e+00
1.0e+50
2.3e+00
1.6e+00
1.1e+00
cases:2.03%
controls:1.09%
cases:1.81%
controls:0.49%
cases:0.96%
controls:0.06%
cases:1.07%
controls:0.00%
cases:0.96%
controls:0.10%
cases:2.40%
controls:0.48%
cases:5.97%
controls:2.15%
36
192
1734
17478
32
87
1738
17583
17
10
1753
17660
19
0
1751
17670
17
17
1751
17623
41
83
1667
17108
88
326
1387
14814
Acute cystitis
N30.0 [45601724]
N30.0 [45601724]
9.5e-01
1.4e+00
2.3e+00
—
2.9e+00
1.4e+00
7.3e-01
cases:3.39%
controls:1.34%
cases:2.15%
controls:0.52%
cases:0.45%
controls:0.05%
—
—
cases:0.85%
controls:0.05%
cases:2.52%
controls:0.63%
cases:4.61%
controls:2.29%
60
236
1710
17434
38
92
1732
17578
8
8
1762
17662
—
15
8
1753
17632
43
108
1665
17083
68
346
1407
14794
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
N08.39*E11.2 [2000503133]
1.5e+00
2.4e+00
—
—
—
3.3e+00
2.6e+00
cases:0.62%
controls:0.14%
cases:0.90%
controls:0.08%
—
—
—
—
—
—
cases:2.11%
controls:0.08%
cases:2.92%
controls:0.23%
11
25
1759
17645
16
15
1754
17655
—
—
—
36
14
1672
17177
43
35
1432
15105
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.3e-01
1.2e+00
3.1e+00
—
2.3e+00
1.6e+00
1.2e+00
cases:8.98%
controls:6.64%
cases:11.47%
controls:3.73%
cases:11.47%
controls:0.58%
—
—
cases:6.11%
controls:0.66%
cases:17.56%
controls:4.07%
cases:25.69%
controls:9.80%
159
1174
1611
16496
203
659
1567
17011
203
103
1567
17567
—
108
117
1660
17523
300
700
1408
16491
379
1483
1096
13657
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
5.5e-01
1.3e+00
3.0e+00
—
2.6e+00
1.4e+00
7.3e-01
cases:7.68%
controls:4.60%
cases:9.04%
controls:2.58%
cases:7.57%
controls:0.40%
—
—
cases:4.13%
controls:0.33%
cases:10.95%
controls:2.92%
cases:15.53%
controls:8.16%
136
812
1634
16858
160
456
1610
17214
134
70
1636
17600
—
73
59
1695
17581
187
502
1521
16689
229
1236
1246
13904
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
6.8e-01
8.9e-01
1.1e+00
2.9e+00
1.4e+00
1.3e+00
1.2e+00
cases:11.58%
controls:6.24%
cases:11.69%
controls:5.16%
cases:4.86%
controls:1.73%
cases:1.13%
controls:0.06%
cases:6.17%
controls:1.55%
cases:17.86%
controls:5.61%
cases:22.78%
controls:8.52%
205
1102
1565
16568
207
912
1563
16758
86
305
1684
17365
20
11
1750
17659
109
274
1659
17366
305
964
1403
16227
336
1290
1139
13850
Cystoscopic insertion of stent into ureter
KBV02 [2001305891]
KBV02 [2001305891]
1.9e+00
3.0e+00
—
—
—
2.9e+00
1.6e+00
cases:0.90%
controls:0.13%
cases:0.68%
controls:0.03%
—
—
—
—
—
—
cases:0.94%
controls:0.05%
cases:1.08%
controls:0.23%
16
23
1754
17647
12
6
1758
17664
—
—
—
16
9
1692
17182
16
35
1459
15105
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.8e-01
6.5e-01
1.9e+00
3.9e+00
1.7e+00
8.0e-01
4.2e-01
cases:25.03%
controls:21.75%
cases:24.80%
controls:14.66%
cases:17.01%
controls:2.87%
cases:9.15%
controls:0.21%
cases:13.74%
controls:2.83%
cases:28.04%
controls:14.96%
cases:43.05%
controls:33.16%
443
3844
1327
13826
439
2590
1331
15080
301
507
1469
17163
162
37
1608
17633
243
500
1525
17140
479
2571
1229
14620
635
5020
840
10120
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
9.4e-01
2.2e+00
3.5e+00
—
—
2.0e+00
1.6e+00
cases:0.79%
controls:0.31%
cases:1.30%
controls:0.14%
cases:1.30%
controls:0.04%
—
—
—
—
cases:1.17%
controls:0.16%
cases:2.31%
controls:0.48%
14
55
1756
17615
23
25
1747
17645
23
7
1747
17663
—
—
20
27
1688
17164
34
72
1441
15068
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
3.0e-01
1.2e+00
2.1e+00
—
3.4e+00
1.8e+00
7.9e-01
cases:2.71%
controls:2.02%
cases:2.49%
controls:0.75%
cases:1.19%
controls:0.15%
—
—
cases:2.43%
controls:0.09%
cases:4.45%
controls:0.76%
cases:5.90%
controls:2.76%
48
357
1722
17313
44
132
1726
17538
21
27
1749
17643
—
43
15
1725
17625
76
131
1632
17060
87
418
1388
14722
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
5.6e-01
1.4e+00
3.0e+00
—
2.2e+00
1.4e+00
7.4e-01
cases:10.96%
controls:6.57%
cases:11.98%
controls:3.39%
cases:9.44%
controls:0.50%
—
—
cases:4.30%
controls:0.51%
cases:13.35%
controls:3.72%
cases:20.41%
controls:10.89%
194
1161
1576
16509
212
599
1558
17071
167
88
1603
17582
—
76
90
1692
17550
228
639
1480
16552
301
1649
1174
13491
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
5.5e-01
1.4e+00
3.1e+00
—
2.0e+00
1.4e+00
7.5e-01
cases:9.83%
controls:5.94%
cases:11.81%
controls:3.23%
cases:9.21%
controls:0.45%
—
—
cases:4.07%
controls:0.56%
cases:12.94%
controls:3.52%
cases:20.61%
controls:10.93%
174
1050
1596
16620
209
571
1561
17099
163
80
1607
17590
—
72
98
1696
17542
221
605
1487
16586
304
1655
1171
13485
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
14683-7 [3009508]
3.1e-01
1.2e+00
3.1e+00
—
2.6e+00
1.4e+00
9.1e-01
cases:7.18%
controls:5.39%
cases:11.07%
controls:3.59%
cases:8.70%
controls:0.41%
—
—
cases:5.37%
controls:0.43%
cases:14.05%
controls:3.96%
cases:22.17%
controls:10.32%
127
952
1643
16718
196
635
1574
17035
154
73
1616
17597
—
95
76
1673
17564
240
680
1468
16511
327
1563
1148
13577
Albumin [Mass/volume] in Urine
1754-1 [3012516]
1754-1 [3012516]
3.0e-01
1.3e+00
3.1e+00
—
2.5e+00
1.3e+00
9.1e-01
cases:6.67%
controls:5.04%
cases:11.24%
controls:3.43%
cases:8.47%
controls:0.40%
—
—
cases:4.98%
controls:0.41%
cases:13.17%
controls:3.88%
cases:21.22%
controls:9.82%
118
891
1652
16779
199
606
1571
17064
150
71
1620
17599
—
88
72
1680
17568
225
667
1483
16524
313
1486
1162
13654
Protein electrophoresis panel - 24 hour Urine
81231-3 [21494890]
81231-3 [21494890]
1.3e+00
3.5e+00
—
—
—
3.3e+00
2.4e+00
cases:0.45%
controls:0.12%
cases:1.64%
controls:0.05%
—
—
—
—
—
—
cases:1.58%
controls:0.06%
cases:2.37%
controls:0.22%
8
22
1762
17648
29
9
1741
17661
—
—
—
27
10
1681
17181
35
34
1440
15106
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
32294-1 [3020682]
3.2e-01
1.2e+00
3.1e+00
—
2.4e+00
1.3e+00
8.5e-01
cases:7.85%
controls:5.80%
cases:11.98%
controls:3.89%
cases:8.87%
controls:0.45%
—
—
cases:5.09%
controls:0.49%
cases:14.11%
controls:4.42%
cases:21.97%
controls:10.74%
139
1025
1631
16645
212
688
1558
16982
157
79
1613
17591
—
90
87
1678
17553
241
760
1467
16431
324
1626
1151
13514
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
8.6e-01
2.1e+00
3.6e+00
—
—
1.9e+00
1.6e+00
cases:0.68%
controls:0.29%
cases:1.13%
controls:0.14%
cases:1.19%
controls:0.03%
—
—
—
—
cases:1.00%
controls:0.16%
cases:2.10%
controls:0.45%
12
51
1758
17619
20
24
1750
17646
21
6
1749
17664
—
—
17
27
1691
17164
31
68
1444
15072
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
14866-8 [3010566]
1.0e+00
1.9e+00
2.8e+00
—
—
2.6e+00
1.8e+00
cases:0.51%
controls:0.19%
cases:0.68%
controls:0.10%
cases:0.45%
controls:0.03%
—
—
—
—
cases:1.05%
controls:0.08%
cases:1.83%
controls:0.30%
9
33
1761
17637
12
18
1758
17652
8
5
1762
17665
—
—
18
14
1690
17177
27
45
1448
15095
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.0e-01
1.0e+00
2.9e+00
—
2.3e+00
1.4e+00
1.0e+00
cases:9.38%
controls:6.51%
cases:9.72%
controls:3.76%
cases:9.60%
controls:0.57%
—
—
cases:5.43%
controls:0.57%
cases:14.11%
controls:3.81%
cases:23.66%
controls:9.97%
166
1151
1604
16519
172
664
1598
17006
170
101
1600
17569
—
96
101
1672
17539
241
655
1467
16536
349
1509
1126
13631
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
5.4e-01
1.2e+00
3.0e+00
—
2.1e+00
1.4e+00
7.4e-01
cases:5.25%
controls:3.14%
cases:6.72%
controls:2.05%
cases:6.10%
controls:0.31%
—
—
cases:2.60%
controls:0.33%
cases:8.37%
controls:2.14%
cases:12.41%
controls:6.32%
93
555
1677
17115
119
362
1651
17308
108
55
1662
17615
—
46
58
1722
17582
143
368
1565
16823
183
957
1292
14183
nitrofurantoin; oral
J01XE01 [21603058]
J01XE01 [21603058]
6.5e-01
1.3e+00
2.3e+00
—
2.6e+00
1.4e+00
7.6e-01
cases:3.56%
controls:1.89%
cases:2.82%
controls:0.78%
cases:0.62%
controls:0.06%
—
—
cases:1.02%
controls:0.07%
cases:3.04%
controls:0.78%
cases:4.95%
controls:2.38%
63
334
1707
17336
50
138
1720
17532
11
11
1759
17659
—
18
13
1750
17627
52
134
1656
17057
73
360
1402
14780
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
8.6e-01
2.1e+00
3.6e+00
—
—
1.8e+00
1.6e+00
cases:0.68%
controls:0.29%
cases:1.13%
controls:0.14%
cases:1.19%
controls:0.03%
—
—
—
—
cases:0.94%
controls:0.16%
cases:1.97%
controls:0.42%
12
51
1758
17619
20
24
1750
17646
21
6
1749
17664
—
—
16
27
1692
17164
29
64
1446
15076
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
M35.9 [45553174]
2.2e+00
2.1e+00
—
—
—
2.7e+00
2.0e+00
cases:0.51%
controls:0.06%
cases:0.51%
controls:0.06%
—
—
—
—
—
—
cases:0.53%
controls:0.03%
cases:0.54%
controls:0.07%
9
10
1761
17660
9
11
1761
17659
—
—
—
9
6
1699
17185
8
11
1467
15129
Infectious Disease
44 [38004484]
44 [38004484]
9.9e-01
1.4e+00
1.8e+00
—
2.3e+00
1.3e+00
1.2e+00
cases:3.28%
controls:1.25%
cases:2.09%
controls:0.53%
cases:0.79%
controls:0.13%
—
—
cases:0.85%
controls:0.09%
cases:2.11%
controls:0.60%
cases:5.36%
controls:1.62%
58
220
1712
17450
37
93
1733
17577
14
23
1756
17647
—
15
15
1753
17625
36
103
1672
17088
79
246
1396
14894
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
5.3e-01
1.3e+00
3.0e+00
—
2.2e+00
1.2e+00
6.5e-01
cases:7.18%
controls:4.35%
cases:7.57%
controls:2.09%
cases:5.31%
controls:0.27%
—
—
cases:2.60%
controls:0.31%
cases:7.61%
controls:2.33%
cases:12.68%
controls:7.03%
127
769
1643
16901
134
370
1636
17300
94
47
1676
17623
—
46
54
1722
17586
130
400
1578
16791
187
1064
1288
14076
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.5e-01
7.6e-01
1.7e+00
2.9e+00
1.5e+00
9.6e-01
7.8e-01
cases:10.96%
controls:7.98%
cases:10.28%
controls:5.08%
cases:4.52%
controls:0.89%
cases:0.73%
controls:0.04%
cases:4.69%
controls:1.05%
cases:12.41%
controls:5.16%
cases:22.58%
controls:11.80%
194
1410
1576
16260
182
898
1588
16772
80
158
1690
17512
13
7
1757
17663
83
185
1685
17455
212
887
1496
16304
333
1786
1142
13354
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.4e-01
1.0e+00
2.9e+00
—
2.1e+00
1.4e+00
1.0e+00
cases:10.96%
controls:7.37%
cases:11.36%
controls:4.30%
cases:10.62%
controls:0.66%
—
—
cases:6.11%
controls:0.79%
cases:16.39%
controls:4.48%
cases:26.58%
controls:11.43%
194
1302
1576
16368
201
759
1569
16911
188
116
1582
17554
—
108
139
1660
17501
280
771
1428
16420
392
1731
1083
13409
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.4e-01
7.5e-01
1.7e+00
2.9e+00
1.5e+00
9.5e-01
7.9e-01
cases:10.85%
controls:7.94%
cases:10.11%
controls:5.07%
cases:4.46%
controls:0.88%
cases:0.73%
controls:0.04%
cases:4.64%
controls:1.05%
cases:12.30%
controls:5.15%
cases:22.58%
controls:11.74%
192
1403
1578
16267
179
895
1591
16775
79
156
1691
17514
13
7
1757
17663
82
186
1686
17454
210
885
1498
16306
333
1777
1142
13363
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.6e-01
6.7e-01
1.5e+00
3.5e+00
1.5e+00
8.9e-01
5.9e-01
cases:10.45%
controls:7.51%
cases:8.31%
controls:4.41%
cases:3.56%
controls:0.85%
cases:1.47%
controls:0.05%
cases:3.51%
controls:0.84%
cases:10.30%
controls:4.51%
cases:19.53%
controls:11.89%
185
1327
1585
16343
147
780
1623
16890
63
150
1707
17520
26
8
1744
17662
62
149
1706
17491
176
775
1532
16416
288
1800
1187
13340
General Surgery
2 [38004447]
2 [38004447]
3.7e-01
6.6e-01
1.1e+00
4.6e+00
1.1e+00
6.7e-01
4.4e-01
cases:25.08%
controls:18.78%
cases:11.24%
controls:6.16%
cases:3.05%
controls:1.02%
cases:4.12%
controls:0.05%
cases:2.55%
controls:0.86%
cases:10.19%
controls:5.46%
cases:21.97%
controls:15.36%
444
3318
1326
14352
199
1089
1571
16581
54
180
1716
17490
73
8
1697
17662
45
152
1723
17488
174
939
1534
16252
324
2325
1151
12815
trimethoprim; oral, parenteral
J01EA01 [21602931]
J01EA01 [21602931]
6.8e-01
1.4e+00
2.1e+00
—
2.5e+00
1.4e+00
8.3e-01
cases:8.98%
controls:4.75%
cases:6.78%
controls:1.72%
cases:1.64%
controls:0.21%
—
—
cases:2.09%
controls:0.18%
cases:6.50%
controls:1.69%
cases:11.80%
controls:5.54%
159
840
1611
16830
120
304
1650
17366
29
37
1741
17633
—
37
31
1731
17609
111
290
1597
16901
174
838
1301
14302
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.1e-01
7.5e-01
1.6e+00
3.0e+00
1.5e+00
9.5e-01
7.5e-01
cases:11.02%
controls:8.34%
cases:10.56%
controls:5.27%
cases:4.52%
controls:0.93%
cases:0.79%
controls:0.04%
cases:4.81%
controls:1.09%
cases:12.82%
controls:5.37%
cases:23.05%
controls:12.41%
195
1473
1575
16197
187
931
1583
16739
80
165
1690
17505
14
7
1756
17663
85
193
1683
17447
219
923
1489
16268
340
1879
1135
13261
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.7e-01
6.4e-01
1.4e+00
3.7e+00
1.3e+00
8.8e-01
7.4e-01
cases:12.03%
controls:9.48%
cases:11.36%
controls:6.30%
cases:5.20%
controls:1.36%
cases:1.75%
controls:0.05%
cases:5.43%
controls:1.54%
cases:13.64%
controls:6.16%
cases:24.47%
controls:13.36%
213
1675
1557
15995
201
1114
1569
16556
92
240
1678
17430
31
8
1739
17662
96
272
1672
17368
233
1059
1475
16132
361
2022
1114
13118
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
4.4e-01
9.3e-01
2.4e+00
1.0e+50
2.5e+00
1.6e+00
1.5e+00
cases:1.07%
controls:0.70%
cases:1.02%
controls:0.40%
cases:0.79%
controls:0.07%
cases:0.40%
controls:0.00%
cases:0.57%
controls:0.05%
cases:1.76%
controls:0.37%
cases:4.75%
controls:1.15%
19
123
1751
17547
18
71
1752
17599
14
13
1756
17657
7
0
1763
17670
10
8
1758
17632
30
63
1678
17128
70
174
1405
14966
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
3.9e-01
1.0e+00
2.3e+00
1.0e+50
2.5e+00
1.7e+00
1.3e+00
cases:1.47%
controls:1.00%
cases:1.47%
controls:0.53%
cases:0.96%
controls:0.10%
cases:0.40%
controls:0.00%
cases:0.79%
controls:0.06%
cases:2.81%
controls:0.54%
cases:6.37%
controls:1.84%
26
176
1744
17494
26
94
1744
17576
17
17
1753
17653
7
0
1763
17670
14
11
1754
17629
48
92
1660
17099
94
278
1381
14862
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
6.2e-01
1.3e+00
2.9e+00
—
2.0e+00
1.4e+00
6.8e-01
cases:6.84%
controls:3.78%
cases:7.40%
controls:2.16%
cases:5.93%
controls:0.35%
—
—
cases:2.55%
controls:0.35%
cases:8.49%
controls:2.34%
cases:13.42%
controls:7.27%
121
668
1649
17002
131
381
1639
17289
105
62
1665
17608
—
45
61
1723
17579
145
403
1563
16788
198
1100
1277
14040
Neoplasm of uncertain or unknown behaviour: Bladder
D41.4 [45537910]
D41.4 [45537910]
2.4e+00
2.1e+00
—
1.0e+50
—
2.8e+00
1.6e+00
cases:0.79%
controls:0.07%
cases:0.40%
controls:0.05%
—
—
cases:0.79%
controls:0.00%
—
—
cases:0.64%
controls:0.04%
cases:0.81%
controls:0.16%
14
13
1756
17657
7
9
1763
17661
—
14
0
1756
17670
—
11
7
1697
17184
12
24
1463
15116
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
2.5e-01
1.1e+00
2.9e+00
—
2.2e+00
1.4e+00
1.2e+00
cases:4.92%
controls:3.88%
cases:6.67%
controls:2.31%
cases:6.21%
controls:0.36%
—
—
cases:3.79%
controls:0.41%
cases:9.13%
controls:2.41%
cases:18.17%
controls:6.49%
87
685
1683
16985
118
408
1652
17262
110
63
1660
17607
—
67
73
1701
17567
156
415
1552
16776
268
982
1207
14158
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
6.5e-01
1.6e+00
1.7e+00
—
2.7e+00
1.4e+00
7.8e-01
cases:10.85%
controls:5.98%
cases:7.57%
controls:1.61%
cases:1.19%
controls:0.21%
—
—
cases:2.04%
controls:0.14%
cases:5.80%
controls:1.55%
cases:12.07%
controls:5.89%
192
1056
1578
16614
134
285
1636
17385
21
37
1749
17633
—
36
25
1732
17615
99
266
1609
16925
178
892
1297
14248
Severe anaemia associated with chronic renal failure
138 [2001600134]
138 [2001600134]
8.8e-01
2.6e+00
—
—
—
3.3e+00
2.9e+00
cases:0.34%
controls:0.14%
cases:0.45%
controls:0.03%
—
—
—
—
—
—
cases:1.11%
controls:0.04%
cases:2.37%
controls:0.13%
6
25
1764
17645
8
6
1762
17664
—
—
—
19
7
1689
17184
35
20
1440
15120
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.0e-01
6.3e-01
1.9e+00
3.1e+00
1.4e+00
8.7e-01
6.6e-01
cases:18.14%
controls:14.14%
cases:15.99%
controls:9.20%
cases:10.73%
controls:1.79%
cases:1.69%
controls:0.08%
cases:6.45%
controls:1.71%
cases:19.79%
controls:9.34%
cases:33.83%
controls:20.84%
321
2499
1449
15171
283
1626
1487
16044
190
316
1580
17354
30
14
1740
17656
114
301
1654
17339
338
1606
1370
15585
499
3155
976
11985
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.2e-01
7.3e-01
1.6e+00
2.9e+00
1.5e+00
9.3e-01
7.7e-01
cases:11.19%
controls:8.37%
cases:10.34%
controls:5.28%
cases:4.52%
controls:0.93%
cases:0.73%
controls:0.04%
cases:4.75%
controls:1.10%
cases:12.59%
controls:5.39%
cases:23.19%
controls:12.28%
198
1479
1572
16191
183
933
1587
16737
80
165
1690
17505
13
7
1757
17663
84
194
1684
17446
215
926
1493
16265
342
1859
1133
13281
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.5e-01
4.7e-01
1.7e+00
4.1e+00
1.6e+00
6.1e-01
3.0e-01
cases:26.67%
controls:23.89%
cases:24.35%
controls:16.77%
cases:16.10%
controls:3.24%
cases:6.44%
controls:0.12%
cases:13.52%
controls:3.04%
cases:27.58%
controls:17.21%
cases:41.97%
controls:34.92%
472
4221
1298
13449
431
2963
1339
14707
285
572
1485
17098
114
21
1656
17649
239
536
1529
17104
471
2959
1237
14232
619
5287
856
9853
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
5.6e-01
9.6e-01
2.2e+00
—
2.8e+00
1.2e+00
1.0e+00
cases:2.60%
controls:1.51%
cases:1.98%
controls:0.77%
cases:0.79%
controls:0.08%
—
—
cases:1.36%
controls:0.09%
cases:2.81%
controls:0.87%
cases:6.64%
controls:2.51%
46
266
1724
17404
35
136
1735
17534
14
15
1756
17655
—
24
15
1744
17625
48
149
1660
17042
98
380
1377
14760
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
M32.9 [45553167]
1.7e+00
2.2e+00
1.0e+50
—
—
2.6e+00
2.2e+00
cases:0.45%
controls:0.08%
cases:0.56%
controls:0.06%
cases:0.40%
controls:0.00%
—
—
—
—
cases:0.70%
controls:0.05%
cases:0.88%
controls:0.10%
8
15
1762
17655
10
11
1760
17659
7
0
1763
17670
—
—
12
9
1696
17182
13
15
1462
15125
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
5.0e-01
1.3e+00
3.2e+00
—
1.7e+00
1.3e+00
6.5e-01
cases:4.92%
controls:3.04%
cases:6.61%
controls:1.82%
cases:4.92%
controls:0.21%
—
—
cases:1.70%
controls:0.31%
cases:6.38%
controls:1.87%
cases:11.53%
controls:6.36%
87
537
1683
17133
117
321
1653
17349
87
37
1683
17633
—
30
55
1738
17585
109
322
1599
16869
170
963
1305
14177
Catheterisation of bladder
TKC20 [2001306020]
TKC20 [2001306020]
7.5e-01
1.8e+00
—
—
2.8e+00
1.9e+00
1.4e+00
cases:1.47%
controls:0.70%
cases:1.07%
controls:0.19%
—
—
—
—
cases:0.45%
controls:0.03%
cases:1.05%
controls:0.16%
cases:2.98%
controls:0.76%
26
123
1744
17547
19
33
1751
17637
—
—
8
5
1760
17635
18
27
1690
17164
44
115
1431
15025
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.3e-01
7.1e-01
1.7e+00
2.8e+00
1.4e+00
9.0e-01
7.5e-01
cases:10.23%
controls:7.59%
cases:9.10%
controls:4.70%
cases:4.12%
controls:0.79%
cases:0.56%
controls:0.03%
cases:3.68%
controls:0.95%
cases:10.66%
controls:4.64%
cases:20.54%
controls:10.90%
181
1341
1589
16329
161
830
1609
16840
73
139
1697
17531
10
6
1760
17664
65
168
1703
17472
182
798
1526
16393
303
1651
1172
13489
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.3e-01
7.1e-01
1.7e+00
2.8e+00
1.4e+00
8.8e-01
7.4e-01
cases:10.23%
controls:7.60%
cases:9.10%
controls:4.67%
cases:4.12%
controls:0.79%
cases:0.56%
controls:0.03%
cases:3.68%
controls:0.94%
cases:10.54%
controls:4.65%
cases:20.47%
controls:10.90%
181
1343
1589
16327
161
826
1609
16844
73
139
1697
17531
10
6
1760
17664
65
166
1703
17474
180
800
1528
16391
302
1650
1173
13490
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.3e-01
7.2e-01
1.7e+00
2.8e+00
1.4e+00
8.7e-01
7.3e-01
cases:10.23%
controls:7.55%
cases:9.10%
controls:4.66%
cases:4.12%
controls:0.80%
cases:0.56%
controls:0.03%
cases:3.73%
controls:0.94%
cases:10.54%
controls:4.69%
cases:20.27%
controls:10.94%
181
1334
1589
16336
161
823
1609
16847
73
141
1697
17529
10
6
1760
17664
66
166
1702
17474
180
807
1528
16384
299
1657
1176
13483
Transurethral resection of bladder
KCD02 [2001305938]
KCD02 [2001305938]
1.9e+00
2.1e+00
—
1.0e+50
—
3.1e+00
1.5e+00
cases:1.02%
controls:0.15%
cases:0.40%
controls:0.05%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.29%
controls:0.06%
cases:1.15%
controls:0.26%
18
27
1752
17643
7
9
1763
17661
—
11
0
1759
17670
—
22
10
1686
17181
17
40
1458
15100
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.6e-01
5.0e-01
1.8e+00
3.7e+00
1.6e+00
5.8e-01
3.2e-01
cases:27.40%
controls:24.28%
cases:28.76%
controls:19.63%
cases:19.15%
controls:3.77%
cases:8.70%
controls:0.23%
cases:15.95%
controls:3.72%
cases:32.08%
controls:20.86%
cases:45.15%
controls:37.40%
485
4290
1285
13380
509
3469
1261
14201
339
666
1431
17004
154
40
1616
17630
282
657
1486
16983
548
3586
1160
13605
666
5663
809
9477
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
2.9e-01
6.5e-01
1.6e+00
3.0e+00
1.4e+00
8.9e-01
7.2e-01
cases:9.83%
controls:7.56%
cases:8.59%
controls:4.66%
cases:3.79%
controls:0.79%
cases:0.56%
controls:0.03%
cases:3.56%
controls:0.93%
cases:10.71%
controls:4.70%
cases:19.93%
controls:10.83%
174
1335
1596
16335
152
824
1618
16846
67
139
1703
17531
10
5
1760
17665
63
164
1705
17476
183
808
1525
16383
294
1640
1181
13500
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.6e-01
4.9e-01
1.8e+00
3.7e+00
1.6e+00
5.7e-01
3.2e-01
cases:27.46%
controls:24.35%
cases:28.87%
controls:19.90%
cases:19.27%
controls:3.81%
cases:8.36%
controls:0.23%
cases:16.40%
controls:3.76%
cases:32.20%
controls:21.09%
cases:45.49%
controls:37.69%
486
4302
1284
13368
511
3517
1259
14153
341
673
1429
16997
148
40
1622
17630
290
663
1478
16977
550
3626
1158
13565
671
5707
804
9433
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.1e-01
6.9e-01
1.6e+00
2.8e+00
1.4e+00
8.6e-01
7.1e-01
cases:10.40%
controls:7.81%
cases:9.15%
controls:4.82%
cases:4.12%
controls:0.82%
cases:0.56%
controls:0.03%
cases:3.73%
controls:0.98%
cases:10.77%
controls:4.86%
cases:20.68%
controls:11.33%
184
1380
1586
16290
162
851
1608
16819
73
145
1697
17525
10
6
1760
17664
66
172
1702
17468
184
835
1524
16356
305
1716
1170
13424
Other and unspecified hydronephrosis
N13.3 [45553432]
N13.3 [45553432]
1.8e+00
2.3e+00
—
—
—
2.2e+00
2.1e+00
cases:0.62%
controls:0.10%
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:0.64%
controls:0.07%
cases:1.22%
controls:0.16%
11
18
1759
17652
9
9
1761
17661
—
—
—
11
12
1697
17179
18
24
1457
15116
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
1.5e+00
1.9e+00
1.9e+00
1.0e+50
—
1.8e+00
1.4e+00
cases:0.96%
controls:0.22%
cases:0.56%
controls:0.08%
cases:0.40%
controls:0.06%
cases:0.45%
controls:0.00%
—
—
cases:0.59%
controls:0.10%
cases:1.63%
controls:0.42%
17
39
1753
17631
10
15
1760
17655
7
11
1763
17659
8
0
1762
17670
—
10
17
1698
17174
24
64
1451
15076
Malignant neoplasm: Bladder, unspecified
C67.9 [45571528]
C67.9 [45571528]
1.6e+00
2.0e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.73%
controls:0.15%
cases:0.68%
controls:0.09%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.17%
controls:0.09%
cases:1.97%
controls:0.24%
13
26
1757
17644
12
16
1758
17654
—
6
0
1764
17670
—
20
16
1688
17175
29
36
1446
15104
Rheumatology
66 [38004491]
66 [38004491]
9.1e-01
1.5e+00
1.8e+00
—
1.5e+00
1.6e+00
1.1e+00
cases:6.10%
controls:2.55%
cases:6.44%
controls:1.56%
cases:1.98%
controls:0.33%
—
—
cases:1.92%
controls:0.45%
cases:7.03%
controls:1.58%
cases:8.54%
controls:3.00%
108
450
1662
17220
114
276
1656
17394
35
59
1735
17611
—
34
79
1734
17561
120
271
1588
16920
126
454
1349
14686
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.9e-01
8.8e-01
2.1e+00
2.3e+00
1.6e+00
6.9e-01
3.9e-01
cases:17.57%
controls:13.74%
cases:15.54%
controls:7.06%
cases:7.12%
controls:0.89%
cases:0.51%
controls:0.05%
cases:5.03%
controls:1.07%
cases:13.47%
controls:7.21%
cases:26.85%
controls:19.86%
311
2427
1459
15243
275
1248
1495
16422
126
157
1644
17513
9
9
1761
17661
89
189
1679
17451
230
1240
1478
15951
396
3007
1079
12133
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
3520-4 [3010375]
2.2e+00
1.9e+00
—
—
—
2.1e+00
2.0e+00
cases:0.40%
controls:0.05%
cases:0.40%
controls:0.06%
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:0.88%
controls:0.12%
7
8
1763
17662
7
10
1763
17660
—
—
—
10
12
1698
17179
13
18
1462
15122
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
1.4e+00
2.9e+00
—
—
—
2.5e+00
1.4e+00
cases:2.37%
controls:0.58%
cases:2.32%
controls:0.14%
—
—
—
—
—
—
cases:1.70%
controls:0.15%
cases:2.98%
controls:0.73%
42
103
1728
17567
41
24
1729
17646
—
—
—
29
25
1679
17166
44
111
1431
15029
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
3.9e-01
6.1e-01
1.1e+00
4.0e+00
1.1e+00
6.0e-01
4.7e-01
cases:8.25%
controls:5.74%
cases:5.88%
controls:3.29%
cases:1.92%
controls:0.66%
cases:1.75%
controls:0.03%
cases:1.98%
controls:0.69%
cases:5.80%
controls:3.28%
cases:10.37%
controls:6.76%
146
1015
1624
16655
104
582
1666
17088
34
116
1736
17554
31
6
1739
17664
35
121
1733
17519
99
564
1609
16627
153
1023
1322
14117
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
4.6e-02
4.5e-01
1.5e+00
3.8e+00
1.2e+00
5.2e-01
6.3e-01
cases:6.89%
controls:6.60%
cases:8.19%
controls:5.37%
cases:4.58%
controls:1.05%
cases:2.26%
controls:0.05%
cases:4.13%
controls:1.22%
cases:9.02%
controls:5.56%
cases:18.44%
controls:10.75%
122
1167
1648
16503
145
948
1625
16722
81
185
1689
17485
40
9
1730
17661
73
216
1695
17424
154
956
1554
16235
272
1627
1203
13513
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
5.1e-01
8.6e-01
2.8e+00
—
1.9e+00
1.4e+00
1.1e+00
cases:1.75%
controls:1.06%
cases:1.13%
controls:0.48%
cases:0.68%
controls:0.04%
—
—
cases:0.40%
controls:0.06%
cases:1.58%
controls:0.40%
cases:4.47%
controls:1.51%
31
187
1739
17483
20
85
1750
17585
12
7
1758
17663
—
7
10
1761
17630
27
68
1681
17123
66
229
1409
14911
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
3.7e-01
7.5e-01
2.5e+00
1.0e+50
2.4e+00
1.5e+00
1.1e+00
cases:2.03%
controls:1.42%
cases:1.81%
controls:0.86%
cases:1.75%
controls:0.15%
cases:0.45%
controls:0.00%
cases:1.75%
controls:0.16%
cases:3.81%
controls:0.90%
cases:6.71%
controls:2.36%
36
251
1734
17419
32
152
1738
17518
31
27
1739
17643
8
0
1762
17670
31
29
1737
17611
65
155
1643
17036
99
357
1376
14783
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
1.2e+00
2.2e+00
—
—
—
2.9e+00
1.7e+00
cases:1.07%
controls:0.32%
cases:1.47%
controls:0.16%
—
—
—
—
—
—
cases:2.11%
controls:0.12%
cases:2.71%
controls:0.48%
19
56
1751
17614
26
28
1744
17642
—
—
—
36
20
1672
17171
40
73
1435
15067
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.4e-01
4.5e-01
1.7e+00
3.6e+00
1.5e+00
4.9e-01
2.6e-01
cases:28.76%
controls:25.92%
cases:31.24%
controls:22.39%
cases:22.32%
controls:4.77%
cases:8.93%
controls:0.27%
cases:18.33%
controls:4.77%
cases:33.78%
controls:23.81%
cases:46.98%
controls:40.62%
509
4580
1261
13090
553
3957
1217
13713
395
842
1375
16828
158
48
1612
17622
324
842
1444
16798
577
4094
1131
13097
693
6150
782
8990
CT of urinary organs
KH1AD [2001306328]
KH1AD [2001306328]
1.4e+00
1.8e+00
—
1.0e+50
—
3.4e+00
1.4e+00
cases:0.85%
controls:0.20%
cases:0.79%
controls:0.13%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.88%
controls:0.03%
cases:1.22%
controls:0.32%
15
36
1755
17634
14
23
1756
17647
—
6
0
1764
17670
—
15
5
1693
17186
18
48
1457
15092
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
1.0e+00
1.6e+00
—
1.0e+50
2.7e+00
1.8e+00
9.0e-01
cases:1.30%
controls:0.48%
cases:1.02%
controls:0.21%
—
—
cases:0.62%
controls:0.00%
cases:0.51%
controls:0.03%
cases:1.41%
controls:0.24%
cases:3.19%
controls:1.32%
23
85
1747
17585
18
37
1752
17633
—
11
0
1759
17670
9
6
1759
17634
24
41
1684
17150
47
200
1428
14940
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
1.1e+00
1.6e+00
—
1.0e+50
2.7e+00
1.7e+00
9.3e-01
cases:1.30%
controls:0.46%
cases:1.02%
controls:0.21%
—
—
cases:0.62%
controls:0.00%
cases:0.51%
controls:0.03%
cases:1.29%
controls:0.24%
cases:3.25%
controls:1.31%
23
81
1747
17589
18
37
1752
17633
—
11
0
1759
17670
9
6
1759
17634
22
41
1686
17150
48
199
1427
14941
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
7.1e-01
1.1e+00
1.9e+00
—
1.9e+00
1.4e+00
1.0e+00
cases:4.41%
controls:2.21%
cases:2.49%
controls:0.88%
cases:0.68%
controls:0.10%
—
—
cases:0.79%
controls:0.12%
cases:3.22%
controls:0.83%
cases:8.07%
controls:3.09%
78
390
1692
17280
44
155
1726
17515
12
18
1758
17652
—
14
21
1754
17619
55
142
1653
17049
119
468
1356
14672
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
7.1e-01
7.7e-01
2.4e+00
1.0e+50
3.1e+00
1.3e+00
1.2e+00
cases:1.36%
controls:0.67%
cases:0.79%
controls:0.37%
cases:0.79%
controls:0.07%
cases:0.40%
controls:0.00%
cases:0.74%
controls:0.03%
cases:1.52%
controls:0.44%
cases:3.19%
controls:0.96%
24
119
1746
17551
14
65
1756
17605
14
13
1756
17657
7
0
1763
17670
13
6
1755
17634
26
75
1682
17116
47
146
1428
14994
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
1.2e-01
4.9e-01
1.0e+00
4.1e+00
1.1e+00
7.5e-01
4.9e-01
cases:5.37%
controls:4.77%
cases:4.07%
controls:2.54%
cases:1.36%
controls:0.50%
cases:1.98%
controls:0.03%
cases:1.47%
controls:0.48%
cases:5.50%
controls:2.68%
cases:9.63%
controls:6.14%
95
843
1675
16827
72
449
1698
17221
24
89
1746
17581
35
6
1735
17664
26
85
1742
17555
94
460
1614
16731
142
930
1333
14210
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
1.5e-01
9.9e-01
2.9e+00
—
2.5e+00
9.6e-01
6.1e-01
cases:1.75%
controls:1.51%
cases:1.64%
controls:0.62%
cases:1.53%
controls:0.08%
—
—
cases:0.74%
controls:0.06%
cases:1.81%
controls:0.70%
cases:2.98%
controls:1.64%
31
267
1739
17403
29
109
1741
17561
27
15
1743
17655
—
13
11
1755
17629
31
121
1677
17070
44
249
1431
14891
Other chronic renal failure
N18.8 [45534123]
N18.8 [45534123]
5.5e-01
1.4e+00
2.1e+00
1.0e+50
1.9e+00
2.2e+00
2.4e+00
cases:0.45%
controls:0.26%
cases:0.62%
controls:0.15%
cases:0.28%
controls:0.03%
cases:0.45%
controls:0.00%
cases:0.40%
controls:0.06%
cases:1.41%
controls:0.16%
cases:3.25%
controls:0.30%
8
46
1762
17624
11
26
1759
17644
5
6
1765
17664
8
0
1762
17670
7
11
1761
17629
24
27
1684
17164
48
45
1427
15095
Hematology
82 [38004501]
82 [38004501]
4.8e-01
1.0e+00
1.9e+00
—
2.0e+00
1.7e+00
1.2e+00
cases:1.64%
controls:1.02%
cases:1.69%
controls:0.63%
cases:1.07%
controls:0.17%
—
—
cases:1.41%
controls:0.20%
cases:3.51%
controls:0.63%
cases:4.27%
controls:1.27%
29
180
1741
17490
30
111
1740
17559
19
30
1751
17640
—
25
35
1743
17605
60
109
1648
17082
63
193
1412
14947
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.9e-01
6.3e-01
9.8e-01
3.3e+00
1.1e+00
8.0e-01
5.7e-01
cases:11.53%
controls:8.14%
cases:9.10%
controls:5.04%
cases:4.75%
controls:1.83%
cases:2.49%
controls:0.09%
cases:5.37%
controls:1.84%
cases:11.01%
controls:5.29%
cases:18.51%
controls:11.43%
204
1438
1566
16232
161
890
1609
16780
84
323
1686
17347
44
16
1726
17654
95
324
1673
17316
188
909
1520
16282
273
1730
1202
13410
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
2.8e-01
9.4e-01
2.2e+00
—
2.1e+00
1.5e+00
9.7e-01
cases:1.47%
controls:1.11%
cases:1.47%
controls:0.58%
cases:0.62%
controls:0.07%
—
—
cases:0.62%
controls:0.07%
cases:1.93%
controls:0.42%
cases:4.41%
controls:1.72%
26
197
1744
17473
26
102
1744
17568
11
12
1759
17658
—
11
13
1757
17627
33
73
1675
17118
65
260
1410
14880
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
E11.2 [45605400]
1.3e+00
2.2e+00
—
1.0e+50
—
2.2e+00
2.1e+00
cases:1.36%
controls:0.37%
cases:1.64%
controls:0.19%
—
—
cases:0.40%
controls:0.00%
—
—
cases:2.05%
controls:0.22%
cases:3.93%
controls:0.52%
24
65
1746
17605
29
33
1741
17637
—
7
0
1763
17670
—
35
38
1673
17153
58
79
1417
15061
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
3.7e-01
1.6e+00
—
—
3.0e+00
1.8e+00
1.4e+00
cases:0.68%
controls:0.47%
cases:1.02%
controls:0.20%
—
—
—
—
cases:0.57%
controls:0.03%
cases:1.52%
controls:0.26%
cases:3.32%
controls:0.86%
12
83
1758
17587
18
36
1752
17634
—
—
10
5
1758
17635
26
44
1682
17147
49
130
1426
15010
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
5.6e-01
1.4e+00
1.4e+00
—
2.7e+00
1.8e+00
1.3e+00
cases:2.54%
controls:1.47%
cases:1.81%
controls:0.45%
cases:0.34%
controls:0.08%
—
—
cases:0.68%
controls:0.05%
cases:2.63%
controls:0.47%
cases:5.49%
controls:1.55%
45
259
1725
17411
32
80
1738
17590
6
15
1764
17655
—
12
8
1756
17632
45
80
1663
17111
81
235
1394
14905
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
8.4e-01
1.7e+00
—
1.0e+50
2.3e+00
1.9e+00
9.7e-01
cases:1.53%
controls:0.66%
cases:1.47%
controls:0.27%
—
—
cases:0.79%
controls:0.00%
cases:0.68%
controls:0.07%
cases:2.22%
controls:0.34%
cases:4.27%
controls:1.66%
27
117
1743
17553
26
48
1744
17622
—
14
0
1756
17670
12
12
1756
17628
38
58
1670
17133
63
252
1412
14888
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
3.5e-01
1.0e+00
2.7e+00
—
2.2e+00
1.1e+00
7.3e-01
cases:3.56%
controls:2.55%
cases:2.82%
controls:1.03%
cases:1.36%
controls:0.09%
—
—
cases:0.79%
controls:0.09%
cases:2.81%
controls:0.98%
cases:6.64%
controls:3.30%
63
450
1707
17220
50
182
1720
17488
24
16
1746
17654
—
14
16
1754
17624
48
169
1660
17022
98
500
1377
14640
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
6.6e-01
1.1e+00
1.9e+00
—
1.9e+00
1.3e+00
8.6e-01
cases:2.20%
controls:1.15%
cases:1.53%
controls:0.51%
cases:0.51%
controls:0.07%
—
—
cases:0.45%
controls:0.07%
cases:2.34%
controls:0.68%
cases:5.02%
controls:2.18%
39
203
1731
17467
27
91
1743
17579
9
13
1761
17657
—
8
12
1760
17628
40
117
1668
17074
74
330
1401
14810
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
6.6e-01
1.1e+00
1.9e+00
—
1.9e+00
1.3e+00
8.6e-01
cases:2.20%
controls:1.15%
cases:1.53%
controls:0.51%
cases:0.51%
controls:0.07%
—
—
cases:0.45%
controls:0.07%
cases:2.34%
controls:0.68%
cases:5.02%
controls:2.19%
39
203
1731
17467
27
91
1743
17579
9
13
1761
17657
—
8
12
1760
17628
40
117
1668
17074
74
331
1401
14809
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
7.0e-01
1.1e+00
1.9e+00
—
1.9e+00
1.2e+00
8.2e-01
cases:2.32%
controls:1.16%
cases:1.53%
controls:0.51%
cases:0.51%
controls:0.07%
—
—
cases:0.45%
controls:0.07%
cases:2.34%
controls:0.69%
cases:4.75%
controls:2.15%
41
205
1729
17465
27
91
1743
17579
9
13
1761
17657
—
8
12
1760
17628
40
118
1668
17073
70
325
1405
14815
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
7.0e-01
1.1e+00
1.9e+00
—
1.9e+00
1.2e+00
8.3e-01
cases:2.32%
controls:1.17%
cases:1.47%
controls:0.50%
cases:0.51%
controls:0.07%
—
—
cases:0.45%
controls:0.07%
cases:2.34%
controls:0.69%
cases:4.88%
controls:2.18%
41
206
1729
17464
26
88
1744
17582
9
13
1761
17657
—
8
12
1760
17628
40
119
1668
17072
72
330
1403
14810
prazosin; oral
C02CA01 [21600411]
C02CA01 [21600411]
5.0e-01
1.4e+00
1.7e+00
—
2.1e+00
1.9e+00
2.3e+00
cases:0.62%
controls:0.38%
cases:0.96%
controls:0.25%
cases:0.28%
controls:0.05%
—
—
cases:0.79%
controls:0.10%
cases:1.52%
controls:0.23%
cases:3.19%
controls:0.33%
11
67
1759
17603
17
44
1753
17626
5
9
1765
17661
—
14
17
1754
17623
26
39
1682
17152
47
50
1428
15090
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
5.1e-01
1.0e+00
2.2e+00
—
1.8e+00
1.5e+00
1.2e+00
cases:2.49%
controls:1.51%
cases:2.71%
controls:0.99%
cases:1.19%
controls:0.13%
—
—
cases:1.02%
controls:0.17%
cases:4.39%
controls:1.06%
cases:9.36%
controls:3.10%
44
266
1726
17404
48
175
1722
17495
21
23
1749
17647
—
18
30
1750
17610
75
183
1633
17008
138
470
1337
14670
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 [2000503126]
N08.2*D89.80 [2000503126]
—
2.5e+00
—
1.0e+50
—
—
5.2e+00
—
—
cases:0.34%
controls:0.03%
—
—
cases:0.45%
controls:0.00%
—
—
—
—
cases:6.44%
controls:0.04%
—
6
5
1764
17665
—
8
0
1762
17670
—
—
95
6
1380
15134
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
3.6e-01
9.1e-01
2.7e+00
—
2.0e+00
1.1e+00
9.4e-01
cases:5.59%
controls:3.98%
cases:4.46%
controls:1.84%
cases:3.39%
controls:0.24%
—
—
cases:1.81%
controls:0.26%
cases:5.97%
controls:1.98%
cases:13.56%
controls:5.78%
99
704
1671
16966
79
325
1691
17345
60
43
1710
17627
—
32
45
1736
17595
102
341
1606
16850
200
875
1275
14265
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
3.3e-01
8.9e-01
2.7e+00
1.0e+50
2.2e+00
1.2e+00
7.0e-01
cases:2.26%
controls:1.63%
cases:2.09%
controls:0.87%
cases:1.92%
controls:0.14%
cases:0.28%
controls:0.00%
cases:1.02%
controls:0.12%
cases:2.99%
controls:0.91%
cases:3.66%
controls:1.86%
40
288
1730
17382
37
153
1733
17517
34
24
1736
17646
5
0
1765
17670
18
21
1750
17619
51
156
1657
17035
54
281
1421
14859
moxonidine; oral
C02AC05 [21600401]
C02AC05 [21600401]
7.0e-01
1.1e+00
1.4e+00
—
1.8e+00
1.6e+00
1.6e+00
cases:1.30%
controls:0.65%
cases:1.24%
controls:0.41%
cases:0.56%
controls:0.14%
—
—
cases:0.74%
controls:0.12%
cases:2.11%
controls:0.42%
cases:3.80%
controls:0.76%
23
115
1747
17555
22
73
1748
17597
10
24
1760
17646
—
13
22
1755
17618
36
73
1672
17118
56
115
1419
15025
pH of Urine by Test strip
5803-2 [3022621]
5803-2 [3022621]
2.6e-01
1.2e+00
3.1e+00
—
2.2e+00
9.9e-01
4.3e-01
cases:1.41%
controls:1.09%
cases:1.86%
controls:0.55%
cases:1.30%
controls:0.06%
—
—
cases:0.74%
controls:0.09%
cases:1.58%
controls:0.59%
cases:3.19%
controls:2.10%
25
193
1745
17477
33
97
1737
17573
23
10
1747
17660
—
13
15
1755
17625
27
102
1681
17089
47
318
1428
14822
Calculus of kidney
N20.0 [45567830]
N20.0 [45567830]
1.3e+00
2.2e+00
—
1.0e+50
—
2.5e+00
1.5e+00
cases:0.85%
controls:0.23%
cases:0.79%
controls:0.08%
—
—
cases:0.28%
controls:0.00%
—
—
cases:1.05%
controls:0.09%
cases:1.15%
controls:0.26%
15
41
1755
17629
14
15
1756
17655
—
5
0
1765
17670
—
18
15
1690
17176
17
40
1458
15100
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
4.4e-01
1.0e+00
2.1e+00
—
1.8e+00
1.4e+00
1.1e+00
cases:2.49%
controls:1.61%
cases:2.88%
controls:1.05%
cases:1.13%
controls:0.14%
—
—
cases:1.13%
controls:0.18%
cases:4.51%
controls:1.15%
cases:9.76%
controls:3.43%
44
285
1726
17385
51
186
1719
17484
20
24
1750
17646
—
20
32
1748
17608
77
197
1631
16994
144
520
1331
14620
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
7.3e-02
4.2e-01
1.7e+00
3.3e+00
1.5e+00
3.9e-01
2.4e-01
cases:18.42%
controls:17.35%
cases:21.47%
controls:15.29%
cases:15.03%
controls:3.16%
cases:5.65%
controls:0.23%
cases:12.10%
controls:3.12%
cases:22.60%
controls:16.44%
cases:34.24%
controls:29.02%
326
3065
1444
14605
380
2701
1390
14969
266
559
1504
17111
100
40
1670
17630
214
551
1554
17089
386
2826
1322
14365
505
4393
970
10747
Chronic hypertension
205 [2001600203]
205 [2001600203]
7.5e-01
8.9e-01
—
—
2.7e+00
2.7e+00
1.4e+00
cases:3.56%
controls:1.72%
cases:0.85%
controls:0.35%
—
—
—
—
cases:0.57%
controls:0.04%
cases:3.57%
controls:0.25%
cases:4.14%
controls:1.09%
63
304
1707
17366
15
62
1755
17608
—
—
10
7
1758
17633
61
43
1647
17148
61
165
1414
14975
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
6.7e-01
1.3e+00
—
—
1.9e+00
1.9e+00
2.3e+00
cases:0.45%
controls:0.23%
cases:0.73%
controls:0.20%
—
—
—
—
cases:0.40%
controls:0.06%
cases:1.35%
controls:0.20%
cases:3.39%
controls:0.36%
8
41
1762
17629
13
35
1757
17635
—
—
7
11
1761
17629
23
35
1685
17156
50
55
1425
15085
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
6.7e-01
1.3e+00
—
—
1.9e+00
1.9e+00
2.3e+00
cases:0.45%
controls:0.23%
cases:0.73%
controls:0.20%
—
—
—
—
cases:0.40%
controls:0.06%
cases:1.35%
controls:0.20%
cases:3.39%
controls:0.36%
8
41
1762
17629
13
35
1757
17635
—
—
7
11
1761
17629
23
35
1685
17156
50
55
1425
15085
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
4.6e-02
3.6e-01
1.4e+00
3.5e+00
1.3e+00
4.7e-01
2.7e-01
cases:18.31%
controls:17.63%
cases:20.23%
controls:15.07%
cases:12.66%
controls:3.38%
cases:6.33%
controls:0.20%
cases:11.20%
controls:3.38%
cases:22.78%
controls:15.61%
cases:34.17%
controls:28.45%
324
3116
1446
14554
358
2662
1412
15008
224
598
1546
17072
112
35
1658
17635
198
596
1570
17044
389
2684
1319
14507
504
4308
971
10832
Albumin [Mass/time] in Urine collected for unspecified duration
49002-9 [3050449]
49002-9 [3050449]
6.3e-01
1.8e+00
2.5e+00
—
2.3e+00
6.8e-01
7.2e-01
cases:1.02%
controls:0.54%
cases:1.47%
controls:0.25%
cases:0.34%
controls:0.03%
—
—
cases:0.34%
controls:0.03%
cases:0.47%
controls:0.24%
cases:1.97%
controls:0.97%
18
96
1752
17574
26
45
1744
17625
6
5
1764
17665
—
6
6
1762
17634
8
41
1700
17150
29
147
1446
14993
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
4.6e-01
9.6e-01
2.2e+00
—
1.7e+00
1.4e+00
1.1e+00
cases:2.82%
controls:1.81%
cases:3.05%
controls:1.19%
cases:1.36%
controls:0.16%
—
—
cases:1.07%
controls:0.20%
cases:4.63%
controls:1.20%
cases:10.24%
controls:3.77%
50
319
1720
17351
54
210
1716
17460
24
28
1746
17642
—
19
35
1749
17605
79
207
1629
16984
151
571
1324
14569
Ultrasound measurement of residual urine
KC1EE [2001305918]
KC1EE [2001305918]
4.4e-01
1.1e+00
2.2e+00
—
2.3e+00
1.6e+00
4.9e-01
cases:3.28%
controls:2.14%
cases:2.09%
controls:0.68%
cases:0.79%
controls:0.08%
—
—
cases:0.62%
controls:0.06%
cases:3.16%
controls:0.67%
cases:3.53%
controls:2.19%
58
379
1712
17291
37
121
1733
17549
14
15
1756
17655
—
11
11
1757
17629
54
115
1654
17076
52
332
1423
14808
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
4.6e-01
9.2e-01
2.1e+00
—
2.0e+00
1.3e+00
8.9e-01
cases:3.45%
controls:2.20%
cases:2.37%
controls:0.96%
cases:0.90%
controls:0.11%
—
—
cases:1.07%
controls:0.15%
cases:3.57%
controls:1.02%
cases:7.19%
controls:3.07%
61
388
1709
17282
42
169
1728
17501
16
19
1754
17651
—
19
27
1749
17613
61
175
1647
17016
106
465
1369
14675
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
N08.39*E10.2 [2000503132]
1.1e+00
2.1e+00
—
—
—
2.8e+00
2.3e+00
cases:0.28%
controls:0.10%
cases:0.45%
controls:0.06%
—
—
—
—
—
—
cases:0.88%
controls:0.05%
cases:1.42%
controls:0.15%
5
17
1765
17653
8
10
1762
17660
—
—
—
15
9
1693
17182
21
23
1454
15117
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
8.5e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.00%
controls:28.25%
cases:32.15%
controls:24.58%
cases:22.09%
controls:5.55%
cases:8.98%
controls:0.31%
cases:17.70%
controls:5.63%
cases:34.72%
controls:25.84%
cases:47.80%
controls:44.06%
531
4992
1239
12678
569
4343
1201
13327
391
980
1379
16690
159
54
1611
17616
313
994
1455
16646
593
4442
1115
12749
705
6671
770
8469
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
8.7e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.11%
controls:28.32%
cases:32.20%
controls:24.62%
cases:22.09%
controls:5.56%
cases:9.04%
controls:0.31%
cases:17.70%
controls:5.67%
cases:34.78%
controls:25.91%
cases:47.93%
controls:44.13%
533
5004
1237
12666
570
4351
1200
13319
391
983
1379
16687
160
54
1610
17616
313
1000
1455
16640
594
4455
1114
12736
707
6681
768
8459
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
8.3e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:29.94%
controls:28.23%
cases:32.03%
controls:24.52%
cases:22.03%
controls:5.54%
cases:8.98%
controls:0.31%
cases:17.65%
controls:5.62%
cases:34.72%
controls:25.82%
cases:47.73%
controls:43.99%
530
4988
1240
12682
567
4333
1203
13337
390
979
1380
16691
159
54
1611
17616
312
992
1456
16648
593
4439
1115
12752
704
6660
771
8480
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
8.4e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.00%
controls:28.26%
cases:32.15%
controls:24.62%
cases:22.09%
controls:5.55%
cases:8.98%
controls:0.31%
cases:17.70%
controls:5.65%
cases:34.72%
controls:25.88%
cases:47.80%
controls:44.08%
531
4994
1239
12676
569
4351
1201
13319
391
981
1379
16689
159
54
1611
17616
313
996
1455
16644
593
4449
1115
12742
705
6673
770
8467
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
8.4e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.00%
controls:28.27%
cases:32.15%
controls:24.63%
cases:22.09%
controls:5.55%
cases:8.98%
controls:0.31%
cases:17.70%
controls:5.65%
cases:34.72%
controls:25.89%
cases:47.80%
controls:44.09%
531
4996
1239
12674
569
4352
1201
13318
391
980
1379
16690
159
54
1611
17616
313
997
1455
16643
593
4451
1115
12740
705
6675
770
8465
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
8.3e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.00%
controls:28.30%
cases:32.15%
controls:24.61%
cases:22.09%
controls:5.55%
cases:8.98%
controls:0.31%
cases:17.70%
controls:5.65%
cases:34.72%
controls:25.90%
cases:47.80%
controls:44.10%
531
5000
1239
12670
569
4349
1201
13321
391
981
1379
16689
159
54
1611
17616
313
997
1455
16643
593
4452
1115
12739
705
6676
770
8464
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
8.8e-02
3.7e-01
1.6e+00
3.5e+00
1.3e+00
4.2e-01
1.5e-01
cases:30.11%
controls:28.30%
cases:32.09%
controls:24.69%
cases:22.15%
controls:5.59%
cases:9.04%
controls:0.31%
cases:17.70%
controls:5.66%
cases:34.84%
controls:25.95%
cases:47.80%
controls:44.15%
533
5000
1237
12670
568
4362
1202
13308
392
987
1378
16683
160
54
1610
17616
313
999
1455
16641
595
4461
1113
12730
705
6684
770
8456
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
1.0e+00
1.1e+00
1.4e+00
—
1.5e+00
1.1e+00
9.1e-01
cases:2.66%
controls:0.96%
cases:2.26%
controls:0.76%
cases:1.02%
controls:0.25%
—
—
cases:0.90%
controls:0.20%
cases:2.17%
controls:0.72%
cases:2.64%
controls:1.08%
47
170
1723
17500
40
135
1730
17535
18
44
1752
17626
—
16
35
1752
17605
37
124
1671
17067
39
164
1436
14976
Cardiology
6 [38004451]
6 [38004451]
3.4e-01
5.4e-01
9.6e-01
3.0e+00
9.5e-01
6.9e-01
6.1e-01
cases:12.60%
controls:9.34%
cases:8.08%
controls:4.86%
cases:1.86%
controls:0.72%
cases:0.68%
controls:0.03%
cases:1.81%
controls:0.71%
cases:8.37%
controls:4.36%
cases:18.31%
controls:10.89%
223
1651
1547
16019
143
859
1627
16811
33
128
1737
17542
12
6
1758
17664
32
125
1736
17515
143
750
1565
16441
270
1648
1205
13492
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
4.1e-01
1.2e+00
2.1e+00
1.0e+50
1.6e+00
1.2e+00
9.4e-01
cases:2.20%
controls:1.47%
cases:2.26%
controls:0.68%
cases:0.68%
controls:0.08%
cases:0.45%
controls:0.00%
cases:0.68%
controls:0.14%
cases:2.40%
controls:0.74%
cases:6.58%
controls:2.69%
39
260
1731
17410
40
120
1730
17550
12
15
1758
17655
8
0
1762
17670
12
24
1756
17616
41
127
1667
17064
97
407
1378
14733
Multiple myeloma
C90.0 [45600562]
C90.0 [45600562]
—
—
—
—
1.9e+00
2.7e+00
2.5e+00
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.06%
cases:1.23%
controls:0.08%
cases:1.22%
controls:0.11%
—
—
—
—
7
11
1761
17629
21
14
1687
17177
18
16
1457
15124
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
1.3e+00
1.2e+00
—
—
1.3e+00
2.1e+00
2.4e+00
cases:0.90%
controls:0.25%
cases:0.68%
controls:0.20%
—
—
—
—
cases:0.28%
controls:0.08%
cases:1.58%
controls:0.19%
cases:2.64%
controls:0.25%
16
44
1754
17626
12
35
1758
17635
—
—
5
14
1763
17626
27
33
1681
17158
39
38
1436
15102
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
7.9e-01
1.4e+00
2.6e+00
—
2.1e+00
1.5e+00
7.4e-01
cases:1.58%
controls:0.72%
cases:1.13%
controls:0.27%
cases:0.51%
controls:0.04%
—
—
cases:0.28%
controls:0.03%
cases:1.70%
controls:0.39%
cases:2.78%
controls:1.35%
28
128
1742
17542
20
48
1750
17622
9
7
1761
17663
—
5
6
1763
17634
29
67
1679
17124
41
204
1434
14936
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.1e+00
1.1e+00
1.2e+00
—
1.4e+00
1.6e+00
1.6e+00
cases:1.58%
controls:0.51%
cases:1.19%
controls:0.40%
cases:0.45%
controls:0.13%
—
—
cases:0.57%
controls:0.14%
cases:1.87%
controls:0.37%
cases:2.71%
controls:0.54%
28
91
1742
17579
21
70
1749
17600
8
23
1762
17647
—
10
24
1758
17616
32
64
1676
17127
40
81
1435
15059
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
6.6e-01
7.1e-01
1.9e+00
—
1.8e+00
1.0e+00
7.2e-01
cases:5.99%
controls:3.19%
cases:3.39%
controls:1.70%
cases:1.47%
controls:0.22%
—
—
cases:1.47%
controls:0.24%
cases:4.98%
controls:1.80%
cases:11.05%
controls:5.72%
106
564
1664
17106
60
301
1710
17369
26
38
1744
17632
—
26
42
1742
17598
85
310
1623
16881
163
866
1312
14274
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
1.2e+00
2.1e+00
—
1.0e+50
1.9e+00
1.7e+00
4.6e-01
cases:0.90%
controls:0.27%
cases:0.90%
controls:0.11%
—
—
cases:0.62%
controls:0.00%
cases:0.40%
controls:0.06%
cases:1.00%
controls:0.17%
cases:1.29%
controls:0.82%
16
48
1754
17622
16
20
1754
17650
—
11
0
1759
17670
7
11
1761
17629
17
30
1691
17161
19
124
1456
15016
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
4.7e-02
3.4e-01
1.2e+00
2.8e+00
1.3e+00
7.6e-01
8.3e-01
cases:4.24%
controls:4.05%
cases:3.28%
controls:2.35%
cases:1.41%
controls:0.44%
cases:0.45%
controls:0.03%
cases:1.75%
controls:0.48%
cases:4.57%
controls:2.20%
cases:10.98%
controls:5.11%
75
716
1695
16954
58
415
1712
17255
25
77
1745
17593
8
5
1762
17665
31
85
1737
17555
78
378
1630
16813
162
773
1313
14367
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.5e-01
5.4e-01
1.1e+00
2.2e+00
1.4e+00
6.6e-01
5.0e-01
cases:38.70%
controls:28.72%
cases:15.37%
controls:9.57%
cases:3.11%
controls:1.05%
cases:0.40%
controls:0.05%
cases:3.68%
controls:0.92%
cases:15.87%
controls:8.92%
cases:39.32%
controls:28.30%
685
5074
1085
12596
272
1691
1498
15979
55
186
1715
17484
7
8
1763
17662
65
162
1703
17478
271
1533
1437
15658
580
4284
895
10856
candesartan; oral
C09CA06 [21601829]
C09CA06 [21601829]
3.9e-01
5.0e-01
6.0e-01
2.4e+00
1.4e+00
1.1e+00
1.0e+00
cases:6.16%
controls:4.24%
cases:5.82%
controls:3.62%
cases:1.86%
controls:1.03%
cases:0.62%
controls:0.06%
cases:3.68%
controls:0.91%
cases:10.54%
controls:3.77%
cases:14.58%
controls:5.87%
109
750
1661
16920
103
640
1667
17030
33
182
1737
17488
11
10
1759
17660
65
161
1703
17479
180
648
1528
16543
215
889
1260
14251
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
1.1e+00
2.0e+00
—
—
—
2.3e+00
1.4e+00
cases:1.19%
controls:0.40%
cases:1.58%
controls:0.21%
—
—
—
—
—
—
cases:1.87%
controls:0.19%
cases:2.17%
controls:0.56%
21
70
1749
17600
28
37
1742
17633
—
—
—
32
33
1676
17158
32
85
1443
15055
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
4.7e-02
3.3e-01
1.5e+00
3.4e+00
1.2e+00
3.6e-01
1.2e-01
cases:21.58%
controls:20.79%
cases:22.09%
controls:16.91%
cases:14.46%
controls:3.54%
cases:5.71%
controls:0.20%
cases:11.26%
controls:3.80%
cases:23.54%
controls:17.64%
cases:35.86%
controls:33.15%
382
3674
1388
13996
391
2988
1379
14682
256
626
1514
17044
101
36
1669
17634
199
670
1569
16970
402
3032
1306
14159
529
5019
946
10121
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
4.9e-01
9.9e-01
1.7e+00
—
2.0e+00
1.1e+00
4.8e-01
cases:3.79%
controls:2.35%
cases:2.32%
controls:0.88%
cases:0.73%
controls:0.14%
—
—
cases:0.74%
controls:0.10%
cases:2.34%
controls:0.81%
cases:4.54%
controls:2.87%
67
416
1703
17254
41
155
1729
17515
13
24
1757
17646
—
13
17
1755
17623
40
139
1668
17052
67
435
1408
14705
Chronic kidney disease
N18 [45582391]
N18 [45582391]
1.0e+00
1.9e+00
—
—
—
2.6e+00
2.3e+00
cases:0.51%
controls:0.19%
cases:0.51%
controls:0.08%
—
—
—
—
—
—
cases:1.11%
controls:0.09%
cases:2.64%
controls:0.26%
9
33
1761
17637
9
14
1761
17656
—
—
—
19
15
1689
17176
39
40
1436
15100
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
8.7e-01
2.1e+00
—
—
—
2.4e+00
1.4e+00
cases:1.07%
controls:0.45%
cases:1.81%
controls:0.22%
—
—
—
—
—
—
cases:1.58%
controls:0.15%
cases:1.97%
controls:0.52%
19
80
1751
17590
32
39
1738
17631
—
—
—
27
25
1681
17166
29
78
1446
15062
Biopsy of kidney with ultrasound guidance
KA3AT [2001305778]
KA3AT [2001305778]
—
3.0e+00
—
1.0e+50
1.0e+50
—
3.7e+00
—
—
cases:0.56%
controls:0.03%
—
—
cases:2.82%
controls:0.00%
cases:4.02%
controls:0.00%
—
—
cases:2.78%
controls:0.07%
—
10
5
1760
17665
—
50
0
1720
17670
71
0
1697
17640
—
41
11
1434
15129
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
1.6e+00
1.8e+00
—
—
—
1.9e+00
1.3e+00
cases:0.85%
controls:0.16%
cases:0.51%
controls:0.08%
—
—
—
—
—
—
cases:0.47%
controls:0.07%
cases:0.95%
controls:0.26%
15
29
1755
17641
9
15
1761
17655
—
—
—
8
12
1700
17179
14
39
1461
15101
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
9.5e-01
1.5e+00
—
—
—
2.3e+00
1.9e+00
cases:1.19%
controls:0.46%
cases:0.85%
controls:0.19%
—
—
—
—
—
—
cases:1.99%
controls:0.20%
cases:3.39%
controls:0.51%
21
82
1749
17588
15
34
1755
17636
—
—
—
34
35
1674
17156
50
77
1425
15063
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
3.3e-01
7.2e-01
1.1e+00
2.5e+00
1.1e+00
5.3e-01
4.0e-01
cases:10.11%
controls:7.47%
cases:6.44%
controls:3.25%
cases:1.75%
controls:0.57%
cases:0.34%
controls:0.03%
cases:1.75%
controls:0.62%
cases:5.44%
controls:3.28%
cases:12.88%
controls:9.02%
179
1320
1591
16350
114
575
1656
17095
31
101
1739
17569
6
5
1764
17665
31
109
1737
17531
93
564
1615
16627
190
1366
1285
13774
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
8.1e-01
1.3e+00
1.8e+00
1.0e+50
2.3e+00
1.2e+00
9.9e-01
cases:1.86%
controls:0.84%
cases:1.07%
controls:0.29%
cases:0.28%
controls:0.05%
cases:0.62%
controls:0.00%
cases:0.40%
controls:0.04%
cases:1.23%
controls:0.36%
cases:4.07%
controls:1.55%
33
148
1737
17522
19
52
1751
17618
5
8
1765
17662
11
0
1759
17670
7
7
1761
17633
21
62
1687
17129
60
234
1415
14906
Immunofixation for Serum or Plasma
25700-6 [3037756]
25700-6 [3037756]
1.3e+00
1.8e+00
—
—
—
1.8e+00
1.7e+00
cases:0.85%
controls:0.24%
cases:0.68%
controls:0.11%
—
—
—
—
—
—
cases:1.17%
controls:0.20%
cases:1.83%
controls:0.32%
15
42
1755
17628
12
19
1758
17651
—
—
—
20
35
1688
17156
27
49
1448
15091
Chronic disorders of vitamin D metabolism
123 [2001600122]
123 [2001600122]
1.3e+00
—
—
—
—
3.3e+00
3.3e+00
cases:0.45%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.04%
cases:3.80%
controls:0.15%
8
21
1762
17649
—
—
—
—
19
7
1689
17184
56
23
1419
15117
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
24467-3 [3028167]
1.9e+00
2.5e+00
—
—
—
—
2.1e+00
cases:0.40%
controls:0.06%
cases:0.34%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.07%
7
10
1763
17660
6
5
1764
17665
—
—
—
—
8
10
1467
15130
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
2.4e-01
7.4e-01
2.0e+00
—
2.2e+00
1.2e+00
4.8e-01
cases:8.25%
controls:6.61%
cases:5.76%
controls:2.85%
cases:2.20%
controls:0.30%
—
—
cases:3.22%
controls:0.39%
cases:7.85%
controls:2.62%
cases:13.76%
controls:8.96%
146
1168
1624
16502
102
503
1668
17167
39
53
1731
17617
—
57
68
1711
17572
134
451
1574
16740
203
1357
1272
13783
pivmecillinam; oral
J01CA08 [21602827]
J01CA08 [21602827]
5.7e-01
1.1e+00
1.7e+00
—
1.7e+00
8.9e-01
5.5e-01
cases:11.02%
controls:6.55%
cases:6.33%
controls:2.22%
cases:1.30%
controls:0.23%
—
—
cases:1.64%
controls:0.32%
cases:5.80%
controls:2.45%
cases:11.86%
controls:7.19%
195
1158
1575
16512
112
393
1658
17277
23
41
1747
17629
—
29
56
1739
17584
99
422
1609
16769
175
1088
1300
14052
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
1.7e-01
8.7e-01
2.0e+00
—
2.5e+00
1.1e+00
1.8e-01
cases:6.10%
controls:5.18%
cases:3.05%
controls:1.31%
cases:1.13%
controls:0.15%
—
—
cases:1.98%
controls:0.16%
cases:3.63%
controls:1.30%
cases:6.17%
controls:5.20%
108
916
1662
16754
54
231
1716
17439
20
27
1750
17643
—
35
28
1733
17612
62
223
1646
16968
91
788
1384
14352
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
5.8e-01
9.0e-01
1.4e+00
—
1.7e+00
1.1e+00
7.7e-01
cases:15.37%
controls:9.26%
cases:9.44%
controls:4.06%
cases:2.49%
controls:0.63%
—
—
cases:3.73%
controls:0.70%
cases:11.48%
controls:4.11%
cases:20.20%
controls:10.45%
272
1637
1498
16033
167
718
1603
16952
44
111
1726
17559
—
66
124
1702
17516
196
707
1512
16484
298
1582
1177
13558
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
5.4e-01
1.3e+00
1.4e+00
—
1.9e+00
1.7e+00
1.5e+00
cases:1.75%
controls:1.02%
cases:1.30%
controls:0.35%
cases:0.34%
controls:0.08%
—
—
cases:0.79%
controls:0.12%
cases:2.22%
controls:0.40%
cases:4.20%
controls:0.97%
31
181
1739
17489
23
62
1747
17608
6
15
1764
17655
—
14
21
1754
17619
38
69
1670
17122
62
147
1413
14993
Hypertension secondary to other renal disorders
I15.1 [45557535]
I15.1 [45557535]
—
—
—
—
—
3.1e+00
3.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.06%
cases:3.12%
controls:0.12%
—
—
—
—
—
25
11
1683
17180
46
18
1429
15122
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.7e-01
9.0e-01
1.4e+00
—
1.7e+00
1.1e+00
7.7e-01
cases:15.37%
controls:9.29%
cases:9.44%
controls:4.08%
cases:2.49%
controls:0.63%
—
—
cases:3.73%
controls:0.70%
cases:11.48%
controls:4.11%
cases:20.27%
controls:10.52%
272
1642
1498
16028
167
721
1603
16949
44
111
1726
17559
—
66
124
1702
17516
196
707
1512
16484
299
1592
1176
13548
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
5.1e-01
7.1e-01
1.5e+00
—
1.8e+00
1.1e+00
7.0e-01
cases:13.50%
controls:8.59%
cases:5.54%
controls:2.80%
cases:1.81%
controls:0.39%
—
—
cases:2.32%
controls:0.37%
cases:7.79%
controls:2.68%
cases:14.98%
controls:8.08%
239
1518
1531
16152
98
495
1672
17175
32
69
1738
17601
—
41
66
1727
17574
133
461
1575
16730
221
1223
1254
13917
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
8.7e-02
4.0e-01
1.5e+00
2.8e+00
1.1e+00
4.3e-01
2.5e-01
cases:26.33%
controls:24.67%
cases:26.16%
controls:19.26%
cases:13.67%
controls:3.48%
cases:2.60%
controls:0.16%
cases:9.33%
controls:3.40%
cases:28.34%
controls:20.49%
cases:44.34%
controls:38.36%
466
4360
1304
13310
463
3403
1307
14267
242
615
1528
17055
46
29
1724
17641
165
600
1603
17040
484
3523
1224
13668
654
5807
821
9333
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
3.1e-01
7.2e-01
1.9e+00
1.0e+50
2.4e+00
1.4e+00
7.7e-01
cases:1.98%
controls:1.45%
cases:1.36%
controls:0.66%
cases:0.51%
controls:0.08%
cases:0.51%
controls:0.00%
cases:0.79%
controls:0.07%
cases:2.46%
controls:0.62%
cases:4.47%
controls:2.12%
35
257
1735
17413
24
117
1746
17553
9
14
1761
17656
9
0
1761
17670
14
13
1754
17627
42
107
1666
17084
66
321
1409
14819
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
D47.2 [45566693]
1.1e+00
2.0e+00
—
—
—
2.3e+00
2.1e+00
cases:0.28%
controls:0.10%
cases:0.45%
controls:0.06%
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:1.02%
controls:0.13%
5
17
1765
17653
8
11
1762
17659
—
—
—
12
12
1696
17179
15
19
1460
15121
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
6.3e-02
2.4e-01
1.4e+00
3.4e+00
1.2e+00
2.8e-01
8.4e-02
cases:32.60%
controls:31.23%
cases:35.42%
controls:30.08%
cases:29.89%
controls:9.86%
cases:14.12%
controls:0.57%
cases:25.96%
controls:9.91%
cases:38.11%
controls:31.82%
cases:50.37%
controls:48.28%
577
5518
1193
12152
627
5315
1143
12355
529
1743
1241
15927
250
100
1520
17570
459
1749
1309
15891
651
5471
1057
11720
743
7309
732
7831
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.3e-01
7.3e-01
6.7e-01
1.8e+00
1.1e+00
1.1e+00
1.1e+00
cases:94.69%
controls:93.38%
cases:90.56%
controls:82.29%
cases:61.02%
controls:44.48%
cases:12.77%
controls:2.46%
cases:69.74%
controls:44.10%
cases:93.44%
controls:82.94%
cases:98.24%
controls:94.93%
1676
16500
94
1170
1603
14541
167
3129
1080
7860
690
9810
226
434
1544
17236
1233
7780
535
9860
1596
14258
112
2933
1449
14372
26
768
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
7.5e-01
5.6e-01
2.2e+00
—
3.2e+00
8.0e-01
1.0e+00
cases:1.36%
controls:0.65%
cases:0.62%
controls:0.36%
cases:0.68%
controls:0.08%
—
—
cases:0.68%
controls:0.03%
cases:0.88%
controls:0.40%
cases:1.97%
controls:0.71%
24
114
1746
17556
11
63
1759
17607
12
14
1758
17656
—
12
5
1756
17635
15
68
1693
17123
29
108
1446
15032
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
4.3e-01
7.8e-01
2.0e+00
—
1.5e+00
8.9e-01
7.4e-01
cases:5.14%
controls:3.41%
cases:3.84%
controls:1.79%
cases:1.30%
controls:0.18%
—
—
cases:1.24%
controls:0.27%
cases:4.92%
controls:2.07%
cases:11.80%
controls:6.02%
91
602
1679
17068
68
317
1702
17353
23
32
1747
17638
—
22
48
1746
17592
84
356
1624
16835
174
911
1301
14229
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
3.9e-01
1.3e+00
2.7e+00
—
—
1.3e+00
1.0e+00
cases:1.58%
controls:1.08%
cases:1.30%
controls:0.36%
cases:0.51%
controls:0.03%
—
—
—
—
cases:1.05%
controls:0.29%
cases:3.59%
controls:1.33%
28
190
1742
17480
23
63
1747
17607
9
6
1761
17664
—
—
18
49
1690
17142
53
201
1422
14939
Malignant neoplasm of renal pelvis
C65 [45552268]
C65 [45552268]
2.1e+00
—
—
—
—
3.1e+00
3.3e+00
cases:0.28%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.03%
cases:1.02%
controls:0.04%
5
6
1765
17664
—
—
—
—
13
6
1695
17185
15
6
1460
15134
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
2.5e-01
9.5e-01
1.9e+00
—
2.0e+00
8.1e-01
6.3e-01
cases:2.94%
controls:2.30%
cases:2.54%
controls:1.00%
cases:0.56%
controls:0.08%
—
—
cases:0.68%
controls:0.09%
cases:2.28%
controls:1.02%
cases:6.58%
controls:3.60%
52
407
1718
17263
45
176
1725
17494
10
15
1760
17655
—
12
16
1756
17624
39
176
1669
17015
97
545
1378
14595
losartan; oral
C09CA01 [21601824]
C09CA01 [21601824]
2.8e-01
4.9e-01
5.7e-01
2.8e+00
1.0e+00
1.1e+00
8.7e-01
cases:6.21%
controls:4.78%
cases:6.72%
controls:4.22%
cases:2.32%
controls:1.32%
cases:0.85%
controls:0.05%
cases:3.51%
controls:1.28%
cases:12.00%
controls:4.44%
cases:14.44%
controls:6.59%
110
845
1660
16825
119
746
1651
16924
41
233
1729
17437
15
9
1755
17661
62
226
1706
17414
205
764
1503
16427
213
997
1262
14143
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
5.3e-01
9.2e-01
1.7e+00
—
1.6e+00
8.3e-01
6.7e-01
cases:4.63%
controls:2.77%
cases:2.94%
controls:1.19%
cases:0.73%
controls:0.14%
—
—
cases:0.79%
controls:0.16%
cases:3.16%
controls:1.41%
cases:8.20%
controls:4.37%
82
490
1688
17180
52
210
1718
17460
13
24
1757
17646
—
14
28
1754
17612
54
242
1654
16949
121
661
1354
14479
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
3.1e-01
1.0e+00
2.0e+00
—
1.8e+00
8.3e-01
5.3e-01
cases:5.71%
controls:4.26%
cases:4.29%
controls:1.58%
cases:1.58%
controls:0.22%
—
—
cases:1.30%
controls:0.21%
cases:4.57%
controls:2.04%
cases:10.24%
controls:6.27%
101
752
1669
16918
76
280
1694
17390
28
38
1742
17632
—
23
37
1745
17603
78
350
1630
16841
151
950
1324
14190
labetalol; oral, parenteral
C07AG01 [21601699]
C07AG01 [21601699]
—
2.3e+00
—
—
—
2.3e+00
1.6e+00
—
—
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:0.64%
controls:0.06%
cases:0.95%
controls:0.19%
—
9
9
1761
17661
—
—
—
11
11
1697
17180
14
29
1461
15111
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.3e-01
7.6e-01
2.1e+00
—
1.3e+00
9.7e-01
7.5e-01
cases:7.23%
controls:5.32%
cases:6.44%
controls:3.13%
cases:3.11%
controls:0.37%
—
—
cases:1.53%
controls:0.43%
cases:8.37%
controls:3.34%
cases:18.51%
controls:9.71%
128
940
1642
16730
114
553
1656
17117
55
66
1715
17604
—
27
76
1741
17564
143
574
1565
16617
273
1470
1202
13670
Transluminal endoscopic removal of stent from ureter
KBV12 [2001305895]
KBV12 [2001305895]
2.0e+00
—
—
—
—
2.5e+00
1.7e+00
cases:0.73%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:0.75%
controls:0.14%
13
17
1757
17653
—
—
—
—
6
5
1702
17186
11
21
1464
15119
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-8.2e-01
-8.1e-01
1.5e-01
—
2.4e+00
2.6e+00
2.8e+00
cases:12.09%
controls:23.72%
cases:3.67%
controls:7.87%
cases:0.85%
controls:0.73%
—
—
cases:0.85%
controls:0.08%
cases:5.44%
controls:0.42%
cases:14.51%
controls:0.98%
214
4191
1556
13479
65
1391
1705
16279
15
129
1755
17541
—
15
14
1753
17626
93
72
1615
17119
214
149
1261
14991
Neurology
13 [38004458]
13 [38004458]
2.5e-01
6.2e-01
1.1e+00
3.4e+00
6.7e-01
7.1e-01
4.0e-01
cases:12.09%
controls:9.72%
cases:7.23%
controls:4.02%
cases:1.86%
controls:0.66%
cases:0.85%
controls:0.03%
cases:1.41%
controls:0.73%
cases:7.32%
controls:3.75%
cases:14.58%
controls:10.30%
214
1717
1556
15953
128
711
1642
16959
33
116
1737
17554
15
5
1755
17665
25
128
1743
17512
125
644
1583
16547
215
1559
1260
13581
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
5.4e-01
9.6e-01
1.7e+00
—
1.6e+00
9.4e-01
4.7e-01
cases:6.95%
controls:4.18%
cases:4.52%
controls:1.79%
cases:1.30%
controls:0.25%
—
—
cases:1.13%
controls:0.23%
cases:4.86%
controls:1.95%
cases:10.44%
controls:6.80%
123
739
1647
16931
80
316
1690
17354
23
44
1747
17626
—
20
41
1748
17599
83
335
1625
16856
154
1029
1321
14111
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
1.4e-01
3.9e-01
1.2e+00
3.1e+00
8.0e-01
4.0e-01
2.9e-01
cases:15.03%
controls:13.34%
cases:10.68%
controls:7.50%
cases:2.66%
controls:0.84%
cases:0.62%
controls:0.03%
cases:2.04%
controls:0.92%
cases:10.48%
controls:7.28%
cases:24.00%
controls:19.07%
266
2358
1504
15312
189
1325
1581
16345
47
148
1723
17522
11
5
1759
17665
36
163
1732
17477
179
1252
1529
15939
354
2887
1121
12253
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.2e-01
9.3e-01
1.6e+00
—
1.7e+00
8.3e-01
5.3e-01
cases:5.42%
controls:3.29%
cases:4.75%
controls:1.94%
cases:1.24%
controls:0.26%
—
—
cases:1.64%
controls:0.29%
cases:5.21%
controls:2.34%
cases:12.41%
controls:7.66%
96
581
1674
17089
84
342
1686
17328
22
46
1748
17624
—
29
51
1739
17589
89
403
1619
16788
183
1160
1292
13980
Gastroenterology
10 [38004455]
10 [38004455]
6.4e-01
9.0e-01
1.2e+00
—
1.3e+00
1.2e+00
8.7e-01
cases:7.63%
controls:4.17%
cases:4.35%
controls:1.81%
cases:1.24%
controls:0.38%
—
—
cases:1.13%
controls:0.30%
cases:5.74%
controls:1.84%
cases:11.66%
controls:5.25%
135
737
1635
16933
77
320
1693
17350
22
67
1748
17603
—
20
53
1748
17587
98
316
1610
16875
172
795
1303
14345
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
9.6e-02
5.9e-01
1.9e+00
—
2.6e+00
1.0e+00
2.7e-01
cases:3.84%
controls:3.50%
cases:2.37%
controls:1.33%
cases:0.56%
controls:0.08%
—
—
cases:1.53%
controls:0.11%
cases:3.10%
controls:1.16%
cases:5.69%
controls:4.39%
68
619
1702
17051
42
235
1728
17435
10
15
1760
17655
—
27
20
1741
17620
53
199
1655
16992
84
665
1391
14475
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
4.1e-01
6.8e-01
1.8e+00
—
1.6e+00
9.1e-01
7.4e-01
cases:7.46%
controls:5.06%
cases:6.05%
controls:3.15%
cases:2.94%
controls:0.50%
—
—
cases:2.71%
controls:0.58%
cases:7.49%
controls:3.17%
cases:13.90%
controls:7.17%
132
894
1638
16776
107
556
1663
17114
52
88
1718
17582
—
48
103
1720
17537
128
545
1580
16646
205
1085
1270
14055
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.8e-01
8.2e-01
1.8e+00
—
1.7e+00
9.0e-01
5.3e-01
cases:12.88%
controls:9.15%
cases:10.56%
controls:4.96%
cases:3.73%
controls:0.62%
—
—
cases:3.45%
controls:0.68%
cases:11.18%
controls:4.89%
cases:22.71%
controls:14.80%
228
1617
1542
16053
187
877
1583
16793
66
110
1704
17560
—
61
120
1707
17520
191
841
1517
16350
335
2240
1140
12900
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
5.2e-01
9.2e-01
1.8e+00
1.0e+50
2.0e+00
8.8e-01
5.7e-01
cases:2.54%
controls:1.52%
cases:2.26%
controls:0.91%
cases:0.85%
controls:0.15%
cases:0.85%
controls:0.00%
cases:0.96%
controls:0.14%
cases:2.69%
controls:1.13%
cases:5.22%
controls:3.03%
45
269
1725
17401
40
161
1730
17509
15
26
1755
17644
15
0
1755
17670
17
24
1751
17616
46
195
1662
16996
77
458
1398
14682
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
14278-6 [3003284]
5.7e-01
2.2e+00
—
—
—
2.5e+00
1.4e+00
cases:0.51%
controls:0.29%
cases:0.85%
controls:0.10%
—
—
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.02%
controls:0.26%
9
51
1761
17619
15
17
1755
17653
—
—
—
12
10
1696
17181
15
39
1460
15101
lercanidipine; oral
C08CA13 [21601759]
C08CA13 [21601759]
6.2e-01
8.7e-01
1.2e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:5.03%
controls:2.78%
cases:5.08%
controls:2.18%
cases:2.09%
controls:0.65%
—
—
cases:2.09%
controls:0.62%
cases:6.21%
controls:2.22%
cases:9.56%
controls:3.53%
89
491
1681
17179
90
386
1680
17284
37
114
1733
17556
—
37
110
1731
17530
106
381
1602
16810
141
534
1334
14606
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
1.2e+00
2.0e+00
—
—
—
1.6e+00
1.2e+00
cases:0.90%
controls:0.27%
cases:0.68%
controls:0.10%
—
—
—
—
—
—
cases:0.70%
controls:0.14%
cases:1.63%
controls:0.48%
16
48
1754
17622
12
17
1758
17653
—
—
—
12
24
1696
17167
24
73
1451
15067
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
8.6e-01
2.4e+00
—
—
—
2.4e+00
1.2e+00
cases:0.73%
controls:0.31%
cases:1.64%
controls:0.15%
—
—
—
—
—
—
cases:1.41%
controls:0.13%
cases:1.49%
controls:0.47%
13
55
1757
17615
29
26
1741
17644
—
—
—
24
22
1684
17169
22
71
1453
15069
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
9.9e-01
1.2e+00
1.8e+00
—
2.2e+00
1.0e+00
6.5e-01
cases:1.75%
controls:0.66%
cases:1.13%
controls:0.35%
cases:0.28%
controls:0.05%
—
—
cases:0.40%
controls:0.05%
cases:1.35%
controls:0.49%
cases:2.71%
controls:1.43%
31
116
1739
17554
20
62
1750
17608
5
8
1765
17662
—
7
8
1761
17632
23
85
1685
17106
40
217
1435
14923
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
14277-8 [3004383]
5.7e-01
2.1e+00
—
—
—
2.5e+00
1.4e+00
cases:0.51%
controls:0.29%
cases:0.85%
controls:0.10%
—
—
—
—
—
—
cases:0.76%
controls:0.06%
cases:1.02%
controls:0.26%
9
51
1761
17619
15
18
1755
17652
—
—
—
13
11
1695
17180
15
39
1460
15101
Pediatric Nephrology
OMOP4822026 [45756813]
OMOP4822026 [45756813]
—
—
—
—
—
3.0e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.03%
cases:1.02%
controls:0.05%
—
—
—
—
—
12
6
1696
17185
15
8
1460
15132
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
3.4e-01
9.5e-01
7.2e-01
—
2.5e+00
1.5e+00
9.8e-01
cases:6.27%
controls:4.54%
cases:3.79%
controls:1.51%
cases:0.51%
controls:0.25%
—
—
cases:2.21%
controls:0.18%
cases:5.97%
controls:1.37%
cases:8.54%
controls:3.38%
111
802
1659
16868
67
266
1703
17404
9
44
1761
17626
—
39
32
1729
17608
102
235
1606
16956
126
512
1349
14628
Chloride [Moles/volume] in Venous blood
41649-5 [3035285]
41649-5 [3035285]
1.5e+00
2.3e+00
—
1.0e+50
—
2.1e+00
2.3e-01
cases:0.73%
controls:0.16%
cases:0.51%
controls:0.05%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.64%
controls:0.08%
cases:0.54%
controls:0.43%
13
28
1757
17642
9
9
1761
17661
—
7
0
1763
17670
—
11
14
1697
17177
8
65
1467
15075
Potassium [Moles/volume] in Venous blood
39789-3 [3041354]
39789-3 [3041354]
1.5e+00
2.3e+00
—
1.0e+50
—
2.1e+00
2.3e-01
cases:0.73%
controls:0.16%
cases:0.51%
controls:0.05%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.64%
controls:0.08%
cases:0.54%
controls:0.43%
13
28
1757
17642
9
9
1761
17661
—
7
0
1763
17670
—
11
14
1697
17177
8
65
1467
15075
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.8e-02
6.5e-01
1.7e+00
—
1.8e+00
1.1e+00
6.2e-01
cases:4.86%
controls:4.69%
cases:3.67%
controls:1.96%
cases:1.19%
controls:0.21%
—
—
cases:1.41%
controls:0.24%
cases:5.33%
controls:1.83%
cases:10.51%
controls:5.92%
86
828
1684
16842
65
346
1705
17324
21
37
1749
17633
—
25
42
1743
17598
91
314
1617
16877
155
896
1320
14244
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.5e-01
7.6e-01
2.0e+00
—
1.6e+00
8.0e-01
4.3e-01
cases:8.36%
controls:6.03%
cases:6.27%
controls:3.03%
cases:2.20%
controls:0.31%
—
—
cases:1.98%
controls:0.42%
cases:6.32%
controls:2.96%
cases:13.56%
controls:9.27%
148
1066
1622
16604
111
536
1659
17134
39
54
1731
17616
—
35
74
1733
17566
108
508
1600
16683
200
1403
1275
13737
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.2e+00
1.6e+00
—
—
—
1.7e+00
2.6e+00
cases:0.40%
controls:0.12%
cases:0.51%
controls:0.11%
—
—
—
—
—
—
cases:0.47%
controls:0.09%
cases:2.37%
controls:0.17%
7
21
1763
17649
9
19
1761
17651
—
—
—
8
15
1700
17176
35
26
1440
15114
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
41645-3 [3033705]
1.5e+00
2.3e+00
—
1.0e+50
—
2.1e+00
2.5e-01
cases:0.68%
controls:0.15%
cases:0.51%
controls:0.05%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.64%
controls:0.08%
cases:0.54%
controls:0.42%
12
27
1758
17643
9
9
1761
17661
—
7
0
1763
17670
—
11
14
1697
17177
8
64
1467
15076
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
6.2e-01
1.3e+00
9.2e-01
—
1.8e+00
1.3e+00
8.9e-01
cases:2.26%
controls:1.23%
cases:2.20%
controls:0.62%
cases:0.34%
controls:0.14%
—
—
cases:0.74%
controls:0.12%
cases:3.10%
controls:0.87%
cases:4.75%
controls:2.01%
40
218
1730
17452
39
110
1731
17560
6
24
1764
17646
—
13
22
1755
17618
53
149
1655
17042
70
305
1405
14835
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
6969-0 [3023150]
1.1e+00
2.0e+00
—
—
—
2.3e+00
1.6e+00
cases:0.51%
controls:0.16%
cases:0.79%
controls:0.11%
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:1.22%
controls:0.25%
9
29
1761
17641
14
20
1756
17650
—
—
—
8
8
1700
17183
18
38
1457
15102
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
6.6e-01
1.2e+00
1.9e+00
—
1.7e+00
1.4e+00
7.8e-01
cases:1.98%
controls:1.04%
cases:1.36%
controls:0.43%
cases:0.40%
controls:0.06%
—
—
cases:0.28%
controls:0.05%
cases:2.17%
controls:0.55%
cases:4.27%
controls:2.01%
35
183
1735
17487
24
76
1746
17594
7
11
1763
17659
—
5
9
1763
17631
37
94
1671
17097
63
304
1412
14836
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
3.9e-01
7.3e-01
1.4e+00
—
1.5e+00
1.2e+00
6.9e-01
cases:6.21%
controls:4.30%
cases:2.77%
controls:1.35%
cases:0.96%
controls:0.25%
—
—
cases:1.07%
controls:0.24%
cases:3.86%
controls:1.26%
cases:8.47%
controls:4.44%
110
759
1660
16911
49
239
1721
17431
17
44
1753
17626
—
19
43
1749
17597
66
216
1642
16975
125
672
1350
14468
Inpatient Visit
IP [9201]
IP [9201]
2.7e-01
7.9e-01
1.3e+00
—
1.8e+00
1.2e+00
6.3e-01
cases:5.76%
controls:4.48%
cases:4.35%
controls:2.03%
cases:0.85%
controls:0.23%
—
—
cases:1.70%
controls:0.28%
cases:5.97%
controls:1.82%
cases:11.66%
controls:6.55%
102
791
1668
16879
77
358
1693
17312
15
40
1755
17630
—
30
49
1738
17591
102
313
1606
16878
172
992
1303
14148
Hypertensive renal disease with renal failure
I12.0 [45596187]
I12.0 [45596187]
1.7e+00
—
—
1.0e+50
—
2.9e+00
2.9e+00
cases:0.28%
controls:0.05%
—
—
—
—
cases:0.40%
controls:0.00%
—
—
cases:1.05%
controls:0.06%
cases:1.63%
controls:0.09%
5
9
1765
17661
—
—
7
0
1763
17670
—
18
10
1690
17181
24
14
1451
15126
allopurinol; oral, parenteral
M04AA01 [21604131]
M04AA01 [21604131]
8.2e-01
9.3e-01
9.2e-01
—
8.7e-01
9.5e-01
1.3e+00
cases:6.21%
controls:2.84%
cases:5.25%
controls:2.14%
cases:1.19%
controls:0.48%
—
—
cases:1.36%
controls:0.57%
cases:5.80%
controls:2.33%
cases:11.19%
controls:3.34%
110
501
1660
17169
93
378
1677
17292
21
84
1749
17586
—
24
101
1744
17539
99
400
1609
16791
165
505
1310
14635
Polyuria
R35 [45539331]
R35 [45539331]
4.6e-01
1.9e+00
2.1e+00
1.0e+50
—
1.8e+00
4.5e-01
cases:1.13%
controls:0.72%
cases:1.13%
controls:0.18%
cases:0.34%
controls:0.04%
cases:0.51%
controls:0.00%
—
—
cases:1.23%
controls:0.22%
cases:1.49%
controls:0.96%
20
127
1750
17543
20
31
1750
17639
6
7
1764
17663
9
0
1761
17670
—
21
37
1687
17154
22
145
1453
14995
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
4.3e-01
9.6e-01
2.6e+00
1.0e+50
1.8e+00
1.1e+00
1.0e+00
cases:2.03%
controls:1.33%
cases:1.30%
controls:0.50%
cases:0.79%
controls:0.06%
cases:1.30%
controls:0.00%
cases:0.34%
controls:0.06%
cases:1.41%
controls:0.46%
cases:4.95%
controls:1.80%
36
235
1734
17435
23
89
1747
17581
14
10
1756
17660
23
0
1747
17670
6
10
1762
17630
24
79
1684
17112
73
272
1402
14868
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
8.0e-02
5.9e-01
1.4e+00
—
2.0e+00
1.1e+00
7.2e-01
cases:3.95%
controls:3.66%
cases:3.50%
controls:1.98%
cases:1.13%
controls:0.29%
—
—
cases:2.09%
controls:0.30%
cases:4.80%
controls:1.61%
cases:9.56%
controls:4.91%
70
647
1700
17023
62
350
1708
17320
20
51
1750
17619
—
37
53
1731
17587
82
276
1626
16915
141
744
1334
14396
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
7.6e-01
9.0e-01
1.5e+00
—
2.1e+00
1.1e+00
8.6e-01
cases:2.09%
controls:0.99%
cases:1.47%
controls:0.60%
cases:0.34%
controls:0.07%
—
—
cases:0.57%
controls:0.07%
cases:1.52%
controls:0.54%
cases:3.53%
controls:1.53%
37
175
1733
17495
26
106
1744
17564
6
13
1764
17657
—
10
12
1758
17628
26
92
1682
17099
52
231
1423
14909
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
6.5e-01
1.2e+00
2.3e+00
—
—
1.4e+00
7.9e-01
cases:1.47%
controls:0.77%
cases:0.85%
controls:0.26%
cases:0.40%
controls:0.04%
—
—
—
—
cases:1.35%
controls:0.33%
cases:2.51%
controls:1.15%
26
136
1744
17534
15
46
1755
17624
7
7
1763
17663
—
—
23
57
1685
17134
37
174
1438
14966
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.1e-01
2.9e-01
6.7e-01
3.3e+00
6.0e-01
3.9e-01
2.6e-01
cases:58.81%
controls:53.66%
cases:54.52%
controls:47.17%
cases:31.02%
controls:18.66%
cases:22.94%
controls:1.13%
cases:29.81%
controls:18.93%
cases:59.19%
controls:49.52%
cases:74.31%
controls:68.94%
1041
9482
729
8188
965
8335
805
9335
549
3298
1221
14372
406
199
1364
17471
527
3339
1241
14301
1011
8513
697
8678
1096
10437
379
4703
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.1e-01
4.7e-01
1.2e+00
2.6e+00
1.1e+00
3.9e-01
1.8e-01
cases:12.20%
controls:10.12%
cases:7.63%
controls:4.92%
cases:1.86%
controls:0.59%
cases:0.45%
controls:0.03%
cases:1.81%
controls:0.64%
cases:7.49%
controls:5.22%
cases:18.17%
controls:15.59%
216
1789
1554
15881
135
870
1635
16800
33
105
1737
17565
8
6
1762
17664
32
113
1736
17527
128
897
1580
16294
268
2360
1207
12780
Erysipelas
A46 [45561706]
A46 [45561706]
7.3e-01
1.0e+00
1.2e+00
—
1.8e+00
1.1e+00
8.9e-01
cases:3.45%
controls:1.70%
cases:1.64%
controls:0.58%
cases:0.40%
controls:0.12%
—
—
cases:0.57%
controls:0.09%
cases:1.87%
controls:0.60%
cases:5.08%
controls:2.15%
61
300
1709
17370
29
103
1741
17567
7
22
1763
17648
—
10
16
1758
17624
32
104
1676
17087
75
326
1400
14814
Erythrocyte sedimentation rate above reference range
165468009 [4013526]
165468009 [4013526]
1.2e+00
3.6e+00
—
1.0e+50
—
1.7e+00
2.0e+00
cases:0.45%
controls:0.14%
cases:1.02%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.29%
controls:0.05%
cases:0.95%
controls:0.13%
8
24
1762
17646
18
5
1752
17665
—
6
0
1764
17670
—
5
9
1703
17182
14
19
1461
15121
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.3e-01
6.8e-01
1.8e+00
—
1.6e+00
6.7e-01
4.2e-01
cases:7.34%
controls:4.91%
cases:2.99%
controls:1.54%
cases:1.24%
controls:0.22%
—
—
cases:1.07%
controls:0.21%
cases:2.93%
controls:1.51%
cases:8.14%
controls:5.48%
130
868
1640
16802
53
273
1717
17397
22
38
1748
17632
—
19
37
1749
17603
50
260
1658
16931
120
830
1355
14310
ramipril; oral
C09AA05 [21601789]
C09AA05 [21601789]
2.2e-01
4.6e-01
4.4e-01
2.8e+00
9.3e-01
7.4e-01
6.5e-01
cases:7.57%
controls:6.19%
cases:8.25%
controls:5.35%
cases:2.77%
controls:1.79%
cases:0.85%
controls:0.05%
cases:3.68%
controls:1.49%
cases:10.77%
controls:5.46%
cases:13.15%
controls:7.34%
134
1094
1636
16576
146
946
1624
16724
49
317
1721
17353
15
9
1755
17661
65
262
1703
17378
184
939
1524
16252
194
1112
1281
14028
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
3.4e-01
9.1e-01
1.8e+00
1.0e+50
2.3e+00
7.2e-01
5.9e-01
cases:2.26%
controls:1.61%
cases:1.58%
controls:0.65%
cases:0.40%
controls:0.07%
cases:0.34%
controls:0.00%
cases:0.74%
controls:0.07%
cases:1.29%
controls:0.63%
cases:3.59%
controls:2.01%
40
285
1730
17385
28
114
1742
17556
7
12
1763
17658
6
0
1764
17670
13
13
1755
17627
22
108
1686
17083
53
305
1422
14835
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
7.7e-01
1.1e+00
—
—
1.8e+00
1.2e+00
7.5e-01
cases:4.35%
controls:2.07%
cases:1.81%
controls:0.60%
—
—
—
—
cases:0.40%
controls:0.07%
cases:2.11%
controls:0.67%
cases:5.08%
controls:2.47%
77
366
1693
17304
32
106
1738
17564
—
—
7
12
1761
17628
36
115
1672
17076
75
374
1400
14766
Dysuria
R30.0 [45592416]
R30.0 [45592416]
1.0e+00
2.1e+00
—
—
—
2.4e+00
1.0e+00
cases:0.85%
controls:0.31%
cases:0.73%
controls:0.09%
—
—
—
—
—
—
cases:0.76%
controls:0.07%
cases:0.88%
controls:0.32%
15
55
1755
17615
13
16
1757
17654
—
—
—
13
12
1695
17179
13
49
1462
15091
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
4.5e-01
9.6e-01
1.3e+00
—
2.7e+00
8.8e-01
5.4e-01
cases:3.79%
controls:2.44%
cases:1.92%
controls:0.75%
cases:0.34%
controls:0.10%
—
—
cases:0.57%
controls:0.04%
cases:1.93%
controls:0.81%
cases:5.15%
controls:3.06%
67
431
1703
17239
34
132
1736
17538
6
17
1764
17653
—
10
7
1758
17633
33
140
1675
17051
76
464
1399
14676
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
1.3e+00
1.2e+00
—
—
—
1.9e+00
2.3e+00
cases:0.62%
controls:0.17%
cases:0.51%
controls:0.15%
—
—
—
—
—
—
cases:1.11%
controls:0.17%
cases:2.44%
controls:0.24%
11
30
1759
17640
9
27
1761
17643
—
—
—
19
30
1689
17161
36
37
1439
15103
lenalidomide; oral
L04AX04 [21603930]
L04AX04 [21603930]
—
—
—
—
—
2.9e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.03%
cases:0.61%
controls:0.05%
—
—
—
—
—
9
5
1699
17186
9
7
1466
15133
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
4.3e-01
8.2e-01
1.2e+00
—
1.4e+00
9.1e-01
6.6e-01
cases:4.69%
controls:3.11%
cases:4.29%
controls:1.95%
cases:1.13%
controls:0.35%
—
—
cases:1.70%
controls:0.41%
cases:4.39%
controls:1.81%
cases:9.36%
controls:5.06%
83
550
1687
17120
76
344
1694
17326
20
61
1750
17609
—
30
72
1738
17568
75
312
1633
16879
138
766
1337
14374
tamsulosin; oral
G04CA02 [21602669]
G04CA02 [21602669]
3.0e-01
7.2e-01
7.9e-01
2.5e+00
8.5e-01
6.3e-01
2.2e-01
cases:7.34%
controls:5.53%
cases:7.34%
controls:3.72%
cases:2.26%
controls:1.04%
cases:0.40%
controls:0.03%
cases:2.43%
controls:1.05%
cases:7.26%
controls:4.01%
cases:8.68%
controls:7.10%
130
977
1640
16693
130
658
1640
17012
40
184
1730
17486
7
6
1763
17664
43
186
1725
17454
124
689
1584
16502
128
1075
1347
14065
Seronegative rheumatoid arthritis
M06.0 [45577103]
M06.0 [45577103]
1.2e+00
1.4e+00
—
—
2.0e+00
1.3e+00
1.5e+00
cases:0.90%
controls:0.28%
cases:0.73%
controls:0.18%
—
—
—
—
cases:0.28%
controls:0.04%
cases:0.64%
controls:0.17%
cases:1.02%
controls:0.22%
16
50
1754
17620
13
32
1757
17638
—
—
5
7
1763
17633
11
30
1697
17161
15
33
1460
15107
methenamine; oral
J01XX05 [21603065]
J01XX05 [21603065]
1.3e+00
1.3e+00
1.7e+00
—
—
1.5e+00
1.3e+00
cases:1.02%
controls:0.27%
cases:0.62%
controls:0.17%
cases:0.28%
controls:0.05%
—
—
—
—
cases:0.76%
controls:0.17%
cases:1.22%
controls:0.35%
18
47
1752
17623
11
30
1759
17640
5
9
1765
17661
—
—
13
29
1695
17162
18
53
1457
15087
Uroflowmetry
44856007 [4261340]
44856007 [4261340]
5.3e-01
1.2e+00
1.4e+00
—
1.7e+00
1.4e+00
5.9e-01
cases:4.63%
controls:2.78%
cases:2.88%
controls:0.89%
cases:0.51%
controls:0.12%
—
—
cases:0.51%
controls:0.10%
cases:3.81%
controls:0.94%
cases:4.81%
controls:2.71%
82
492
1688
17178
51
157
1719
17513
9
22
1761
17648
—
9
17
1759
17623
65
162
1643
17029
71
411
1404
14729
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
4.7e-01
9.5e-01
2.5e+00
—
1.4e+00
1.1e+00
8.5e-01
cases:1.75%
controls:1.10%
cases:1.53%
controls:0.59%
cases:0.79%
controls:0.07%
—
—
cases:0.51%
controls:0.12%
cases:1.76%
controls:0.58%
cases:3.25%
controls:1.42%
31
195
1739
17475
27
105
1743
17565
14
12
1756
17658
—
9
22
1759
17618
30
100
1678
17091
48
215
1427
14925
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
SPAT1137 [2001700238]
8.8e-01
9.7e-01
1.2e+00
1.3e+00
1.4e+00
9.1e-01
1.7e-01
cases:1.24%
controls:0.52%
cases:1.19%
controls:0.45%
cases:0.90%
controls:0.27%
cases:0.40%
controls:0.11%
cases:0.79%
controls:0.20%
cases:1.17%
controls:0.48%
cases:1.15%
controls:0.97%
22
92
1748
17578
21
80
1749
17590
16
47
1754
17623
7
20
1763
17650
14
36
1754
17604
20
82
1688
17109
17
147
1458
14993
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
MA2AE [2001306829]
MA2AE [2001306829]
5.9e-02
1.3e+00
1.8e+00
1.0e+50
2.2e+00
7.5e-01
3.7e-01
cases:1.36%
controls:1.28%
cases:1.86%
controls:0.51%
cases:0.62%
controls:0.10%
cases:0.28%
controls:0.00%
cases:0.62%
controls:0.07%
cases:0.82%
controls:0.39%
cases:2.44%
controls:1.69%
24
226
1746
17444
33
91
1737
17579
11
18
1759
17652
5
0
1765
17670
11
12
1757
17628
14
67
1694
17124
36
256
1439
14884
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
2.0e-01
3.6e-01
2.3e+00
—
1.5e+00
1.0e+00
5.7e-01
cases:3.73%
controls:3.07%
cases:2.32%
controls:1.62%
cases:2.03%
controls:0.22%
—
—
cases:1.24%
controls:0.29%
cases:3.69%
controls:1.38%
cases:5.29%
controls:3.07%
66
542
1704
17128
41
287
1729
17383
36
38
1734
17632
—
22
51
1746
17589
63
237
1645
16954
78
465
1397
14675
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
5.2e-01
1.1e+00
2.0e+00
—
1.8e+00
1.4e+00
7.8e-01
cases:1.58%
controls:0.95%
cases:1.19%
controls:0.40%
cases:0.45%
controls:0.06%
—
—
cases:0.28%
controls:0.05%
cases:2.17%
controls:0.53%
cases:3.80%
controls:1.78%
28
167
1742
17503
21
71
1749
17599
8
11
1762
17659
—
5
8
1763
17632
37
91
1671
17100
56
270
1419
14870
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
3.5e-01
7.4e-01
1.1e+00
—
1.5e+00
9.4e-01
6.7e-01
cases:7.06%
controls:5.09%
cases:5.20%
controls:2.54%
cases:1.41%
controls:0.50%
—
—
cases:2.32%
controls:0.53%
cases:6.91%
controls:2.81%
cases:12.14%
controls:6.61%
125
899
1645
16771
92
449
1678
17221
25
88
1745
17582
—
41
93
1727
17547
118
483
1590
16708
179
1000
1296
14140
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
3.2e-01
8.1e-01
9.7e-01
—
1.7e+00
1.5e+00
1.2e+00
cases:2.32%
controls:1.70%
cases:1.24%
controls:0.55%
cases:0.28%
controls:0.11%
—
—
cases:0.74%
controls:0.14%
cases:2.40%
controls:0.52%
cases:4.20%
controls:1.32%
41
300
1729
17370
22
98
1748
17572
5
19
1765
17651
—
13
24
1755
17616
41
90
1667
17101
62
200
1413
14940
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
5.6e-01
1.5e+00
—
—
—
2.3e+00
1.3e+00
cases:1.36%
controls:0.78%
cases:0.68%
controls:0.15%
—
—
—
—
—
—
cases:1.58%
controls:0.16%
cases:2.71%
controls:0.72%
24
137
1746
17533
12
26
1758
17644
—
—
—
27
27
1681
17164
40
109
1435
15031
Urinary symptom/complaint other
U29 [2002001149]
U29 [2002001149]
1.1e+00
1.7e+00
—
—
—
2.1e+00
1.4e+00
cases:0.68%
controls:0.22%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
cases:0.47%
controls:0.06%
cases:1.15%
controls:0.28%
12
39
1758
17631
8
15
1762
17655
—
—
—
8
10
1700
17181
17
42
1458
15098
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
828
2219
6.07
310.72
15.0
6.3
1.11
1.05
mmol/l
8.75
812
2071
307
193
18.98
307.65
3.4
2.4
1.76
1.44
g/24h
0.46
223
116
722
1553
7.11
307.65
14.8
7.8
11.15
9.95
mmol/l
3.92
706
1492
541
1198
6.03
243.93
8.5
4.2
115.68
92.87
ng/l
3.39
503
1051
325
521
7.40
200.49
5.8
4.8
1.73
1.54
mg/l
2.58
313
473
889
3640
3.86
172.70
5.9
2.7
3.74
5.40
e6/l
4.08
848
3307
1095
5246
3.79
165.39
8.2
3.4
123.26
90.35
e6/l
0.26
965
4021
1073
5156
3.69
159.48
9.1
4.3
49.35
8.52
mg/mmol
36.22
944
3360
1057
5063
3.65
157.19
8.0
3.6
289.32
48.98
mg/l
28.52
938
3394
466
1359
4.28
143.90
3.3
2.9
65.20
66.42
g/l
2.32
454
1258
1085
5494
3.47
143.25
8.3
3.5
7.18
7.85
mmol/l
6.27
1018
4697
1142
6002
3.48
141.07
10.0
4.0
92.19
99.38
e6/l
0.12
994
4231
281
557
5.80
138.19
4.8
3.5
44.75
89.62
mg/l
0.91
239
488
309
668
5.38
138.05
1.8
1.5
24.18
20.58
iu/ml
—
6
19
280
558
5.76
136.86
4.8
3.5
74.50
59.12
mg/l
0.44
241
488
258
484
6.06
134.38
3.0
1.5
0.24
0.24
g/l
0.28
251
463
260
499
5.92
132.14
3.0
1.5
1.21
1.20
g/l
0.15
254
477
936
4518
3.24
130.19
7.7
3.3
0.26
0.43
e6/l
3.63
802
3329
257
496
5.88
129.77
4.6
3.4
4.88
3.91
ratio
0.13
148
296
1219
6942
3.36
126.18
12.6
5.3
34.48
35.52
g/l
8.73
1185
6516
511
1761
3.66
122.22
8.7
4.2
5.88
5.82
kpa
0.77
502
1713
424
1326
3.88
116.64
4.8
2.5
0.23
0.50
e6/l
2.17
414
1271
493
1708
3.60
116.34
8.8
4.2
0.62
1.77
mmol/l
8.54
438
1457
602
2403
3.27
112.63
6.4
2.7
23.02
22.81
%
0.16
584
2249
628
2608
3.17
109.35
6.2
2.7
2.19
2.30
g/l
5.38
607
2418
647
2787
3.07
104.97
6.2
2.7
12.64
13.01
umol/l
0.65
632
2599
256
607
4.75
101.23
6.8
3.7
912.06
283.51
mg/l
7.40
202
279
1265
7900
3.04
101.01
20.7
7.5
1.21
1.21
mmol/l
0.04
1155
6828
1295
8311
3.01
95.98
8.5
3.8
10.15
4.51
estimate
0.34
318
1811
1284
8212
2.98
95.60
8.5
3.8
0.00
0.00
estimate
0.38
311
1789
808
4081
2.78
95.58
5.8
2.9
379.29
349.57
umol/l
13.14
767
3605
1297
8356
2.99
94.94
8.6
3.8
0.00
0.19
estimate
0.54
293
1685
252
629
4.50
93.13
3.3
1.8
9.46
7.34
iu/ml
0.40
76
142
1160
7115
2.78
92.09
17.4
6.9
1.21
1.21
mmol/l
2.90
1124
6580
204
441
5.09
89.78
2.1
1.2
12.29
6.04
iu/ml
—
12
7
608
2835
2.73
81.56
6.1
3.0
0.96
0.97
e6/l
0.01
435
1525
397
1477
3.17
80.60
6.3
3.6
4.99
4.57
kpa
2.49
384
1438
237
653
4.03
76.21
3.2
2.5
4.27
4.17
g/l
0.83
227
603
237
653
4.03
76.21
3.2
2.5
7.68
7.33
g/l
1.99
226
602
237
653
4.03
76.21
3.2
2.5
3.89
3.74
g/l
0.71
227
602
227
613
4.09
75.01
3.3
2.6
2.81
2.96
g/l
1.33
216
563
260
792
3.67
72.20
2.4
2.0
1.48
1.51
g/l
0.17
234
698
451
1929
2.79
70.17
5.1
4.3
227.00
247.80
u/l
3.10
436
1835
1409
10213
2.77
69.47
9.0
4.6
2254.32
1156.90
e6/l
0.21
31
153
379
1491
2.95
68.82
3.8
2.8
70.81
69.54
e9/l
0.23
267
1103
548
2645
2.54
66.29
7.0
3.2
1.61
2.14
e6/l
1.39
373
1331
162
376
4.64
64.98
11.0
5.6
858.15
807.12
iu/ml
0.02
26
49
207
579
3.91
64.83
3.4
2.6
0.66
1.19
g/l
1.20
190
507
71
69
10.67
64.42
30.7
27.3
90.47
127.39
ug/l
3.31
58
54
531
2558
2.53
64.20
2.7
2.2
29.44
29.71
s
0.51
523
2485
141
300
5.02
62.77
4.8
3.4
800.57
1968.22
u/ml
—
7
23
1198
8276
2.35
61.62
10.1
6.5
1.85
1.94
e9/l
1.08
1086
7277
1052
6914
2.26
60.58
4.1
2.5
73.72
76.43
nmol/l
2.76
1010
6277
135
290
4.95
59.38
1.4
1.2
467.50
287.00
titre
—
8
20
198
570
3.78
59.35
3.2
2.6
9.77
10.52
g/l
1.34
185
516
1201
8384
2.31
59.05
10.3
6.7
0.21
0.19
e9/l
1.62
1082
7300
327
1287
2.88
58.61
4.1
2.7
10.08
10.79
g/l
2.00
311
1186
535
2721
2.38
56.27
5.0
3.5
0.81
0.82
mmol/l
0.73
512
2579
959
6214
2.17
55.33
8.1
3.8
0.02
0.03
estimate
0.37
268
1495
1246
9005
2.26
53.74
13.0
9.6
4.37
4.16
e9/l
2.73
1119
7798
122
266
4.85
52.65
2.1
1.4
18.67
8.93
u/ml
—
6
6
760
4596
2.13
51.31
8.6
3.9
0.02
0.00
estimate
0.59
237
1642
172
496
3.73
51.24
3.6
2.6
0.01
0.02
g/l
0.23
164
452
143
364
4.18
50.72
2.9
2.3
353.19
107.91
ug/min
3.06
96
227
270
1037
2.89
50.16
6.3
3.7
120.70
129.39
g/l
7.47
263
1010
59
64
9.50
49.40
1.1
1.1
—
—
—
0
0
165
482
3.67
48.16
3.6
2.6
0.00
0.00
g/l
-0.00
151
428
261
1006
2.87
48.06
2.7
1.8
1.12
1.42
g/l
1.93
246
928
292
1208
2.69
46.89
4.7
2.9
47.02
66.42
ml/min/173m2
14.04
157
513
262
1027
2.82
46.68
7.3
3.9
1.20
1.76
mmol/l
1.31
183
765
288
1192
2.69
46.16
7.8
4.0
5.13
5.14
kpa
0.09
282
1153
1081
7673
2.03
44.97
10.5
6.6
26.01
27.45
%
4.48
1053
7279
126
321
4.15
44.56
2.5
1.4
146.10
146.24
au/ml
0.00
40
90
1062
7542
2.00
43.49
10.3
6.4
58.85
57.51
%
3.34
1040
7207
1031
7278
1.98
42.59
21.1
15.9
1.27
1.28
inr
0.21
892
6105
1460
11706
2.33
42.59
14.9
8.3
79.93
79.89
u/l
0.01
1432
11140
708
4413
2.00
41.80
6.2
2.9
0.45
0.03
0.69
11
96
1113
8148
1.96
40.37
8.6
6.7
10.63
11.88
umol/l
3.19
1079
7790
201
737
2.95
40.28
6.2
3.5
24.31
25.14
mmol/l
2.56
194
709
1229
9346
2.00
39.43
9.8
5.4
6.97
6.74
mmol/l
2.51
1208
8848
695
4382
1.96
39.03
3.0
2.4
3.15
2.80
mg/l
3.11
636
3764
753
4878
1.94
39.01
3.8
2.7
59.87
77.14
u/l
0.54
720
4556
205
778
2.85
38.51
3.6
2.2
0.03
1.07
estimate
0.49
66
238
323
1544
2.33
37.49
10.7
8.3
1.21
1.37
mmol/l
2.25
312
1514
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
162
558
3.09
36.14
3.2
3.0
0.35
0.36
iu/ml
0.05
77
294
1036
7571
1.87
35.87
5.9
3.2
153.29
125.63
ug/l
3.07
1002
7076
264
1201
2.40
34.09
1.9
1.7
—
—
—
0
0
42
51
8.41
32.18
2.2
2.6
0.62
0.61
mmol/l
0.15
42
51
682
4523
1.82
30.92
7.3
3.3
0.21
0.03
estimate
0.69
238
1422
303
1522
2.19
30.77
2.6
2.2
353.58
375.24
nmol/l
1.18
286
1413
951
6993
1.77
30.02
20.8
11.6
0.00
0.00
e9/l
1.84
803
5715
574
3648
1.84
29.65
8.0
3.9
1.02
1.43
kg/l
0.50
441
2449
711
4836
1.78
29.18
2.9
2.2
164.01
230.52
u/l
1.93
673
4600
116
372
3.26
29.09
1.8
1.2
231.65
253.38
u/ml
0.37
75
214
81
204
4.11
29.03
2.5
2.5
8.28
44.35
iu/ml
—
6
22
1366
11299
1.88
27.70
7.2
4.4
18.04
11.91
mm/h
27.09
1326
10571
117
390
3.14
27.51
1.8
1.2
—
41.02
—
0
5
58
117
5.09
27.35
2.7
2.4
798.34
614.82
ml
1.45
38
76
758
5323
1.73
27.31
4.9
3.4
2.35
2.35
mmol/l
0.40
712
4836
353
1957
2.00
27.30
9.7
8.3
5.01
5.12
kpa
1.32
338
1882
353
1958
2.00
27.26
9.7
8.3
11.61
12.07
kpa
1.08
337
1887
460
2791
1.87
27.15
2.5
1.9
—
—
—
0
0
134
489
2.88
26.87
1.6
1.3
—
—
—
0
0
368
2087
1.96
26.59
2.2
1.8
—
—
—
0
0
323
1759
2.02
26.17
9.7
8.7
94.90
95.51
%
0.95
311
1704
346
1933
1.98
26.07
9.7
8.3
0.18
0.86
mmol/l
1.75
267
1584
296
1566
2.07
25.96
2.4
2.5
0.21
0.21
g/l
0.59
279
1466
606
4056
1.75
25.48
6.4
4.3
94.19
87.69
%
7.17
584
3967
685
4753
1.71
25.24
4.3
3.3
3939.98
1449.48
ng/l
5.36
617
4118
116
406
2.99
25.06
1.6
1.7
—
—
—
0
0
965
7432
1.65
23.14
3.8
2.9
—
—
estimate
—
0
0
341
1969
1.90
23.04
2.3
1.9
—
—
—
0
0
96
319
3.12
22.69
6.9
4.6
2.43
2.42
mmol/l
0.02
64
213
806
5963
1.64
22.46
5.4
4.0
83.47
78.26
ng/l
0.06
636
4230
422
2641
1.78
21.87
2.1
1.8
1259.99
1145.98
nmol/l
1.41
349
2015
235
1223
2.06
21.31
10.5
3.8
1.22
1.22
mmol/l
0.10
223
1054
38
66
5.86
21.06
1.4
1.3
154.20
181.93
mmol/24h
0.77
38
66
140
591
2.48
21.00
1.4
1.2
2.02
0.85
u/ml
—
8
42
648
4638
1.62
20.00
2.1
1.7
18.57
20.02
nmol/l
1.84
589
3925
28
12
23.68
19.97
1.2
1.2
—
—
—
0
0
94
337
2.89
19.46
1.5
1.2
13.93
5.51
u/ml
—
9
22
108
417
2.69
19.44
1.5
1.2
30.92
7.93
u/ml
0.83
17
58
177
861
2.17
19.09
1.8
1.5
—
—
—
0
0
147
663
2.33
19.02
1.7
2.0
40.84
39.03
u/l
0.42
122
597
104
399
2.71
18.95
3.3
2.3
130.06
129.92
g/l
0.02
95
316
30
19
16.03
18.81
2.9
3.6
88.85
18.77
mg/l
—
6
7
895
6985
1.56
18.67
2.5
2.2
98.64
94.91
pmol/l
1.59
514
3854
128
548
2.44
18.61
2.0
1.4
—
—
—
0
0
487
3295
1.66
18.55
2.2
1.5
2.69
2.47
g/l
1.45
371
2021
110
439
2.60
18.54
1.4
1.2
29.94
34.71
u/ml
—
9
18
106
416
2.65
18.48
1.5
1.2
23.92
2.73
u/ml
0.81
14
34
113
458
2.57
18.45
1.9
1.6
—
—
—
0
0
280
1633
1.85
18.01
5.5
3.4
—
—
—
0
0
85
305
2.88
17.58
1.8
1.7
—
—
—
0
0
1646
15110
2.08
16.55
43.2
19.8
4.06
3.98
mmol/l
22.11
1629
14790
1630
14913
2.02
16.52
34.9
16.6
22.96
25.06
mg/l
2.18
1480
12360
497
3464
1.60
16.47
2.0
1.8
1.64
1.29
mg/l
1.19
407
2649
1644
15090
2.07
16.46
42.1
19.6
139.32
139.61
mmol/l
4.90
1627
14797
192
1036
1.96
15.57
12.0
10.3
23.35
24.27
mmol/l
2.94
185
1019
105
449
2.42
15.32
2.0
1.6
—
—
—
0
0
694
5282
1.51
15.25
4.6
3.3
36.83
33.91
u/l
0.33
665
4996
151
755
2.09
15.12
7.5
3.4
1.02
1.02
ratio
1.12
142
701
67
230
2.99
15.02
1.7
1.5
—
—
—
0
0
142
699
2.12
14.81
2.0
1.8
1.92
1.99
ug/l
0.03
128
626
465
3261
1.57
14.76
1.8
1.7
453.83
34136095.89
pmol/l
3.26
403
2742
98
417
2.43
14.46
1.9
2.2
15.26
11.94
mg/l
2.13
93
385
64
222
2.95
14.10
1.6
1.6
—
—
—
0
0
127
614
2.15
13.88
2.4
2.2
387.50
408.56
ug/l
0.05
121
584
30
62
4.90
13.81
2.1
1.5
41.52
40.14
g/l
0.68
30
62
148
761
2.03
13.74
6.2
5.3
1.65
1.58
%
0.41
141
713
44
123
3.64
13.71
1.5
1.4
—
—
—
0
0
542
3989
1.51
13.63
3.3
2.4
—
—
—
0
0
290
1843
1.68
13.61
3.3
2.9
7.05
8.35
umol/l
0.70
247
1630
35
85
4.18
13.24
3.8
1.6
155.03
105.22
ng/l
0.63
35
85
100
449
2.30
13.09
2.1
1.7
—
—
—
0
0
67
250
2.75
12.94
2.4
1.9
1.49
1.76
mmol/l
2.07
67
244
65
242
2.75
12.61
1.2
1.3
—
—
—
0
0
19
11
17.44
12.51
3.6
3.6
—
—
—
0
0
56
194
2.95
12.40
3.2
2.3
-1.17
0.47
mmol/l
1.98
51
188
47
147
3.26
12.36
1.3
1.1
123.33
198.85
titre
—
9
26
426
3060
1.51
11.75
5.2
4.0
366.45
433.71
ng/l
0.28
353
2393
242
1531
1.67
11.45
3.5
2.5
73.31
71.63
u/l
0.01
214
1294
55
198
2.83
11.39
1.4
1.3
343.91
328.48
pmol/l
0.12
47
170
66
262
2.58
11.32
3.0
4.0
1.30
1.31
%
0.02
61
237
1538
14134
1.62
11.30
33.4
15.9
69.76
81.77
ml/min/173m2
49.96
1481
13062
42
130
3.28
11.25
1.4
1.5
—
—
—
0
0
1510
13829
1.58
11.12
9.8
6.4
40.73
39.28
mmol/mol
6.72
1457
12962
61
240
2.60
10.67
2.1
1.9
4.36
4.68
mmol/24h
0.30
55
212
299
2027
1.57
10.63
2.7
2.6
172.27
129.50
ug/g
0.93
249
1617
29
73
4.02
10.50
1.6
4.4
54.92
66.07
mg/l
0.59
24
56
30
78
3.89
10.40
1.9
1.5
7.96
4.76
u/field
0.32
23
57
75
330
2.33
10.33
1.6
1.2
27.44
49.78
u/ml
0.85
12
29
90
429
2.16
10.23
4.2
3.6
5.26
2.40
index
0.91
46
231
1386
12568
1.45
9.71
39.6
20.3
13.96
13.61
%
17.61
1374
12414
114
608
1.93
9.56
3.3
2.8
—
—
—
0
0
1296
11627
1.41
9.49
5.0
4.2
14.92
14.77
pmol/l
1.31
1214
10685
80
377
2.17
9.38
1.8
1.4
—
—
—
0
0
37
121
3.10
9.11
1.1
1.1
—
43.20
—
0
5
70
317
2.26
9.05
1.7
1.4
—
—
—
0
0
91
461
2.03
8.85
1.6
1.3
—
—
—
0
0
60
257
2.38
8.82
1.2
1.1
—
1.88
—
0
9
30
89
3.41
8.64
2.4
1.7
—
—
—
0
0
30
89
3.41
8.64
2.4
1.7
—
—
—
0
0
12
6
20.12
8.47
5.6
5.2
496.00
406.67
umol/l
—
12
6
29
86
3.41
8.36
1.4
1.6
10.05
7.18
u/l
0.27
19
73
475
3683
1.39
8.33
1.4
1.3
1.48
1.81
u/ml
0.26
129
987
57
246
2.36
8.26
1.3
1.2
3.19
5.28
u/ml
0.79
31
111
69
324
2.17
8.20
1.6
1.4
—
—
—
0
0
167
1045
1.66
8.20
2.0
1.7
—
—
—
0
0
1658
15747
1.70
8.11
44.7
21.3
112.14
79.50
umol/l
40.22
1645
15566
12
7
17.25
8.07
2.5
5.9
—
—
—
0
0
42
162
2.63
7.72
3.8
2.6
—
—
—
0
0
101
557
1.86
7.70
1.6
1.5
0.53
14.02
iu/ml
0.47
17
86
91
486
1.92
7.65
1.6
1.4
267.66
284.60
ug/g
0.32
66
293
1644
15614
1.63
7.61
21.4
12.0
25.31
26.42
u/l
2.33
1627
15188
39
150
2.64
7.22
1.4
1.2
—
—
titre
—
0
0
17
39
4.39
6.96
1.4
1.3
27.79
10.37
pmol/l
—
8
17
42
171
2.49
6.95
2.0
1.7
—
—
—
0
0
47
202
2.36
6.92
2.3
1.6
22.27
30.77
ng/l
0.71
47
202
28
92
3.08
6.90
1.1
1.0
1481.27
1534.51
miu/ml
0.09
28
92
55
254
2.20
6.86
1.3
1.2
3.57
4.54
u/ml
0.18
23
97
144
910
1.63
6.82
3.5
3.6
4.37
4.55
pmol/l
1.25
131
810
31
109
2.88
6.80
3.0
2.9
41.77
40.81
%
0.06
12
58
28
93
3.04
6.78
1.4
1.5
—
—
—
0
0
1073
9567
1.30
6.76
3.5
3.1
—
—
—
0
0
55
257
2.18
6.67
1.6
1.4
—
—
—
0
0
394
3060
1.37
6.66
3.4
3.0
2.47
2.45
mmol/l
3.45
355
2746
27
90
3.03
6.51
1.4
1.5
—
—
—
0
0
24
75
3.23
6.43
1.3
1.1
—
—
—
0
0
43
186
2.34
6.27
1.9
1.7
—
—
—
0
0
9
5
18.08
6.26
9.2
8.4
—
—
—
0
0
24
77
3.15
6.17
2.6
3.6
—
—
—
0
0
33
127
2.63
6.15
1.3
1.1
—
—
—
0
0
33
127
2.63
6.15
1.3
1.1
—
—
—
0
0
1470
13785
1.37
5.99
6.0
4.2
1.48
1.27
mmol/l
13.66
1402
12700
33
129
2.59
5.97
2.6
1.9
1.05
1.72
u/field
0.73
19
71
9
6
15.06
5.90
1.9
6.2
—
—
—
0
0
336
2591
1.37
5.88
1.3
1.3
17.40
11.55
u/ml
0.61
136
972
1473
13833
1.36
5.82
6.2
5.2
1.93
1.92
mu/l
0.11
1402
12821
1556
14751
1.41
5.74
7.5
5.7
2.49
2.65
mmol/l
10.94
1496
13739
67
359
1.90
5.65
1.8
1.5
—
—
—
0
0
1130
10263
1.27
5.59
4.4
3.4
54.39
48.69
u/l
1.37
1089
9681
9
7
12.91
5.58
7.1
5.0
—
—
—
0
0
31
122
2.57
5.55
1.3
1.2
—
—
—
0
0
33
134
2.49
5.55
1.3
1.1
—
—
—
0
0
41
185
2.24
5.47
1.8
1.5
—
—
—
0
0
41
186
2.23
5.40
1.8
1.5
—
—
—
0
0
44
206
2.16
5.37
1.3
1.3
34.54
22.43
u/l
1.17
36
168
41
187
2.22
5.34
1.8
1.5
—
—
—
0
0
35
149
2.38
5.33
1.3
1.2
—
—
—
0
0
186
1316
1.46
5.31
2.6
2.4
5.90
7.37
ug/l
0.37
159
1173
28
108
2.62
5.23
1.4
1.4
—
—
—
0
0
232
1715
1.41
5.22
11.8
7.2
—
—
—
0
0
16
44
3.66
5.20
1.4
1.7
179.19
90.50
nmol/24h
0.78
16
44
1533
14548
1.37
5.17
7.0
5.0
4.37
4.53
mmol/l
7.57
1475
13609
75
431
1.77
5.10
1.5
1.4
—
—
—
0
0
30
122
2.48
5.05
1.3
1.1
—
—
—
0
0
1524
14461
1.36
5.04
6.8
4.9
1.36
1.43
mmol/l
8.51
1464
13434
41
193
2.15
4.96
1.8
1.4
—
—
—
0
0
20
66
3.05
4.95
1.8
2.6
385.00
43486.00
u/ml
—
5
11
24
88
2.75
4.95
1.3
1.1
—
—
—
0
0
350
2782
1.32
4.94
1.4
1.3
29.49
30.80
iu/ml
0.10
114
832
42
200
2.13
4.94
1.1
1.0
—
—
—
0
0
61
336
1.84
4.78
6.6
7.8
105.25
105.05
mmol/l
0.14
56
300
37
171
2.19
4.70
1.4
1.2
—
—
—
0
0
40
191
2.12
4.69
1.8
1.4
—
—
—
0
0
23
85
2.73
4.68
2.0
2.9
887.70
1206.92
u/ml
0.42
23
85
26
103
2.55
4.64
2.8
2.5
—
—
—
0
0
10
15
6.70
4.47
1.5
1.7
—
—
—
0
0
1674
16202
1.50
4.39
49.5
25.1
249.24
247.12
e9/l
0.64
1652
15887
1674
16207
1.49
4.33
49.3
24.9
91.32
91.00
fl
1.87
1662
16031
1674
16210
1.49
4.29
49.5
25.0
4.37
4.50
e12/l
14.08
1649
15857
1674
16210
1.49
4.29
50.8
25.6
39.38
40.91
%
3.64
1660
16023
11
20
5.53
4.29
1.3
1.4
—
—
—
0
0
1674
16214
1.48
4.24
50.0
25.2
130.92
135.38
g/l
22.64
1662
16034
1674
16215
1.48
4.23
49.6
25.1
7.23
6.82
e9/l
6.74
1650
15854
23
90
2.58
4.22
1.1
1.2
—
—
—
0
0
1490
14177
1.30
4.19
7.1
5.1
6.14
5.95
mmol/l
5.19
1414
13017
39
194
2.03
4.14
1.6
1.5
270.69
280.47
mosm/kgh2o
1.48
29
150
66
394
1.70
3.99
1.4
1.5
—
—
—
0
0
86
552
1.59
3.93
1.5
1.6
21.69
12.97
u/ml
0.48
18
128
32
151
2.14
3.91
5.3
3.8
12.71
12.67
index
0.01
24
100
14
37
3.81
3.89
1.1
1.5
—
—
—
0
0
23
95
2.44
3.81
2.3
1.4
—
—
—
0
0
23
95
2.44
3.81
2.3
1.4
—
—
—
0
0
30
141
2.15
3.71
1.8
1.6
—
—
—
0
0
28
128
2.21
3.71
1.1
1.1
83.32
105.60
pmol/l
1.70
28
128
170
1267
1.38
3.67
3.4
3.2
250.65
212.66
ng/l
0.67
163
1159
67
412
1.65
3.66
1.8
1.6
10002.00
13530.98
e6/l
0.62
56
299
37
190
1.97
3.64
1.2
1.4
—
—
—
0
0
57
336
1.72
3.64
1.5
1.3
—
—
—
0
0
57
336
1.72
3.64
1.5
1.3
—
—
—
0
0
18
68
2.66
3.56
2.6
1.4
—
—
—
0
0
18
68
2.66
3.56
2.6
1.4
—
—
—
0
0
37
193
1.94
3.49
1.9
1.4
—
—
—
0
0
667
5920
1.20
3.42
5.5
5.7
2.11
3.00
ug/l
2.31
604
5349
14
48
2.93
3.30
1.1
1.2
—
—
—
0
0
19
77
2.48
3.30
1.7
1.8
—
—
—
0
0
32
163
1.98
3.25
1.5
1.5
—
—
—
0
0
30
150
2.02
3.21
2.2
1.5
—
—
—
0
0
30
150
2.02
3.21
2.2
1.5
—
—
—
0
0
30
150
2.02
3.21
2.2
1.5
—
—
—
0
0
11
29
3.81
3.18
1.1
1.1
—
—
—
0
0
15
55
2.74
3.15
2.0
1.5
—
—
—
0
0
18
73
2.48
3.13
3.5
3.1
1.08
1.18
%
0.09
18
73
31
159
1.97
3.10
1.4
1.4
218909.12
143871.89
e6/l
0.14
25
109
85
577
1.50
3.08
2.4
1.8
—
—
—
0
0
201
1581
1.31
3.06
3.5
4.3
42.84
20.27
ug/l
0.37
169
1303
7
12
5.85
3.02
23.3
3.5
106.71
95.75
g/l
—
7
12
91
630
1.47
3.00
2.8
1.9
—
—
—
0
0
22
100
2.21
3.00
2.7
2.4
8.28
8.06
mmol/l
0.13
22
100
12
38
3.17
2.85
15.0
7.2
7.15
5.34
kpa
0.93
12
38
17
71
2.41
2.80
1.5
2.1
2.32
1.87
umol/l
1.18
17
64
18
78
2.32
2.75
2.3
2.3
55.18
48.57
umol/l
0.39
18
68
38
219
1.75
2.70
1.1
1.1
3.97
2.48
eliau/ml
0.46
14
91
90
637
1.43
2.68
2.8
2.3
6448.39
5895.56
u/l
0.06
35
264
32
176
1.83
2.64
1.9
1.4
0.17
0.28
nmol/l
0.55
22
139
55
356
1.56
2.53
3.6
2.0
1.11
0.86
nmol/l
1.27
47
301
85
1177
0.71
2.51
1.6
1.7
3.51
3.45
mmol/l
0.14
63
827
17
75
2.28
2.51
1.2
1.1
362.99
198.70
iu/ml
0.75
17
75
17
75
2.28
2.51
2.6
2.9
61.30
106.35
umol/l
—
10
40
120
1572
0.75
2.49
1.8
1.9
3.55
3.52
ratio
0.06
94
1210
8
21
3.82
2.46
2.5
1.9
—
—
—
0
0
25
130
1.94
2.46
1.2
1.5
38.61
31.68
%
0.31
13
85
55
360
1.54
2.42
1.9
1.6
—
—
—
0
0
6
12
5.01
2.40
2.0
2.7
—
—
—
0
0
51
331
1.56
2.34
3.5
3.5
0.72
0.82
nmol/l
1.07
42
274
60
404
1.50
2.33
2.5
2.0
2.31
18.15
iu/l
0.59
22
166
79
562
1.42
2.33
1.7
1.7
—
—
—
0
0
9
28
3.23
2.30
1.3
1.3
—
—
—
0
0
23
120
1.93
2.26
1.9
1.5
64.60
19.13
u/ml
—
5
23
24
128
1.89
2.21
1.7
1.4
13.04
13.62
u/l
0.17
24
121
31
181
1.73
2.15
1.3
1.4
8.15
7.39
mmol/l
0.80
24
157
61
420
1.47
2.15
1.3
1.2
—
—
—
0
0
45
292
1.56
2.09
1.7
1.7
—
—
—
0
0
61
424
1.45
2.06
1.3
1.2
—
—
—
0
0
62
433
1.45
2.05
1.1
1.1
3.31
3.96
—
7
52
39
247
1.59
2.02
1.4
1.5
28.98
31.99
g/l
0.72
39
219
18
90
2.01
2.00
1.0
1.1
—
—
—
0
0
80
592
1.37
1.92
3.1
3.5
302.77
6967.11
u/ml
0.82
69
508
103
799
1.31
1.82
1.0
1.1
—
—
—
0
0
14
66
2.13
1.82
2.9
1.7
—
—
—
0
0
14
66
2.13
1.82
2.9
1.7
—
—
—
0
0
239
2044
1.20
1.78
1.5
1.5
—
—
—
0
0
14
67
2.10
1.76
2.9
1.7
—
—
—
0
0
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
6
18
3.34
1.74
1.0
1.2
—
—
—
0
0
146
1192
1.24
1.73
1.5
1.5
—
—
—
0
0
673
6228
1.13
1.72
2.4
1.9
1.56
1.35
mmol/l
4.42
604
5282
236
2024
1.19
1.71
2.1
2.2
—
—
—
0
0
17
89
1.92
1.70
2.9
1.6
—
—
—
0
0
17
89
1.92
1.70
2.9
1.6
—
—
—
0
0
17
89
1.92
1.70
2.9
1.6
—
—
—
0
0
17
89
1.92
1.70
2.9
1.6
—
—
—
0
0
7
25
2.81
1.65
1.1
2.5
—
20850.00
—
0
5
1298
12511
1.14
1.64
40.6
21.1
331.17
332.75
g/l
8.09
1290
12439
5
14
3.58
1.61
1.0
1.4
—
—
—
0
0
132
1077
1.24
1.59
1.4
1.3
244.92
228.05
u/ml
0.09
125
1002
27
167
1.63
1.58
4.3
4.3
—
—
—
0
0
28
176
1.60
1.55
1.3
1.6
63.67
60.15
%
0.16
15
116
33
216
1.54
1.54
1.4
1.5
1186.54
5894.07
e6/l
0.59
26
147
70
528
1.34
1.54
1.3
1.3
306.37
236.05
miu/ml
0.57
26
247
36
242
1.50
1.50
1.1
1.1
—
—
—
0
0
216
1863
1.18
1.49
2.1
2.1
—
—
—
0
0
91
718
1.28
1.47
2.0
1.7
0.27
0.32
mg/l
0.63
40
341
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
87
1.85
1.46
1.1
1.1
—
—
—
0
0
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
127
1047
1.23
1.41
1.2
1.2
223.99
147.38
u/ml
0.85
44
416
11
53
2.08
1.38
1.2
2.7
23.75
171.87
ug/l
0.46
11
45
50
365
1.38
1.37
1.5
1.5
86.27
39.69
e6/l
0.36
37
269
10
48
2.09
1.27
1.0
1.1
—
—
—
0
0
11
55
2.01
1.27
1.5
1.2
—
—
—
0
0
50
372
1.35
1.25
1.6
1.6
49207.76
464.31
e6/l
0.51
37
288
21
131
1.61
1.23
4.9
5.2
35.87
45.06
u/ml
—
7
38
15
85
1.77
1.23
1.5
1.9
—
—
—
0
0
10
49
2.05
1.22
1.0
1.1
—
—
—
0
0
15
86
1.75
1.19
3.0
2.5
—
—
—
0
0
23
149
1.55
1.17
1.0
1.0
—
—
—
0
0
324
2944
1.12
1.10
1.7
1.6
—
—
—
0
0
12
67
1.80
1.04
1.5
2.5
122.00
1022.28
e6/l
—
6
53
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
5
22
2.28
1.03
2.2
1.7
4.46
4.99
nmol/l
—
5
22
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
9
48
1.88
1.00
1.8
1.3
12.57
8.91
ug/l
—
9
48
133
1146
1.17
0.99
2.3
2.1
—
—
—
0
0
27
190
1.43
0.97
1.4
1.4
39334.72
113405.50
e6/l
0.96
18
103
12
70
1.72
0.92
1.0
1.1
—
—
—
0
0
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
36
270
1.34
0.91
1.0
1.1
14.14
96.74
iu/ml
—
7
59
25
177
1.42
0.88
1.3
1.2
94.96
96.05
%
0.07
25
166
31
229
1.36
0.87
2.2
2.7
7.37
8.13
umol/l
0.14
23
170
13
81
1.61
0.81
1.2
1.2
530.46
390.74
u/l
0.25
13
73
8
47
1.71
0.80
6.4
3.2
4.67
4.92
kpa
—
8
47
8
47
1.71
0.80
6.4
3.2
12.23
10.32
kpa
—
8
47
21
294
0.71
0.80
1.5
1.5
68.04
57.41
ug/l
0.62
21
294
69
825
0.83
0.79
1.6
1.6
899.37
1010.65
mu/l
0.28
51
694
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
210
1903
1.12
0.79
1.7
1.8
1.58
1.52
%
0.46
185
1662
119
1042
1.15
0.76
2.5
2.4
11.73
20.49
au/ml
1.92
11
108
504
4769
1.08
0.75
4.7
4.7
24.83
21.55
%
4.46
272
2387
23
167
1.38
0.73
1.3
1.4
242.03
397.62
u/l
1.11
23
161
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
5
25
2.00
0.72
3.4
9.1
10.64
10.92
%
—
5
25
10
60
1.67
0.72
1.1
1.1
—
—
—
0
0
15
102
1.47
0.67
1.1
1.6
—
—
—
0
0
30
233
1.29
0.64
1.1
1.1
1.08
5.99
u/ml
2.91
16
109
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
28
218
1.29
0.60
1.0
1.1
—
—
—
0
0
12
80
1.50
0.59
2.7
1.9
12.14
4.16
nmol/l
0.44
12
67
6
35
1.72
0.57
1.5
3.3
2.50
5.20
ug/l
—
6
35
107
954
1.13
0.57
2.2
2.0
—
—
—
0
0
9
62
1.45
0.53
1.2
1.2
—
—
—
0
0
25
196
1.28
0.52
1.5
1.4
6.34
6.26
mmol/l
0.04
25
184
7
107
0.65
0.48
1.7
1.4
120.70
168.48
pmol/l
—
7
107
7
46
1.52
0.48
1.1
1.1
—
—
—
0
0
37
441
0.84
0.47
1.4
1.5
1.00
0.96
ratio
0.17
16
281
37
441
0.84
0.47
1.4
1.5
0.97
1.20
ratio
0.99
17
281
37
441
0.84
0.47
1.4
1.5
1.37
1.17
ratio
0.41
16
281
12
85
1.41
0.47
1.8
1.9
31.33
28.53
umol/l
0.56
12
78
85
762
1.12
0.44
1.8
1.3
—
—
—
0
0
41
480
0.85
0.44
1.5
1.5
60.65
60.76
ug/l
0.01
31
407
37
436
0.85
0.43
1.4
1.4
—
—
—
0
0
14
185
0.75
0.43
4.0
2.4
12.25
21.47
mg/l
—
8
73
5
31
1.61
0.43
2.4
1.4
—
—
—
0
0
33
392
0.84
0.42
1.4
1.7
—
—
—
0
0
5
32
1.56
0.42
1.0
1.3
0.36
0.32
ug/l
—
5
21
17
131
1.30
0.42
1.4
1.3
0.10
0.90
u/ml
—
10
70
35
295
1.19
0.41
1.1
1.1
3.59
19.61
au/ml
—
7
76
0
15
0.00
0.41
0.0
1.0
—
1.75
—
0
9
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
15
114
1.32
0.40
1.0
1.1
—
—
—
0
0
168
1569
1.08
0.40
2.4
2.4
11.96
13.24
nmol/l
0.91
147
1422
39
334
1.17
0.39
5.0
3.7
28.62
29.19
mg/l
0.03
30
236
5
35
1.43
0.39
1.6
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
0.01
—
0
14
60
533
1.13
0.38
1.4
1.5
10.14
8.70
u/l
0.42
51
423
5
76
0.66
0.35
1.0
2.1
—
5.23
—
0
22
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
40
348
1.15
0.35
1.1
1.1
3.13
3.35
u/ml
0.03
23
194
6
44
1.36
0.34
1.3
1.6
—
—
—
0
0
16
128
1.25
0.32
2.1
1.6
—
—
—
0
0
27
230
1.18
0.31
1.4
1.2
—
—
—
0
0
38
336
1.13
0.28
2.2
3.5
4788.77
482.85
u/ml
0.43
33
315
30
342
0.88
0.26
1.9
1.7
—
—
—
0
0
52
572
0.91
0.26
1.7
1.7
8.45
3.65
mg/l
0.95
44
423
29
254
1.14
0.25
1.1
1.1
0.38
3.74
u/ml
3.34
15
132
9
74
1.22
0.25
1.1
1.2
13.33
8.91
mm/h
—
9
74
9
76
1.19
0.24
1.3
1.2
—
80.22
—
0
9
11
87
1.27
0.24
2.1
1.3
12.25
25.42
umol/l
3.38
11
78
192
1839
1.05
0.24
5.6
4.8
31.66
32.09
%
0.21
155
1227
33
295
1.12
0.22
1.1
1.1
0.34
1.13
u/ml
1.28
15
138
5
42
1.19
0.21
3.0
8.0
68.00
71.15
%
—
5
34
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
7
61
1.15
0.17
3.0
2.4
1.42
1.86
ug/l
—
7
56
41
444
0.92
0.17
2.0
1.9
185.24
213.30
pmol/l
0.88
41
420
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
33
305
1.08
0.13
1.1
1.1
5.19
4.98
u/ml
0.03
18
174
24
221
1.09
0.11
1.1
1.0
0.02
0.25
u/ml
—
10
75
10
115
0.87
0.10
2.9
2.1
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
360
3553
1.02
0.09
3.3
3.3
0.91
0.77
ug/l
1.19
252
2369
13
117
1.11
0.08
1.4
1.2
—
—
—
0
0
9
85
1.06
0.07
1.1
1.4
—
—
—
0
0
84
818
1.03
0.07
1.1
1.1
—
0.87
—
0
6
10
109
0.92
0.04
1.3
1.2
—
—
—
0
0
19
180
1.06
0.04
1.1
1.1
—
—
—
0
0
31
299
1.04
0.03
1.1
1.1
0.15
1.58
u/ml
3.91
16
165
44
428
1.03
0.03
1.5
1.5
—
—
—
0
0
56
551
1.02
0.02
1.5
1.4
—
—
—
0
0
38
373
1.02
0.01
1.2
1.3
—
—
—
0
0
12
115
1.04
0.00
1.3
1.4
104.75
85.45
umol/l
0.58
12
115
12
116
1.03
0.00
1.4
1.2
—
—
—
0
0
10
102
0.98
0.00
1.5
1.6
—
—
—
0
0
20
202
0.99
0.00
1.2
1.6
—
—
—
0
0
10
98
1.02
0.00
1.0
1.2
—
—
—
0
0
15
152
0.99
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
2.78
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
26.90
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.01
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
299.40
—
0
5
20
200
1.00
-0.00
1.7
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
8.29
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
75
750
1.00
-0.00
1.4
1.5
20.23
23.36
iu/l
0.46
66
635
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_ABNORMAL_FINDI_EXAMI_URINE_WO_DIAGNOSIS – Abnormal findings on examination of urine, without diagnosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).